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Abstract  
A lack of a simple index that monitors ventilatory efficiency at the bedside has meant 
that oxygenation has been the predominant variable that is used to monitor adequacy 
of ventilatory strategies and disease severity in mechanically ventilated patients. Due 
to complexities in its measurement, deadspace ventilation, the traditional method to 
track ventilatory failure, has failed to become integral in the management of 
mechanically ventilated patients.  
 
Ventilatory ratio (VR) is an easy to calculate index that uses variables measured at the 
bedside: 
  
where  is taken to be 100 ml.kg-1.min-1 based on predicted body weight and 
 is taken to be 5 kPa. Physiological analysis of VR dictates that it is 
influenced by deadspace fraction and CO2 production.  
 
Physiological analysis of VR was validated in a benchside lung model and a high 
fidelity computational cardiopulmonary physiology model. The impact of CO2 
production on VR was investigated in patients undergoing laparoscopic surgery who 
received exogenous intraperitoneal CO2. This showed that delta values of the 2 
variables were linear. The variability of CO2 production was examined in ICU 
patients and results of the study showed that variability of CO2 production was small. 
In an ICU population correlation of VR was stronger with deadspace in comparison to 
CO2 production. Of these two variables, deadspace had the greater effect on VR. 
 
The clinical uses of VR were examined in 4 databases of ICU patients. VR was 
significantly higher in non-survivors compared to survivors. Higher values of VR 
were associated with increased mortality and more ventilator days. A rising values of 
VR over time was also associated with worse outcome.  
 
VR is a simple bedside index that provides clinicians with useful information 
regarding ventilatory efficiency and is associated with outcome.  
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Hypotheses 
Null 1: An index that is a composite of arterial PCO2 and minute ventilation will not 
be responsive to changes in ventilatory efficiency.  
 
Null 2: Higher values and increasing values of such an index will not be associated 
with worsening disease severity in mechanically ventilated patients. 
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Alveolar ventilation is the amount of air per unit time that is involved in gas 
exchange. Ventilatory efficiency describes this volume as a proportion of the tidal 
volume. The remainder of the tidal volume is not involved in gas exchange and is 
conceptually known as the physiological deadspace. Whilst deadspace ventilation is 
probably of minimal consequence in normal conditions, its inherent clinical 
importance is that pathophysiological states of the lung result in its increase and hence 
a reduction in ventilatory efficiency. At the bedside this will manifest as altered 
carbon dioxide clearance. Such pathological processes are common in the critically ill 
and measurement of physiological deadspace should be a most valuable and intuitive 
tool to manage ventilation, yet it is seldom used. 
 
Over the last five decades emphasis in mechanical ventilation has increasingly 
focused on improving oxygenation, whilst avoiding iatrogenic complications. 
Although carbon dioxide measurements are used to guide ventilatory adequacy, most 
ventilatory strategies are aimed primarily at adequate oxygenation. Measurements and 
indices of oxygenation, such as PaO2, SpO2 and PaO2 / FiO2 or Alveolar-arterial 
gradients are frequently utilized to adjust ventilatory settings and aid in clinical 
decision-making (1-4). Whilst attention is paid to minute ventilation, respiratory rate, 
tidal volumes and PaCO2 , there is no common unifying index that can be easily used 
to assess the efficacy of CO2 elimination at the bedside. Especially in an era where 
permissive hypercapnia is widely practiced (5), the development of such an index 
becomes ever more crucial.  
 
The rationale behind the development of Ventilatory Ratio (VR) was to develop an 
easy to calculate index that monitors ventilatory efficiency at the bedside. Prior to the 
description of VR a brief introduction to ventilatory efficiency and use in clinical 
practice is presented. 
 
1.1 Historical Perspective 
The earliest recorded historical evidence of the identification of carbon dioxide is 
attributed to J.B.Van Helmont, a 17th century Flemish physician and chemist. He 
identified carbon dioxide or “gas sylvestre”, a gas seen on burning charcoal (6). In 
doing so he became one of the first chemists to acknowledge the existence of gases 
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that are distinguishable from air. Interest in carbon dioxide however remained low 
until Joseph Black, a Scottish chemist in the mid-eighteenth century, became the first 
person to isolate carbon dioxide in its pure form. In his experiments he isolated 
carbon dioxide and called it ‘fixed air’, describing it as a non-breathable air produced 
by respiration, fermentation, and burning of charcoal (7, 8). In medical practice there 
has been an increased interest in CO2 since the advent of mechanical ventilation and 
more recently with point of care blood gas analysers. In recent years non-invasive 
methods for continuous carbon dioxide measurements at the bedside are also available 
and are regularly used in anaesthesia and critical care medicine. 
 
The importance of carbon dioxide clearance was first appreciated in the Danish polio 
epidemic when clinicians rapidly realised that existing methods such as negative 
pressure ventilation resulted in deaths despite adequate oxygenation. The turning 
point was the realization that most deaths were due to inadequate ventilation (9, 10). 
This led to the birth of positive pressure ventilation, respiratory physiological 
monitoring and with it intensive care medicine. The initial primacy of carbon dioxide 
clearance in monitoring during mechanical ventilation was key. Since then emphasis 
in practice has slowly changed and adequacy of oxygenation has replaced carbon 
dioxide as the principle focus for managing such patients.  Yet the indirect role of 
ventilation in oxygenation is illustrated by the ability to oxygenate by insufflation. 
Carbon dioxide and its clearance has been considered of still lesser importance 
especially with the advent of permissive hypercapnia. This correctly identifies the 
relatively innocuous nature of mild hypercapnia but in doing so obscures the obvious 
fact that hypercarpnia with adequate ventilation implies a significant increase in 
physiological deadspace with or without alterations in shunt. The pathophysiology 
underlying permissive hypercapnia is directly related to the underlying disease 
processes yet it is considered of secondary importance. It is a clinical paradox that 
while the concept of physiological deadspace has been known since the late 19th 
century, in the critical care setting it remains an underused and poorly understood 
variable in clinical practice. 
 
At present measuring physiological dead space is the most widely used method to 
monitor ventilatory efficiency at the bedside. At present this is mostly limited to the 
research setting. Yet despite extensive evidence of its use in mechanically ventilated 
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patients the variable is seldom measured. Examined in this chapter are current 
physiological concepts of deadspace, describe methods of measurement, and describe 
its common uses as a clinical tool in the critical care setting. Also examined are the 
current available methods to assess ventilatory efficiency at the bedside. 
 
1.2 Deadspace Ventilation 
1.2.1 Terminology 
Deadspace is the portion of tidal volume that does not participate in gas exchange i.e. 
‘wasted’. Physiological deadspace (VDphys) is a composed of airway deadspace 
(VDaw) and alveolar deadspace (VDalv): 
 
   VDphys = VDaw + VDalv  [1] 
 
In mechanically ventilated patients airway deadspace (VDaw) is the sum of anatomical 
deadspace (conducting airways) and apparatus deadspace. Alveolar deadspace is a 
construct that accounts for the remainder of the tidal volume that does not participate 
in gas exchange. In normal healthy subjects the alveolar deadspace is expected to be 
negligible. 
 
1.2.2 History of Physiological Deadspace. 
1.2.2.1 Bohr Equation 
Tidal volume (VT) is the sum of alveolar ventilation (VA) and physiological 
deadspace (VD): 
VT = VA + VD   [2] 
In 1891 Bohr made two basic assumption when considering his approach to 
calculating deadspace (11). Firstly a two-lung model was assumed whereby there was 
either gas exchange (alveolar ventilation) or deadspace. The ‘deadspace’ in this 
instance was assumed to be a fixed entity derived from previous cadaveric 
measurements (airway deadspace). Bohr proposed using equation [2] to calculate the 
alveolar volume. He also assumed that there was no carbon dioxide in inspired air. 
Therefore all carbon dioxide measured in mixed expired gas came from alveolar 
ventilation. The latter assumption is used in most current methods used to calculate 
deadspace. 
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Inserting the appropriate fractioned CO2 concentration (F) into each of the three 
volumes in equation [2] and given that the concentration of CO2 in deadspace gas (
) is 0, using the conservation of mass principle equation [2] can be restated as: 
   [3] 
From equation 2 we also know that VA = VT - VD therefore: 
  [4] 
Solving for VD / VT we get: 
   [5] 
where FACO2  is the alveolar fractional concentration of CO2 and FECO2  is the mixed 
expired fractional concentration of CO2. This equation was originally used by Bohr to 
obtain FACO2  and the associated alveolar volume. Equation [5] is commonly known 
as Bohr’s equation. 
 
Since then equation [5] is frequently restated substituting fractioned CO2 
concentration with partial pressures of CO2 (PCO2 ): 
VD
VT
=
PACO2 !PECO2
PACO2
   [6] 
 
Where PACO2 is the alveolar PCO2  and PECO2  is the mixed expired PCO2 . Subsequent 
to the work of Bohr it was recognized that deadspace was a varying entity. The 
introduction of gas analysis allowed the use of expired CO2 as a surrogate for alveolar 
CO2 (12). Mixed expired CO2 was collected in a reservoir bag and thereby enabling 
the calculation of deadspace using equation [6] (13).  
 
1.2.2.2 Enghoff Modification of Bohr’s Equation 
 
One of the limitations of Bohr’s method of calculating deadspace has been accurately 
measuring alveolar PCO2 (PACO2 ). Given the inter-alveoli heterogeneity of ventilation-
perfusion ratio and the uneven emptying of lung units due to varied time constants, 
! 
FDCO2
! 
VT " FECO2 = VA " FACO2
! 
VT " FECO2 = VT # VD( ) " FACO2
! 
VD
VT
=
FACO 2 " FECO 2
FACO 2
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end-tidal CO2 is an inaccurate representation of PACO2 (14). This is especially true in 
the case of diseased lungs where there is increased disparity in the homogeneity of the 
V / Q matching and alveolar emptying. By assuming that there was no difference in 
the values of alveolar PCO2 and arterialPCO2 (PaCO2 ), in 1938 Enghoff modified the 
Bohr deadspace equation by substituting PACO2  with PaCO2 (15).  Accounting for this 
substitution we can restate equation [5]: 
VD
VT
=
PaCO2 !PECO2
PaCO2
   [7] 
Equation [7] is known as the Bohr-Enghoff equation and to this day remains the most 
commonly used method to calculate deadspace using mixed-expired CO2. 
 
1.2.2.3 Fowler’s Airway Deadspace 
Fowler’s novel method was to use continuous nitrogen gas analysis to calculate 
deadspace (16). His subjects inhaled 99.6% oxygen and the expired volume and 
concentration of nitrogen were continuously measured. Fowler defined ‘physiological 
deadspace’ as the volume representing the conducting airways. He described it as the 
point where a large change in the gas composition occurred. Effectively this is the 
volume represented by what we now know as the airway deadspace. Fowler proposed 
analyzing the graph-form of the nitrogen volume-concentration of expired gas to 
calculate the deadspace (Figure 1.1). 
 
 
  
 
 
 
 
Figure 1.1. Fowler’s method of calculating deadspace. The vertical dashed line is drawn such that the 
areas marked A and B are equal. The deadspace volume is represented by the volume where the line 
intercepts the x-axis. A similar waveform can be drawn for expired CO2 concentration. 
 
A 
B 
Nitrogen 
Concentration 
Expired Volume 
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Since then Bartels and colleagues demonstrated that the deadspace for carbon dioxide 
was the same as that of nitrogen and Fowler’s methods could be applied to calculate 
deadspace using single breath analysis of expired CO2 (17).   
 
More recently Langley and colleagues plotted the expired CO2 volume against the 
expired total volume and described an alternative method of calculating airway 
deadspace (18). This curvilinear graph is shown in Figure 1.2. A straight best-fit line 
is extrapolated from the linear portion of the graph and the intercept of this line on the 
volume axis (x-axis) is representative of the deadspace (Figure 1.2). This method 
correlates with Fowler’s method for calculating VDaw but with the added advantage 
that it does not rely on the visual interpretation for determining equal areas (19, 20). 
 
  
 
 
 
 
 
 
 
Figure 1.2. Langley’s method for calculating anatomical deadspace. Plotted is the volume of expired 
CO2 against the volume of expired gas. The dotted line represents the best-fit line of the linear segment 
of the graph. The point of interception of the dotted line on the x-axis represents the airway deadspace 
volume. 
 
While several factors can influence airway deadspace, in the critical care setting this 
volume remains relatively unchanged. Large stepwise changes in airway deadspace in 
mechanically ventilated patients are usually as a result of equipment deadspace and 
hence easily quantifiable. Any changes in measured physiological deadspace, without 
added equipment deadspace, are mostly a result of changes in alveolar deadspace. It is 
alveolar deadspace and the inherent interaction with physiological deadspace that is 
clearly most important clinically. 
 
 
Expired 
volume of gas 
(ml) VDaw 
Expired 
volume of CO2 
(ml) 
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1.3 Single Breath Test for Carbon Dioxide 
 
The CO2 single breath test (SBT-CO2) of volumetric capnography can used to extract 
useful information about ventilatory efficiency. Breath-by-breath analysis of expired 
CO2 concentrations plotted against the total expired volume allows for meaningful 
calculations of the area under the graph. The volumetric SBT-CO2 expirogram can be 
divided into three phases (Figure 1.3). Phase I is the volume of gas that is in the 
airway (and the apparatus volume in ventilated patients). Phase II is composed of gas 
from the terminal airways and from the alveoli with the shortest transit times. Phase 
III is also known as the alveolar plateau and represents majority of the alveolar 
emptying.  
 
  
 
 
 
 
 
 
Figure 1.3. Volumetric CO2 expirogram. Description of the 3 phases. Phase I is composed of the 
volume in the conducting airways and equipment. Phase II is the volume terminal broncioles and the 
alveoli with the shortest transit times. Phase III represents alveolar emptying.  
 
 
The slopes of phase II and III can impart useful information on visual analysis. A flat 
alveolar plateau (phase III) would be indicative of homogenous lung emptying. 
Conversely an expirogram with an alveolar plateau with a steep continuous gradient 
represents heterogeneity in alveolar emptying. This is frequently encountered in 
diseased lung states. Inhomogeneity in alveolar emptying could either result from 
within the alveolar units where in the more distal alveoli there is likely to be lower 
ventilation-perfusion !V !Q  ratio or due to inter-unit heterogeneity (14).  
 
Fletcher further analyzed the SBT-CO2 and gave a detailed proposal of measuring the 
various parts that contribute to physiological deadspace (21, 22). Figure 1.4 shows 
Phase I Phase II Phase III 
Expired CO2 
concentration 
(%) 
Expired volume 
of gas (ml) 
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that the area under the graph (x) is the volume of CO2 eliminated in a breath. The area 
ABCDA describes the maximum (hypothetical) volume of gas that could be excreted 
in the breath. ‘Efficiency’ which is the portion of volume participating in gas 
exchange is described as: 
 
   Efficiency =    [8] 
 
1 - efficiency represents the same fraction as deadspace. Therefore ‘E’ or efficiency 
can be restated as a product of more familiar terms: 
 
   E = 
!VA
!VE
=1!VDVT
 = EfficiencyFletcher [9] 
 
Where !VA  represents the alveolar volume (ml) and !VE  represents minute ventilation 
(ml). 
  
 
 
 
  
 
 
 
 
 
Figure 1.4. SBT-CO2 demonstrating the fraction of ‘efficiency’. The shaded area X represents the 
volume of CO2 eliminated. The area ABCDA represents the potential maximum volume of elimination. 
 
In diseased lungs where there is significant !V !Q  mismatch the peak PCO2  of the 
alveolar plateau seldom equals alveolar PCO2  or arterial PCO2 . Fletcher proposed 
using this discrepancy to calculate the alveolar deadspace.  As shown in Figure 1.5A a 
horizontal line is drawn from the point on the y-axis that represents the arterial PCO2 . 
As per Fowler’s method a vertical line is drawn to elicit equal areas p and q. Area X 
! 
X
ABCDA
A 
B C 
D 
Expired 
volume of 
gas (ml) 
Expired CO2 
concentration 
(%) 
X 
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once again represents the volume of CO2 eliminated, area Y represents the VDalv and 
area Z represents VDaw.  
 
 
Therefore from the analysis we can deduce that anatomical deadspace fraction is: 
    
      [10] 
 
alveolar deadspace fraction is: 
      [11] 
 
and physiological deadspace can be defined as: 
    [12]  
  
! 
VDaw
VT
=
Z
X + Y + Z
! 
VDalv
VT
=
Y
X + Y + Z
! 
VDphys
VT
=
Y + Z
X + Y + Z
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A.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5(A). Components of SBT-CO2 expirogram as described by Fletcher. Area X represents the 
CO2 elimination volume, area Y is the alveolar deadspace volume, and area Z is the airway deadspace 
volume, where areas p and q are equal. 1.5(B) Shows the SBT-CO2 expirogram for a mechanically 
ventilated patient undergoing elective surgery. 1.5(C) Shows the SBT-CO2 expirogram for a 
mechanically ventilated patient with COPD admitted to intensive care, the slope of phase III is steeper. 
1.5(D) shows SBT-CO2 expirogram of a mechanically ventilated patient with ARDS, the transition 
between phase II and phase III is harder to define. 
 
SBT-CO2 deadspace calculations have been validated against the VDBohr  in both 
animal models and humans (23, 24). There are several advantages to using volumetric 
B. Elective Surgery Vd/Vt 0.37
0 200 400 600
0
2
4
6
8
Phase I Phase II Phase III
EtCO2 [KPa]
PaCO2
VCO2 [ml.min
-1]
C. COPD Vd/Vt 0.6
0 200 400 600
0
2
4
6
8EtCO2 [KPa]
PaCO2
Phase I Phase II Phase III
Expired Tidal Volume [mls]
D. ARDS Patient Vd/Vt .88
0 200 400 600
0
2
4
6
8
EtCO2 [KPa]
PaCO2
Phase I
Expired Tidal Volume [mls]
p 
Z 
q 
VDaw VTalv 
VT 
X 
Ex
pi
re
d 
C
O
2 c
on
ce
nt
ra
tio
n 
(%
) 
ET
  C
O
2 
A
rte
ria
l  
C
O
2 
Expired volume 
of gas (ml) 
Y 
 
26 
capnography (SBT-CO2) over the Douglas bag method for measuring deadspace in 
mechanically ventilated patients. Collecting mixed expired gas in a Douglas bag is 
subject to inherent accuracies due to gas compression predominantly within the 
ventilator circuit (25, 26). On expiration this compressed gas will dilute the mixed 
expired CO2 concentration in the bag, and therefore lower the measured PECO2 , 
resulting in falsely elevated physiological deadspace. Volumetric capnography 
measures the expired CO2 closer to the endotracheal tube and therefore the 
measurements do not require a correction factor accounting for the gas compression 
in the ventilator circuit. Additionally volumetric capnography provides breath-to-
breath analysis of the CO2 capnograph and enables frequent assessment of deadspace 
changes. 
 
Although recent developments in both software and capnography have made this 
method more accessible there continue to be technical difficulties in its use. These 
include adequate capturing of the waveform and differentiating between phase II and 
phase III of the curve especially when tidal volumes are small and gradient of phase 
III is steep (27). Crucial to its utility is the definition of the transition point between 
phase II and phase III. Yet whether defined visually or calculated mathematically this 
point remains arbitrary and can be ambiguous (24). Currently the software 
programme Analysis Plus! calculates the slope of phase by least square regression 
analysis of all the data points between 50% - 70% of the CO2 expirogram as plotted 
against volume. Paradoxically as deadspace volume increases the reliability of the 
method is further compromised. 
 
To overcome these shortcomings Romero et al used the SBT-CO2 to propose an 
alternative method to analyse ventilatory efficiency. This moves away from the visual 
description of the transition from phase II to phase III. Instead as in Figure 1.2, they 
plot the expired volume of CO2 against the expired tidal volume to describe the term 
alveolar ejection volume (VAE) as the predicted point on the !VCO2  curve where 
alveolar emptying begins. This volume attempts quantification of the phase III of the 
slope.  The alveolar ejection volume versus tidal volume ratio (VAE/Vt) (28) is an 
index that monitors alveolar heterogeneity and has been shown to correlate with 
severity of lung diseases as well as being a useful predictor of outcome (29, 30).  
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Limitations of this index as a clinical tool include the requirement of relatively simple 
software to calculate (30) the values and that it is not a previously described 
physiological term. 
 
More recently Tusman and colleagues have used the mid-point of phase III slope to 
describe the point most likely to represent PACO2 . There are several potential 
advantages to this technique. Firstly, ability to obtain PACO2  allows us to estimate true 
Bohr deadspace. Secondly, it would also allow a non-invasive method of calculating 
deadspace. The method to estimate PACO2  and to calculate VD/VT Bohr has been 
validated using Multiple inert gas elimination technique (MIGET) in porcine model 
with excellent correlation with volumetric capnography. There are issues with the 
method. The problem of estimating slope of phase III remains. In addition the concept 
of Bohr-Enghoff dead space and idea of “shunt deadspace” and its clinical value is 
lost from the method. 
 
1.4 Concepts in Deadspace 
1.4.1 Ventilation-Perfusion Mismatch 
Physiological deadspace is a marriage of a tangible anatomical entity and an 
intangible physiological function that cannot be directly measured. Our understanding 
of deadspace and shunt has been largely influenced by the three-lung model as 
proposed by Riley and Cournand (31, 32). In this proposed model there are three 
compartments: 
 
 a) The first compartment is both ventilated and perfused. This is the most efficient 
compartment.  
b) The second compartment lacks in ventilation and hence the blood supply to this 
compartment contributes to shunt. 
c) The final compartment is ventilated but is lacking in perfusion.  
 
This model only defines three isolated points across a broad spectrum of ventilation 
and perfusion matching. In reality all factors that cause inequality of !V !Q  mismatch 
will contribute to deadspace ventilation. Not all alveoli contributing to physiological 
deadspace are completely devoid of perfusion. Alveolar units with excess ventilation 
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relative to perfusion will contribute to deadspace. Diseases such as chronic 
obstructive pulmonary disease or pulmonary fibrosis cause an increase in !V !Q  
mismatch due to defective alveolar gas mixing and inequalities in regional gas 
distribution (33-35). Consequently there is heterogeneous !V !Q  distribution within 
lung units and the entire lungs. Depending on the nature and severity of the pathology 
the levels of !V !Q mismatch can be vastly varied.  
 
1.4.2 Shunt and Physiological Deadspace 
 
The Bohr-Enghoff equation calculates physiological deadspace using the difference 
between the arterial and mixed-expired CO2, so any factor that influences Arterial 
PCO2 will result in altered physiological deadspace. Therefore physiological deadspace 
is influenced by shunt.  If the PCO2 of the venous admixture is large enough and the 
lung compensatory mechanisms are overwhelmed, the resultant elevation of arterial 
PCO2 would increase the calculated physiological (Bohr-Enghoff) deadspace (22, 36). 
Consequently physiological deadspace is not only influenced by a high !V !Q  but also 
by a low !V !Q . 
 
The influence of shunt on deadspace is non-linear. PaCO2 and consequently 
physiological deadspace is only affected in disease processes that result in large shunt. 
At shunt fractions ( !QS !QT ) of 0.2 the influence of shunt on PaCO2  is negligible (37). 
Due to the nature of the variables involved it is very difficult to directly measure the 
influence of shunt on physiological deadspace. Figure 1.6 shows the effects of shunt 
on PaCO2  and hence Enghoff’s modification of deadspace in a high-fidelity computer 
model (38). Shunt fractions of greater than 0.5 shows a rapid increase in physiological 
deadspace (36, 39).  
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Figure 1.6. Recreation of the relationship of pulmonary shunt and PaCO2  as proposed by a 
computerized model by Tang and colleagues (38). 
 
Although shunt plays a role in increasing physiological deadspace, alveolar deadspace 
has a much more profound impact on CO2 elimination as illustrated by Figure 1.7 
(40). Even though the contributions of shunt to alveolar deadspace are not strictly 
“deadspace”, it none-the-less represents an abnormality in gas exchange (CO2 
elimination) and a pointer to abnormal pathology. 
 
 
Figure 1.7A and 1.7B.  Comparison of the relative effects of shunt (1.7A) and  (1.7B) mismatch 
on calculated physiological deadspace. Log SDQ, second moment (dispersion) of the 
ventilation/perfusion distribution on a log scale. Figure recreated with permission from Wagner (40). 
Where Log SDQ is second moment (dispersion) of the ventilation/perfusion distribution on a log scale. 
 
Pathological processes can alter measured physiological deadspace in many ways. For 
example in mechanically ventilated patients with severe acute respiratory distress 
syndrome (ARDS), increased deadspace can result from increased alveolar deadspace 
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as the tidal volume is distributed to poorly or non-perfused parts of the lungs. Over-
distension of segments of the lung that are functioning normally either as a 
manifestation of using high peak end expiratory pressure (PEEP) or due to the use of 
high tidal volumes / ventilatory pressures would result in areas of relatively high 
!V !Q which would also increase the deadspace fraction. Another frequently 
encountered pathological feature in ARDS is the presence of microemboli that can 
further result in !V !Q  abnormalities. This is supported by the randomized control trial 
in which the use of activated protein C resulted in an associated improvement in 
physiological deadspace in patients with acute lung injury (41). Elsewhere the ratio of 
angiopoietin 2 and 1, indicators of endothelial damage, have been shown to have a 
prognostic association with dead space fraction which may also suggest another 
pathophysiological mechanism (42). Additionally, as the severity of illness increases 
the level of intra-pulmonary shunt increases, which would further contribute to the 
deadspace fraction. Theoretically a drop in cardiac output and a resultant drop in the 
pulmonary perfusion pressures could also contribute to raising the !V !Q  ratio. In these 
situations positive pressure ventilation itself may actively redistribute ventilation 
according to local compliance and radically alter !V !Q  ratio.  
 
1.4.3 Goal Standard Measurement 
 
As discussed previously the spectrum of gas exchange within an alveoli ranges from 
!V !Q = 0 (shunt) to !V !Q  = ∞ (dead space). Heterogeneity between alveolar units is 
what dictates the overall !V !Q  state of the lungs. Multiple inert gas elimination 
technique (MIGET) uses simultaneous expired measurements of 6 intravenously 
infused inert gases to compute the ventilation-perfusion state of the lungs. The 
method uses principles of mass conservation. 6 inert gases with varying spectrum of 
blood-gas partition coefficients are used to map the ventilation-perfusion 
heterogeneity within the lungs. Following slow infusion of six inert gases (acetone, 
cyclopropane, enflurane, ethane, ether, SF6), partial pressures measurements are 
made of the gases in systemic arterial, pulmonary arterial (or mixed venous), and 
mixed expired samples.  
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Measurements of these samples alongside measurements for ventilation data, cardiac 
output, temperature, inspired gas concentrations, blood gas measurements and 
calculated partition coefficients are inputted into a software programme.  These are 
values are then used to compute the ventilation-perfusion distribution of the lungs. 
Data derived from this is more informative than using just PCO2 and O2 measurements. 
Whilst there may be several individual unit of varying inhomogeneity it is assumed 
that using six gases with varying partition coefficients will provide a reasonable 
reflection of !V !Q  distribution (43).  
 
There are several limitations to this technique such as the requirement of a steady 
state. The technique is difficult to execute with considerable user variation in 
experimentation and interpretation of results (43). Despite these shortcomings 
MIGET is widely considered as the most robust tool to measure !V !Q  mismatch. 
 
1.5  Deadspace Measurement in Critical Care  
In the critical care setting carbon dioxide clearance or ventilatory efficiency is 
influenced by a limited number of factors which include ventilation, perfusion and to 
a lesser extent CO2 production. This contrasts with indices of oxygenation which are 
determined by numerous factors that are both intrinsic (pathological) and extrinsic 
(physics) to the body. These factors are frequently independent of ventilation. Studies 
on Mount Everest with impressively low oxygen indices in exercising climbers (44, 
45) clearly demonstrate that the relationship of oxygenation to clinical well-being is 
relatively indirect. Nevertheless oxygenation continues to be used as the primary tool 
for the initiation and structuring of ventilatory strategies (3). This may partly be due 
to the key but weak association between commonly used indices of oxygenation and 
survival (46). Equally important is that it is not conventional practice to be guided by 
deadspace either whilst describing or monitoring the severity of pulmonary failure. It 
may be argued that whilst describing conditions such as such as ARDS it would be 
more relevant to also incorporate ventilatory efficiency for categorizing disease 
severity. As this is in effect unexplored, there is a reasonable reluctance amongst 
clinicians to use this most relevant of parameters.  
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Recently there has been a resurgence in interest in using deadspace measurements and 
in particular using SBT-CO2 in the clinical setting. Yet given the potential usefulness 
of ventilatory efficiency / deadspace the reasons for its absence deserve explanation: 
 
1. The methods to calculate deadspace as described above are either the time 
honoured but cumbersome (Douglas bag) or expensive and ancillary (volumetric 
capnography) (47). There are some reliable automated commercially available 
methods of measuring deadspace, few are fully integrated into standard monitoring 
systems (see Table 1.1). 
  
2. As it is seldom measured there is a lack of clinical familiarity with the 
measurement and a therefore natural tendency to continue with a standard approach 
based on oxygenation.  
 
3. Similarly there is a paucity of information regarding interventions that directly 
manipulate deadspace and hence an assumption that it is of limited value.  
  
4.  As it is rarely measured there are very few large studies describing its behaviour in 
critically unwell patients and its true value as a clinical tool has yet to be evaluated. 
 
Device Description 
CO2SMO® Capnograph 
Novametrix Medical Systems  
Stand-alone. Volumetric capnography. Breath-by-breath 
analysis of !VCO2 , VD aw, and other respiratory parameters. 
VD phys on entering PaCO2 . 
NICO®2 Respiratory Profile Monitor 
Novametrix Medical Systems 
Stand-alone. Volumetric capnography. Breath-by-breath 
analysis of !VCO2 , VD aw, and other respiratory parameters. 
VD phys on entering PaCO2 . Second generation. 
Evita® XL Ventilator 
Draeger Medical, Inc 
Integrated into the ventilator. Volumetric capnography. 
Calculates !VCO2 . Displays PECO2  and VD/VT phys. Optional 
extra. 
Hamilton G5 Ventilator 
Hamilton Medical AG 
Integrated into the ventilator. Volumetric capnography. 
Displays !VCO2 . The PECO2  can then be calculated and thus 
VD/VT phys. Calculates VD aw. Optional extra. 
Table 1.1 Some of the devices that are commercially available in Europe that measure dead space using 
volumetric capnography. 
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1.6 Indices of Ventilatory Efficiency  
Recently there has been increasing interest in developing more simple ‘user-friendly’ 
indices to monitor changes in ventilatory efficiency at the bedside. These are 
summarized in table 2. All the indices use variables measured at the bedside and 
broadly fall into 2 main categories. The first uses complex calculations to predict 
numerical values for VD/VT. Unfortunately some of the assumed values inherent to 
either the method of derivation or the proposed calculations will inevitably lead to 
inaccuracies. The second do not offer explicit quantification of deadspace but rather 
look at tracking ventilatory efficiency using bedside variables. The latter whilst easier 
to reproduce and calculate would be subject to similar inaccuracies.  
 
Most of these methods have yet to be adequately validated. The bedside method 
proposed by Siddiki et al uses the alveolar gas equation to estimate VD/VT (48). In 
order to obtain quantitative values of VD/VT they have used the Harris-Benedict 
equation to estimate values of !VCO2  for a given patient. The Harris-Benedict 
equation is not only complex to calculate but also has been shown to be unreliable in 
the critical care setting(49, 50). This brings into question the validity of the VD/VT 
values extracted from the equation.  
 
An alternative approach from Frankenfield et al uses regression analysis to derive a 
predictive equation to estimate VD/VT. The equation has been validated for patients in 
steady state with an FiO2 < 0.6. Although there is good correlation between measured 
and calculated values of VD/VT, this remains validated in a very small select group of 
patients. The difference between arterial and end-tidal ( PaCO2 !ETCO2 ) has been 
proposed to be used to either predict VDalv/VT using (51) or  to track changes in 
VDalv/VT (52). Once again neither methods have been validated in patients. 
Conceptually using ETCO2  as a tool to monitor deadspace is likely to lead to 
inaccuracies due to its dependence on the ventilatory patterns and tidal volumes.  
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 Hardman JG, 
Aitkenhead AR (2003)  
(52) 
Frankfield DC, Alam 
S, et al (2010)  (54) 
Siddiki H, Kojicic, M 
et al (2010)  (48) 
Index Pa ! eCO2 / PaCO2   
Arterial-end-tidal CO2 
gradient is divided by 
arterial PCO2 as a 
measurement to track 
(VDalv/VT) Bohr-Enghoff at the 
bedside. 
 
VD/VT = 0.32 + 0. 0106 
( PaCO2  – ETCO2 ) + 0. 
003 (RR) + 0.0015 
(age) 
VD/VT = 1- [(0.86 x 
!VCO2est )/( !VE  x PaCO2
). 
!VCO2est  is the 
estimated CO2 
production calculated 
from the Harris-
Benedict equation and 
0.863 is a correction 
constant. 
Derivation / 
Validation 
Nunn and Hill first 
described the relationship 
of Pa-ÉCO2 and alveolar 
deadspace (53). Authors 
calculated (VDalv/VT) Bohr-
Enghoff and Pa ! eCO2 /
PaCO2  whilst altering 
variables in a 
computational 
physiological model. 
Linear relationship 
between the 2 fractions is 
demonstrated. 
 
Regression analysis 
used to derive a 
predictive equation for 
VD/VT. Measurements 
of ventilatory and 
clinical variables were 
made in 135 patients. 
Respiratory rate, 
PaCO2 !ETCO2 , and 
age were factors that 
significantly influenced 
VD/VT. Measured 
VD/VT was validated 
against estimated 
VD/VT for that 
population. 
Uses the alveolar gas 
equation to solve for 
VD/VT. 
 
Uses the Harris-
Benedict equation to 
estimate !VCO2 . 
 
 
Advantages - Easy to calculate at the 
bedside 
- Negates the influence of 
airway deadspace 
- Stable under various 
conditions 
- Quantitative value for 
VD/VT 
- Calculated using 
values at the bedside.  
- Quantitative value for 
VD/VT 
- Can be calculated at 
the bedside 
- Equation in 
physiologically 
intuitive 
Disadvantages - Untested in clinical / 
animal setting 
- No evident physiological 
derivation 
- No clinical data available 
- Not quantitative 
- Derived from 
measured values. 
- Not intuitive. 
- Not tested in varying 
clinical conditions. 
- Not tested in patient 
with FiO2 > 0.6 
- Not validated against 
measured VD/VT 
- Harris-Benedict 
equation is unreliable  
- Equation unreliable in 
unsteady state 
- Complicated to 
calculate 
 
  Table 1.2. Description of bedside indices to monitor ventilatory efficiency
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1.7  Deadspace as a Clinical Tool 
In the critical care setting there are diverse but isolated examples of deadspace 
measurements being used as a clinical tool. In pulmonary embolism deadspace-tidal 
volume fraction in conjunction with D-Dimer assays, has been shown to be of 
diagnostic value (55-57). Deadspace fraction has also been used to predict likelihood 
of successful extubation in paediatric patients (58). It would seem likely that from 
first principles monitoring ventilatory efficiency could play a vital role in weaning 
and prediction of extubation. The negative impact of rising deadspace on weaning has 
been demonstrated in the neonatal population (59). Although these population groups 
are distinct from adults, the pathophysiological principles that result in difficult 
weaning stand true in all populations. Currently the most widely used index to predict 
successful weaning is the frequency-tidal volume ratio and it focuses on the 
endurance of breathing (60). This index is simple to calculate and shows high 
sensitivity but has low specificity. It does not incorporate the corresponding 
efficiency of CO2 elimination. A combination of the work of breathing and ventilatory 
efficiency would in theory provide a more refined index to predict successful 
weaning. Studies have demonstrated the superiority of such combined indices in small 
groups of patients resulting in increased specificity as compared to f / VT (61, 62). 
Larger studies are needed to explore the advantages of using a combined index that 
intuitively appears to offer a more comprehensive evaluation of the pathophysiology 
of weaning failure.  
 
Deadspace measurements have been used to assess the impact of varying PEEP on 
carbon dioxide elimination and to determine the optimum levels of PEEP during lung 
recruitment (63, 64). The SBT-CO2 has been used to study the effects of PEEP on the 
2 individual components of deadspace (VDaw and VDalv) in patients with acute lung 
injury (65). This showed that there was no uniform response to PEEP.  
 
In animal studies it has been shown that deadspace is highly specific and sensitive in 
monitoring lung collapse (66). In these studies the lungs use a surfactant-depleted 
model and show large changes with recruitment techniques. This contrasts with the 
findings in adults with acute lung injury where recruitment is far less effective and 
excessive PEEP may exert a negative influence on V/Q matching secondary to over-
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distension (67). Nevertheless lung recruitment manoeuvres have been evaluated using 
deadspace fraction or ventilatory efficiency.(68-70). It appears to be a more useful 
means of assessing the efficacy of recruitment than using indices of oxygenation (71).  
 
1.7.1 Deadspace and ARDS 
Perhaps of greatest interest and relevance in the critical care setting is the utility of 
deadspace measurements in the context of ARDS, and modes of ventilation. In 
patients with ARDS a range of pathophysiological mechanisms increase ventilatory 
inefficiency. Hence as one might anticipate deadspace measurements have been 
shown to be a useful prognostic marker for patients with ARDS. This has been clearly 
demonstrated in several studies where non-survivors have been shown to have a 
significantly higher deadspace ratio than survivors (48, 72-74). Similarly using a 
measurement of ventilatory efficiency, VAE/VT, has been shown to be a useful 
predictor of outcome in patients with lung injury (30). The timing and the magnitude 
of the deadspace abnormality have also been shown to predict the clinical outcome in 
patients with lung injury. While prognostic indicators have their place, measurements 
that allow both monitoring and manipulation of ventilatory management have more 
immediate clinical usefulness. Kallet and colleagues demonstrated that serial 
measurements of deadspace could be used to monitor disease progression in ARDS 
(75, 76). Others have demonstrated its use for monitor manoeuvres such as prone 
positioning that are designed to improve gas exchange (77, 78). Patients with ARDS 
that demonstrate a decrease in arterial PCO2  i.e. increased ventilatory efficiency on 
prone-positioning have shown improved survival compared to those patients that 
show no improvement in arterial PCO2 (79). Clearly measurement of ventilatory 
efficiency has a potential role in the management of ventilation. 
 
There is more recently, linkage between prognosis and potential pathophysiological 
mechanisms underlying deadspace changes. Ong and colleagues have demonstrated a 
prognostic association between dead space fraction and the ratio of angiopoietin 2 and 
1, which are proposed markers of endothelial damage. The interaction between 
deadspace and pulmonary capillary perfusion is clearly important and this may prove 
an exciting and fruitful new direction for clinical study (42).   
 
 
37 
1.8 Ventilatory ‘Efficiency’ 
In the rapidly evolving field of ventilatory management where modalities such as 
extracorporeal membrane CO2 removal and high frequency oscillatory ventilation are 
becoming increasing prevalent, a fresh look at our methods of monitoring gas 
exchange in ventilated patients is essential. CO2 clearance is a crucial part of these 
strategies and needs to be monitored. Routine monitoring of ventilatory efficiency 
could lead to more appropriate diagnostic categorization of respiratory failure in terms 
of CO2 clearance rather than just oxygenation. This may in turn be helpful in earlier 
instigation of these novel therapies. Additionally monitoring efficiency of CO2 
clearance during treatment could aide in the management of the finer aspects of 
extracorporeal membrane CO2 removal such as assessing device efficacy and 
deciding the timeliness of return to more conventional ventilation.  
 
The two common themes in these reports across a spectrum of clinical activity are 
that potential usefulness has been demonstrated but to date investigation and 
application of these measurements are very limited. That should in itself be enough to 
stimulate interest across other areas of clinical practice.  
 
1.8.1 A Novel Index 
It stands to reason that development of an index that is easy to calculate and reflect 
changes in ventilatory efficiency would be a marker of disease severity. In particular 
this should be true in patients with respiratory failure. Given the association of 
pathophysiological processes with deadspace one would anticipate that an increase in 
such an index would be suggestive of worsening lung pathology. Such a tool could 
also perhaps be able to re-categorise patients with ARDS according to disease 
severity.  
 
In the following chapters we describe such a ratio called “Ventilatory Ratio”. We then 
examine the physiological properties of VR in benchside and in silico lung model. 
The factors influencing VR are then examined in mechanically ventilated patients. 
Finally the clinical value of VR is examined in an ICU population. 
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1.9 Null Hypotheses 
 
Null 1: An index that is a composite of arterial PCO2 and minute ventilation 
will not be responsive to changes in ventilatory efficiency.  
 
Null 2: Higher values and increasing values of such an index will not be 
associated with worsening disease severity in mechanically ventilated patients. 
 
The next chapter defines Ventilatory Ratio and examines its physiological properties.  
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Chapter 2: Ventilatory Ratio: Definition and 
Analysis 
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In this chapter Ventilatory Ratio is defined. This is followed by physiological analysis 
of Ventilatory Ratio and subsequent mathematical analysis of the proposed 
physiological properties of VR. 
 
We define the Ventilatory Ratio as:  
    [13]  
Where !VEmeasured  is taken to be 100 ml.kg-1.min-1 based on predicted body weight and 
PaCO2 predicted  is taken to be 5 kPa.  
 
2.1 Physiological Analysis 
 
At steady state, carbon dioxide production and alveolar ventilation are the 
determinants of PaCO2 . Alveolar ventilation is a variable fraction of minute 
ventilation (about two thirds in fit unanaesthetised individuals), the remaining fraction 
being physiological deadspace ventilation. 
 
VR can be analyzed in terms of carbon dioxide production and the fraction of minute 
ventilation that is alveolar ventilation, as follows: 
 
Firstly, 
!VCO2 = !VA !FACO2    [14] 
and  
FACO2 =
PACO2
PB
   [15] 
where PB is the barometric pressure. Equation [15] may be substituted into [14] and 
rearranged: 
PACO2 =
!VCO2
!VA
!PB    [16]   
Assuming, 
   [17] 
predictedCOpredicted
measuredCOmeasured
aE
aE
PV
PV
VR
2
2
!
!
= !
!
! 
PaCO2 " PACO2
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Equation [17] may be restated for PaCO2 : 
PaCO2 =
!VCO2
!VA
!PB    [18] 
This is a restatement of standard concepts in respiratory physiology and the 
assumptions made in the derivation of the terms are conventional. 
 
Secondly, it is helpful to have a way of speaking about alveolar ventilation as a 
fraction of minute ventilation.  We call this the “ventilatory efficiency”, E: 
 E =
!VA
!VE
   [19] 
From which 
 !VE =
!VA
E               [20] 
Equation [21] demonstrates the relationship of ventilatory efficiency to the more 
usually considered deadspace ventilation: 
 
  [21] 
 
(although the right hand side of equation [21] is not required for our purposes). 
 
Thirdly, the concept of “actual” and “predicted” carbon dioxide production and 
ventilatory efficiency is required.  Measured minute ventilation and arterial carbon 
dioxide will be dependent upon actual carbon dioxide production and ventilatory 
efficiency.  Equations [19] and [21] can be applied to these concepts as follows: 
 
PaCO2measured =
!VCO2actual
!VAactual
  and   !VEactual =
!VAactual
Eactual
  [22] 
and 
PaCO2 predicted =
!VCO2 predicted
!VApredicted
  and   !VEpredicted =
!VApredicted
Epredicted
  [23] 
Finally, the right hand sides of the two pairs of equations ([22] and [23]) are 
substituted into [13], the definition of VR, and the result simplified: 
E
D
E
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A
V
V
V
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!
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VR =
!VCO2actual
Eactual
!
Epredicted
!VCO2 predicted
     [24]  
 
This is more conveniently rearranged to give: 
 
VR =
!VCO2actual
!VCO2 predicted
!
Epredicted
Eactual
   [25] 
   
Inspection of equation [25] shows that VR is governed by carbon dioxide production 
and ventilatory efficiency in a logically intuitive way.  VR is a dimensionless 
numerical value. Where predicted values match actual values, as in normal 
individuals, the range of VR will be distributed around unity. When considering 
dynamic changes, a rising VR represents rising carbon dioxide production, or 
decreasing ventilatory efficiency or both.  Conversely a falling VR represents falling 
carbon dioxide production, or increasing ventilatory efficiency or both. Provided the 
other variable remains constant, VR has linear relationship with both PaCO2  and . 
Similarly, VR would have a linear relationship to respiratory rate and tidal volume, 
provided the other variable remains constant. As the ratio is dependent on minute 
ventilation and PaCO2 , any alterations in ventilatory settings that result in a change in 
VR, would either be due to changes in alveolar ventilation or a significant change in 
the CO2 production. Figure 2.1 shows the hyperbolic relationship of minute 
ventilation and PaCO2  as predicted by Equation 14. In the model when VR is higher a 
given change in minute ventilation would have a more profound impact on PaCO2 . 
This would mimic physiological response of the body. When ventilatory demands of 
the body are high (i.e. high VR) smaller changes in ventilation would have a more 
profound impact on CO2 elimination. 
  
EV!
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Figure 2.1. PaCO2  plotted against minute ventilation for values obtained by equation 1 in a 70 Kg 
patient. The isopleths represent the relationship of the 2 varibles with VR values ranging from 1-4.  
 
 
2.2 Rationale for Predicted Values 
In order to calculate VR we must first calculate the predicted values. 
 
For the predicted value of minute ventilation we are using 100 ml.Kg-1.min-1.  This 
value is extracted from population nomograms from anaesthesic practice (80-82). For 
predicted body weight (PBW) we have used the ARDSnet predicted body weight 
calculator. PBW (Kg) is calculated using the formula 50 + 0.91(centimeters of height 
– 152.4) for males, and 45.5 + 0.91(centimeters of height – 152.4) for females(83). 
The ideal value used for PaCO2 is 5 kPa. Because the range of PaCO2 values in healthy 
individuals is narrow, we have used a value that lies close to the mean to represent the 
predicted PaCO2 . The predicted values used to calculate VR are to an extent arbitrary 
and it may lead to a degree of inaccuracy. Paramount to the development of VR as a 
clinical tool however is the concept of keeping it calculations simple. 
 
For clinical application at the bedside VR can be restated in a user-friendly form by 
the insertion of the above mentioned predicted values into Equation [13]: 
 
5100
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This can further simplified to state VR in its simplest form: 
 
VR =
!VE (ml.min!1)"PaCO2 (kPa)
500"PBW    [27] 
 
2.3 Mathematical Analysis of Ventilatory Ratio 
Stated first is VR are described in its original form in Equation 13: 
predictedCOpredicted
measuredCOmeasured
aE
aE
PV
PV
VR
2
2
!
!
= !
!
   [13] 
For any given individual the denominator will always remain constant. Therefore the 
values for VR will vary according to changes in either minute ventilation, PaCO2 , or 
both. Table 2.1a and 2.1b shows the relationship of VR in a 70 Kg individual with 
varying values of PaCO2  and !VE  respectively whilst the other variable remains 
constant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1a and 2.1b Show values of VR in a 70 kg individual. Table 2.1aPaCO2  varies whilst minute 
ventilation is constant at 7000 ml.min-1. Table 2.1b Varying minute volume with constant PaCO2  of 5. 
 
 Table 2.1a 
PaCO2  (kPa) VR 
2.0 0.4 
3.0 0.6 
4.0 0.8 
5.0 1.0 
7.5 1.5 
10.0 2.0 
12.5 2.5 
15.0 3.0 
17.5 3.5 
20.0 4.0 
Table 2.1b 
!VE ( ml.min-1) VR 
3000 0.429 
5000 0.714 
7000 1.0 
10000 1.429 
12500 1.786 
15000 2.143 
17500 2.5 
20000 2.857 
22500 3.214 
25000 3.571 
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Individually both PaCO2  and minute ventilation share a linear relationship with VR 
when the other variable remains constant (Figures 2.2A and 2.2B). This would be 
expected because the variables are compared against a preset standard rather than 
other physiological parameters. The relationship of minute ventilation and PaCO2  as 
illustrated in Figure 2.1 is an intimate one. Minute ventilation or more specifically 
alveolar ventilation exerts the greatest influence on the levels of 
! 
PAco2 and PaCO2 . 
However as a mathematical entity VR is not reliant on the influence of the variable on 
one another. Changes in VR are a composite of the accumulative deviation from our 
preset ideal PaCO2  and minute ventilation.  
 
  
Figure 2 Relationship of Ventilatory Ratio with PaCO2  and minute ventilation in 70 Kg individual. 
Figure 2A represents VR versus minute ventilation when PaCO2  is constant at 5 KPa. Figure 2B 
relationship of VR with varyingPaCO2  whilst minute ventilation is 7000 ml.min-1. 
 
 
 
 
 
 
 
 
 
 
Table 2.2 VR values at varying levels of PaCO2  and varying rates of minute ventilation. The VR 
values are in bold. 
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! 
Paco2  Minute Ventilation 
 3000 5000 7000 10000 12500 14000 17500 21000 
3.0 0.257 0.429 0.6 0.9 1.071 1.2 1.5 1.8 
5.0 0.429 0.714 1 1.5 1.786 2 2.5 3 
7.5 0.643 1.071 1.5 2.25 2.679 3 3.75 4.5 
10 0.857 1.429 2 3 3.571 4 5 6 
12.5 1.071 1.786 2.5 3.75 4.464 5 6.25 7.5 
15 1.286 2.143 3 4.5 5.357 6 7.5 9 
20.0 1.714 2.857 4 6 7.142 8 10 12 
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Table 2.2 shows the mathematical effect of incremental changes in minute ventilation 
and PaCO2 on VR. The relationship of VR with the 2 variables remains linear when 
either or both of the variables change. An acknowledgment must be made regarding 
the fixed nature of the predicted values regardless of where the patient is on the 
isopleth (i.e. the predicted values are not a sliding scale). If the minute volume were 
to be halved PCO2 would have to double in order to meet our predicted standards. In 
reality the dynamic of ventilation and CO2 elimination is unlikely to follow such a 
strict mathematical relationship. As justification for the use of fixed predicted values a 
few arguments are proposed. There is little evidence in the literature defining the 
relationship of 
! 
PAco2 and alveolar ventilation in profound respiratory failure. Given the 
heterogeneous population group and the varying degrees of lung injury in critically 
unwell patients this information would be difficult obtain. Designing a model using 
predicted values that vary according to the relative abnormalities would be complex. 
Were such an index to be defined then it would be complex to calculate. As stated 
previously a key design feature was for the ratio to be easy to use at the bedside.  
 
2.4  Mathematical Analysis of the Physiological Proof of Ventilatory Ratio 
It is on examination of the physiological model (Equation 13) that makes the real 
value of VR more apparent. As stated previously VR represents the ventilatory 
demands on an individual. Increased ventilatory demands are as a result of either 
inefficient ventilation (increased dead space) or increased CO2 production (84). 
Therefore changing values of VR would be as a result of changing dead space, CO2 
production, or both.  
 
Equation 26 can be presented in a more clinically intuitive format: 
 
! 
VR =
˙ V CO2 actual
˙ V CO2 predicted
"
1#VD VT
$ 
% 
& ' 
( 
) 
ideal
1#VD VT
$ 
% 
& ' 
( 
) 
actual
  [28] 
 
We can now analyse the effect of VD/VT and !VCO2  by assigning corresponding 
predicted values for these variables. Carbon dioxide production (
! 
˙ V CO2) for a 70 Kg 
individual is assumed to be 200 ml.min-1 in steady state. This value can be set as the 
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predicted 
! 
˙ V CO2 for the above equation. If normal deadspace fraction is 0.3, then ‘E’ 
(1-VD/VT) would be 0.7, this value is set as the ideal value for ‘E’.  
 
Figure 2.3 shows the relationship of VR and ‘E’ (or 1-VD/VT). The relationship is 
evidently non-linear and hyperbolic, similar to Figure 2.1. More importantly this 
relationship should be intuitive to clinicians as it is similar to the relationship between 
PaCO2  and alveolar ventilation as described by Nunn (85). Of note when large 
deadspace abnormalities are large, relatively small changes in ‘E’ lead to 
proportionately larger changes in VR. 
 
 
Figure 2.4 show the values of VR as derived from Equation 16. The relationship of 
! 
˙ V CO2  and VR is linear. When deadspace fraction is large the gradient of 
! 
˙ V CO2  / VR 
line is steeper. This phenomenon is both clinically and physiologically intuitive.  
 
In clinical settings deadspace is probably the variable of greatest interest. A rise of 
VR form 1 to 2 solely as a result of 
! 
˙ V CO2  would require for it to double. In 
mechanical ventilation this would be a rare finding. Conversely as illustrated in 
Figure 2.3 relatively small changes in dead space could result in the doubling of VR. 
Thus it is anticipated the VR may be a quick and useful reference marker for 
ventilatory efficiency in mechanically ventilated patients. 
 
 
Figure 2.3 shows the Relationship of VR and efficiency ‘E’ (1-VD/VT) at various values of !VCO2  
(150, 200, 250, and 300 ml.min-1) 
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Figure 2.4 shows the Relationship of VR and !VCO2 and at three different dead space fraction 
abnormalities (0.3, 0.5, 0.7) 
 
2.5  Research Questions 
The above description of VR alongside the physiological analysis has generated some 
interesting research questions. These questions listed below form the basis of the 
thesis: 
1. Can the physiological analysis of VR as shown in this chapter be 
demonstrated in a benchside lung model and a high fidelity in silico lung 
simulation model? 
2. 
! 
˙ V CO2  is one of the factors that influences VR. What is the variability 
! 
˙ V CO2  of 
in ICU patients? 
3. What is the relative influence of changing values of 
! 
˙ V CO2 on VR? 
4. Does VR demonstrate the same relationship to VD/VT and !VCO2  in critically 
ill mechanically ventilated patients as described in Equation 26? 
5. What are the clinical uses of VR in an ICU population? 
 
The next chapter discusses the methods and materials used to address these questions. 
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Chapter 3 Methods and Instruments 
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Through the course of the thesis several key pieces of equipment and measurement 
systems have been used. The description of this equipment and techniques is 
presented in this chapter. A multitude of generic equipment such as patient 
monitoring devices that have been used in all the studies and they are too numerous to 
describe each in detail. Therefore detailed description of the workings of only the 
equipment that is integral to our understanding and reproducibility of the experiment 
are described in this chapter. The latter segment of the chapter also has a description 
of the various databases that have been constructed for analysis in the clinical studies 
presented in Chapters 7. 
 
There are many disparate studies and database analyses included in this thesis. 
Methodologies for each of the individual studies are therefore presented in the 
relevant chapters. This will lead to improved flow for readers. The methods and 
measurement systems that are described in detail here will only be mentioned 
succinctly in the proceeding chapters’ experiment methodology.  
 
3.1 Artificial Lung Model 
A simple mechanical model was created to replicate the lungs. An airtight Perspex 
bottle with 2 opening ports was created to represent the thoracic cavity. An 
anaesthetic latex reservoir bag was attached to one of the opening ports. This 
represented the lung. The opening port comprised of a modified T-piece where the top 
of the T-piece contained a small self-sealing opening for introducing CO2 flow via 
simple gas tubing. The second port connects to the chamber within the bottle 
surrounding the bag (Figure 3.1). The port opening into the chamber of the Perspex 
bottle was connected to a pump. The pump, designed specifically for the experiment, 
is a spring loaded, low resistance device consisting of a corrugated self-collapsing air 
bag. Delivery of a breath by the ventilator results in the reservoir bag inflating. The 
gas in the air-tight chamber is displaced and exits via the port connected to the pump. 
The volume of gas is then stored in the corrugated bags of the pump. When the breath 
is no longer delivered, i.e. the expiratory phase of the ventilator the volume of gas in 
the corrugated bags is delivered back to the chamber, thereby displacing the gas that 
had filled the reservoir bag in the inspiratory phase. This recreates passive expiration 
thereby giving an expiratory CO2 waveform similar to a normal breath. This basic 
mechanical lung model was used to test the physiological model of ventilatory ratio.  
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Figure 3.1 Schematic of the artificial lung model designed to examine the relationship of Ventilatory 
Ratio with deadspace and CO2 production. 
 
3.2  Nottingham Physiology Simulator 
The Nottingham physiology simulator (NPS) is a computer simulation model of 
respiratory, cardiovascular, acid-base, cerebrovascular, and renal physiological 
models. For the purposes of the thesis the cardiorespiratory components of the model 
were of interest. The multi-compartment model has been previously described in 
detail (86, 87).  The model uses iterative calculations over several “time-slices” to 
detect changes that may have occurred since the previous time-slice until equilibrium 
and steady state is achieved at the alveolar-capillary level. The calculations are based 
on the principle of mass-conservation and each time-slice represents 1 microsecond 
(88). 
 
3.2.1 Components of the Respiratory Model of the Simulator 
3.2.1.1 The Ventilator 
Intermittent mandatory tidal ventilation was used for study and all breaths were 
humidified and warmed. Minute ventilation was manipulated by altering tidal volume 
or respiratory rate. The model is designed such that the driving pressures, alveolar 
inlet resistance, and inter-alveolar pressure determined distribution of flow from the 
ventilator to the alveoli.  
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3.2.1.2 The Bronchial Tree  
This represents anatomical deadspace and is represented as a single tube that sub-
divides into 500 bronchioles. The true volume of anatomical deadspace is fixed 
during the breathing and can be pre-determined by the operators; the effective volume 
may be affected by mixing within the deadspace. Gas flow in the bronchioles is 
laminar or turbulent as dictated by Reynolds’s number. 
 
3.2.1.3 The Alveoli 
The 500 bronchioles open into 500 alveolar “compartments”. Each compartment has 
an independent flow of gas in and out of the alveolus. This is determined by the 
alveolar compliance, bronchial resistance, and airway pressures within the 
compartment. Each alveolar compartment has an associated pulmonary vessel that 
originates from the pulmonary trunk. The effects of gravity on the interstitial 
pressures in the lung are included in the model and play a part in the resting volumes 
of the alveoli. A simple tissue elasticity model is also included in the study. This 
represents the viscoelasticity of the pulmonary tissue. The model is factored such that 
incremental increases in alveolar volume beyond its normal volume result in changes 
in the compliance of the compartment.  
 
The compliance of the alveoli and the blood vessels can be configured according to 
the conditions required for the study. Equilibrium during gas exchange across the 
alveolar-capillary membrane occurs through iterative time slicing, as described above. 
For a particular configuration gas exchange was considered at end-point when the 
difference between gas tensions across the alveolar-capillary membrane was < 1%. 
 
An additional feature of the simulator that results in more realistic modeling is that 
each of the 500 compartments has their own unique compliance and inlet resistance, 
resulting in varying time-constants. This results in inequalities in the emptying of 
alveoli during expiration. This is a frequently encountered phenomenon in diseased 
lungs. 
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3.2.1.4 Gases 
The rate of O2 consumption and CO2 production could be configured to experimental 
demands. Bohr and Haldane effects on gas carriage are also incorporated into the 
model.  
 
3.2.2 Validation of the Model 
In an earlier version of the NPS responses to changes in ventilatory settings the 
calculated output values from the model were compared against measured output in a 
group of 25 adult ICU patients (86). The study found good agreement between 
observed and predicted values for PaO2, PaCO2 , and pH. There was a tendency for the 
model to overestimate PaCO2  by 0.17 kPa.  
 
More recently a study using a newer version of NPS validated its ability to accurately 
predict deadspace (88). Data from mechanically ventilated patients was used to assess 
the ability of the model to predict changes in dead space and dead space fraction. NPS 
accurately reproduced PaCO2  and PECO2  compared to values seen in healthy 
anaesthetized individuals.  
 
3.3 Volumetric Capnography 
Capnography allows for measurement of expired CO2 concentrations. Integration of 
this technology with flow measurement sensors allows for breath-by-breath 
volumetric capnography. Volumetric capnography results in CO2 curves with volume 
plotted against concentration. Volumetric capnography allows for useful measurement 
and calculation for many variables such as CO2 elimination ( !VCO2 ), dead space, and 
expired tidal volumes. 
 
3.3.1 CO2SMO Plus! 
CO2SMO Plus! (Novametrix Medical Systems, Wallingford, Conn., USA) uses the 
Capnostat CO2 sensor to measure CO2 concentrations using infrared absorption 
technology. A flow sensor is the combined to the capnostat and attached proximal to 
the Y-tubing. Flow measurements are made by a fixed orifice differential pressure 
pneumotachograph. Pressure differential are transmitted to transducers in the monitor 
via the pneumotachograph attached to the patient. PECO2  is calculated by averaging 
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the volumetric gas CO2 concentrations proximal to the sensor. Entering data for 
PaCO2  gives values for physiological dead space. 
 
The additional advantages of having a flow sensor proximal to the Y-connector of the 
ventilator circuit is that an accurate measurement of expired tidal volume is available. 
Expired volumes as obtained by ventilators are subject to inaccuracies due to 
compressed ventilator gas. This makes volumetric capnography a more convenient 
method of calculating dead space compared to using a Douglas Bag, which requires a 
correction factor for the compressed gas volume.  
 
CO2SMO Plus! was used to measure !VCO2  and calculate dead space in studies X1 
and X2. 
 
3.3.1.1 Manufacturer technical specifications:  
• End-Tidal CO2  
• Range: 0-150 mmHg 
• Accuracy: ± 2 mmHg for readings of 0-40 mmHg, ± 5% for readings 
between 40 – 71 mmHg, ± 8% of readings between 71 – 150 mmHg. 
• Flow (Adult): 
• Range: 2 – 180 L/min 
• Accuracy: ± 0.5 L/min  
 
3.3.1.2 Analysis Plus! 
Analysis Plus! for windows (Novametrix Medical Systems, Wallingford, Conn., 
USA) version 2.0 was used for analysis of the waveforms and for calculation of dead 
space. Analysis plus uses the SBT-CO2 waveform areas as described by Fletcher (22) 
to estimate dead space fraction and its components.  Analysis Plus! was used to 
estimate deadspace in Studies 1, 4, and 6. 
 
3.3.2 NICO2  
NICO2 (Respironics, Inc, Wallingford USA) is the next generation device of the 
CO2SMO plus and uses Capnostat® a capnograph that uses infrared absorption 
technology in combination with a pneumotacograph to measure flow. Volumetric 
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capnography and with it calculations of !VCO2  are made by integrating expired gas 
flow with CO2 concentration. The described accuracies of the above device is the 
same as the CO2SMO. 
 
3.4 Measuring Deadspace 
3.4.1 Enghoff Modification of Bohr Deadspace 
The Enghoff modification of the Bohr equation was used to calculate deadspace 
(Equation 7). Details of the methods to collect the expired gas and the correction for 
compressed ventilator gas are described in study 1 later in this chapter. 
 
3.4.2 SBT-CO2 Method 
The program Analysis Plus! for windows was used to calculate deadspace in the 
instances where the CO2SMO was used. Analysis plus uses SBT-CO2 waveforms 
areas to estimate deadspace. NICO2 has inbuilt software that estimates Fowler’s 
anatomical deadspace. Entering of the measured PaCO2  into the monitor calculates VD 
/ VT phys using the estimated PECO2 . Alveolar dead space can be calculated by 
subtracting VD anat.  
 
3.5 Miscellaneous Equipment 
Study 1: All patients in this study were ventilated using Drager Evita XL ventilator 
Study 2: Oxford Ventilator was used as the ventilator for this study. 
Study 4: All patients were ventilated using a Aestiva/5 anaesthetic machine ventilator 
(Datex-Ohmeda, Finland). 
Study 5: All patients in this study were ventilated using Drager Evita XL ventilator 
Study 6: All patients in this study were ventilated using Drager Evita XL ventilator 
Study 7: All patients in this study were ventilated using Drager Evita XL ventilator 
 
The GEM Premier 4000 (Instrumentation Laboratory) blood gas analyser was used in 
all the studies that required blood gas analysis. For the databases a wide variety of 
analyzers were used, as they were collected internationally. Specific details of these 
were not available. 
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3.6 Databases 
3.6.1 Royal Brompton Hospital (RBH) Adult ICU Database 
A waiver was granted from the local ethics committee to analyse previously collected 
data. Data were gathered for all adult patients that were ventilated for 5 days or more. 
The Royal Brompton Hospital is a tertiary referral centre and majority of the 
throughput are post-operative patients requiring prolonged ventilation. The adult 
intensive care unit (AICU) also acts as tertiary referral centre for patients with 
challenging ventilation problems.  
 
In total 622 patients were identified that were mechanically ventilated for 5 days or 
more between January 2004 and January 2009. Respiratory variables for all patient 
admitted to the AICU were recorded hourly in a computerized clinical information 
system (CareVue, Phillips Medical Systems, Andover, Mass). The data from carvue 
was then exported and matched to the clinical notes of the patients. In total complete 
data was available for 497 patients. The hospital notes for the remaining patients were 
inaccessible. Demographic data were collected including admission diagnosis, age, 
sex, weight, height, and past medical history. Predicted body weight was calculated 
using the methods described by the ARDS network (89). 
 
Data at the time-point of arterial blood gas analysis were recorded for the analysis.  
Similar to the database above respiratory variables listed in Table x were recorded and 
these were used to calculate VR, PaO2 / FiO2 ratio, OI, and dynamic compliance. 
Mortality outcomes and ventilator days were also recorded. 
 
Minute Ventilation (ml/min) PaCO2 (kPa)	  
Tidal Volume (ml) PaO2 (kPa) 
RR (Mandatory and spontaneous) PaO2 / FiO2 Ratio 
FiO2 Ventilatory Ratio 
PEEP (cmH2O) Oxygenation Index  
Peak Inspiratory Pressure (cnH2O) Dynamic Compliance 
Mean Airway Pressure (cmH2O)  
Table 3.1 Summary of measured and calculated respiratory variables recorded in the CWH and RBH 
database. 
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3.6.2 Chelsea and Westminster Hospital (CWH) Adult ICU Database 
The local ethics committee permission was granted to anonymously analyse data from 
ICU charts of mechanically ventilated patients admitted to the AICU at Chelsea and 
Westminster Hospital, London. The AICU is a general medical and surgical ICU. All 
mechanically ventilated patients admitted between October 2008 and January 2011 
were considered for recruitment to the study. In total there were 322 patients were 
mechanically ventilated admitted to the ICU during this period. Of these patients data 
was captured for 229 patients. 153 patients were ventilated for 5 days or more. 
Complete clinical data was available for 129 patients.  
 
Demographic data such as height, weight, gender, admission diagnosis, past medical 
history, and smoking history were recorded. Predicted body weight was calculated 
using the methods described by the ARDS network (89). 
 
Routine respiratory data was collected daily, usually at the point of the first blood gas 
analysis of the day. A note was made of the mode of ventilation. Table 1 summarizes 
the recorded variables. These variables values were used to calculate VR, PaO2 / FiO2 
ratio, oxygenation index (OI), and dynamic compliance were calculated. In addition 
mortality outcomes and ventilator days were also recorded.  
 
In order to create a control group respiratory data and ABG measurements were also 
collected on patients undergoing elective surgery. Only results from patients requiring 
peri-operative arterial cannulation were used for the study. Most of the patients in this 
group were undergoing abdominal surgery. The 1st blood gas sample was recorded 
after a period of stability on a ventilator just prior to the start of surgery.  
 
3.6.3 Australia-New Zealand Intensive Care Society Database  
(Released by Prof Andrew Bersten) 
A previously presented database of ALI/ARDS patients prospectively collected by the 
Australian and New Zealand Intensive Care Society Clinical Trials Group was used to 
evaluate the characteristics and clinical utility of VR in this population(90). In the 
database information was collected on all intensive care unit patients in three 
Australian States requiring ventilation (invasive and non-invasive) between October 
and November 1999. All ICU admissions requiring invasive or non-invasive 
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ventilation were screened daily during their entire admission for the development of 
ALI. In total 1,977 consecutive patients were admitted to the ICUs in the three states 
of whom 168 went on develop American–European Consensus Conference (AECC) 
definitions of ALI and ARDS. Of these 121 of these patients were invasively 
ventilated and these patients were considered for analysis. 
 
Standard demographic data was collected alongside aetiology of ALI / ARDS, 
ventilator settings, respiratory and cardiovascular variables. Severity of illness scores 
(APACHE II and SOFA), chest x-ray scores, Murray lung injury score, days of 
mechanical ventilation, and survival outcome scores were also recorded. From the 
above data PaO2 / FiO2 ratio and ventilatory ratio were calculated. Where data was 
missing for the height of the patient, the mean population height specific for sex was 
used to calculate the ideal body weight.  
 
3.6.4 ARDS Network databases 
(Released by Prof Ognjen Gajic) 
The clinical use of VR was examined in a previously collected database of ARDS 
Network trials (89, 91). The database was prospectively collected at University 
Hospitals within the network. The details of the inclusion criteria have been described 
elsewhere and can be accessed on the Internet (www.ardsnet.org). In summary all 
patients that were mechanically ventilated and met the AECC criteria for ALI / ARDS 
were considered eligible for recruitment into the trial. Inclusion criteria for analysis 
into this study were those patients mechanically ventilated for 3 days or more. The 
database contained information on demographics, aetiology of lung injury, the 
presence of shock and APACHE III score (92). Data were also available for 
respiratory variables such as ventilator tidal volume, respiratory rate, peak end-
expiratory pressure (PEEP), peak airway pressure, plateau pressure, FiO2, and arterial 
blood gas measurements. 
From the above data and arterial blood gas results PaO2 / FiO2 ratio and ventilatory 
ratio were calculated. Where data was missing for the height of the patient, the mean 
population height specific for sex was used to calculate the ideal body weight.  
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3.7 Study 1: Comparison of Methods to Calculate physiological deadspace in 
mechanically ventilated ICU patients 
As discussed in Chapter 1 there are predominantly 2 methods in clinical practice to 
measure deadspace. The more traditional Bohr-Enghoff method is a large container to 
collect the expired gas and requires correction for the compressed ventilator gas. 
These features make this an unattractive method in busy ICUs. The alternative 
method using volumetric capnography also has shortcomings particularly when 
transition of Phase II and Phase III of the CO2 expirogram is difficult to assess. This 
method is easier in practice and potentially provides clinicians with additional 
information. Evidence of correlation between the two methods would allow clinicians 
to use the latter method with some confidence and allow for larger studies to be 
carried out over a shorter period of time. 
 
The aims of this study are to compare physiological dead space using volumetric 
capnography and more traditional method of collecting mixed expired gas.  
 
3.7.1 Methods 
The study was approved by the local ethics committee (The National Hospital for 
Neurology and Neurosurgery & Institute of Neurology Joint REC). Informed assent 
was obtained from family prior to recruitment to the study. Data were prospectively 
collected in patients aged > 18 years at the intensive care unit (ICU) at Chelsea and 
Westminster Hospital. All patients were emergency admissions to the ICU. Initial 
measurements of dead space were made following stabilization of the patient and 
within the first 24 hours following admission to the ICU. Measurements were then 
made once daily until either six consecutive recordings had been made, or the patient 
had been weaned from the ventilator or died, whichever was the shorter period. For 
each set of measurements a note was made of the mode of ventilation; mandatory 
(SIMV or BIPAP) or spontaneous (ASB). All modes of ventilation used non-bias flow 
triggering.  
 
3.7.1.1 Deadspace Using Douglas Bag Method 
Deadspace fraction was calculated using the Enghoff modification of the Bohr 
equation. The Enghoff modification of Bohr’s equation states: 
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=
PaCO2 !PECO2
PaCO2
   [7] 
where PaCO2  is the arterial PCO2 and PECO2  is the mixed expired PCO2. A modified 
Douglas Bag was created by attaching a fan to the bottom of a 10 litre Perspex 
chamber. This was used to collect and mix the expired gas from the exhaust port of 
the ventilator. The carbon dioxide concentration of this expired gas was measured 
using a BCI Capnocheck capnograph (Smiths Medical, USA).   
 
One of the drawbacks using the Douglas Bag method (VD / VT DB) for calculating 
dead space fraction is that the collected expired gas contains compressed gas from the 
ventilator. It is difficult to separate this compressed gas from the true expired volume 
and leads to diluting and lowering of the measured PCO2 of the expired gas leading to 
overestimation of VD / VT. Mixed expired CO2 (PECO2 ) was calculated by correcting 
for gas compression in the ventilator circuit using the method described by Forbat 
(93). The corrected tidal volume was calculated using the following equation: 
    [29] 
where  is the corrected tidal volume, PB, Ppeak is the peak airway pressure, and VV 
is the compressible volume of the ventilator and connection tubing. This was set as 
1555 ml as determined by the manufacturer of the ventilator. The corrected gas 
volume was then calculated as follows: 
PECO2 = PECO2m !
VT
VTc
"
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'   [30] 
where PECO2m  is the measured PCO2 in the mixing chamber. The correction method 
described has been shown to be comparable to physical separation of expired gas 
from compressed gas (93). The mean compressible volume was 2.6 (± 0.17) 
ml/cmH2O of peak pressure, which is comparable to other studies where compressible 
gas has been previously measured (74). 
 
Following the attachment of the mixing chamber and capnograph to the ventilator 
expiratory exhaust port, a period of 10 minutes was allowed to approach steady state, 
VTC = PB !
Vv +VT
PB +Ppeak
"
#
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before  was recorded, PECO2 was measured and corrected, and arterial blood drawn 
for measurement of PaCO2 .  
 
3.7.1.2 Deadspace using Volumetric Capnography 
VD / VT VCAP was calculated using the CO2SMO®Plus capnograph (Novometrix 
Medical Systems, Wallingford, USA). The monitor consists of a CO2 sensor that 
measure CO2 concentrations using infrared absorption technology. A flow sensor is 
the combined to the capnostat and attached proximal to the Y-tubing. The integration 
of flow with CO2 concentrations allows the monitor to construct a single-breath CO2 
(SBT-CO2) waveform. The SBT-CO2 waveform can used to derive dead space and its 
components as described by Fletcher (22). The software programme Analysis Plus! 
for Windows (Novometrix Medical Systems, Wallingford, USA) was used to estimate 
values for physiological deadspace and its two components, anatomical deadspace 
and alveolar deadspace, using areas under the SBT-CO2 waveform as described by 
Fletcher and colleagues (94). Analysis Plus! automatically computes the areas X, Y, 
and Z as seen in Figure 1.5A. Physiological deadspace is defined as (Y+Z)/(X+Y+Z).  
 
CO2SMO®Plus monitor estimates PECO2  by dividing the total volume of CO2 in the 
breath over a minute by total expired volume over the same period.  is the 
volume weighted 8 breath average of this calculation and is updated every breath. The 
PECO2  values estimated by the monitor and the measured and corrected values from 
the mixing chamber were compared. The expired tidal volume (VTe ) as recorded by 
the ventilator (measure and corrected) were compared with values measured by  
CO2SMO®Plus monitor. Internal self-calibration was done in both capnographs prior 
to all readings. 
 
3.7.1.3 Statistical Analysis 
Mean values of continuous normally distributed variables are expressed as mean ± 
standard deviation. Non-parametric data are presented as median (inter-quartile 
range). Pearson’s correlation coefficient was used to examine correlation of measured 
values between mesurements. Bland-Altman method was used to assess agreement 
between paired measurements of VD / VT, PECO2 , and VTe (95). 
!VE
PECO2
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3.7.2 Results  
48 patients (33 men and 15 women) were recruited to the study. Table 3.2 
summarizes the demographic data and admission values for respiratory variables for 
the population. In total 168 pairs of daily readings were taken. Table 3.3 summarizes 
the baseline physiological characteristics of the patients.  
 
Bland-Altman analysis showed good agreement between VD / VT VCAP and 
uncorrected VD / VT DB with mean bias of 0.03 with a 95% limits of agreement 
between -0.04 and 0.11 (Figure 3.2A). The agreement between VD / VT VCAP and 
corrected VD / VT DB was similar with a mean bias of 0.02 with 95% agreement limit 
between -0.06 and 0.10 (Figure 3.2B). As would be anticipated there was excellent 
positive correlation between VD / VT VCAP and both uncorrected and corrected VD / VT 
DB (r = 0.96, r2 = 0.91; r = 0.95, r2 = 0.90 respectively; p < 0.001 for both). 
 
Bland-Altman analysis of PECO2  showed good agreement between the measurements 
of the CO2SMO monitor and the uncorrected (bias 0.08 kPa, 95% agreement limit -
0.3 to 0.46 kPa) and corrected values (bias -0.19 kPa, 95% agreement limit -0.61 to 
0.22 kPa) obtained in the mixing chamber. VD / VT phys calculated using the Enghoff 
modification of the Bohr equation with PECO2  derived from the CO2SMO showed 
good agreement with the Douglas bag method (mean bias 0.04, 95% agreement limit -
0.09 to 0.18).  
 
Bland-Altman analysis of uncorrected VTe measured by the ventilator and the 
CO2SMO monitor revealed a relatively large mean bias of 73.9 mls, with a 95% 
agreement limit of -0.8 ml and 148.5 ml. The agreement between corrected ventilator 
VTe and the CO2SMO monitor VTe was better with a mean bias of 43.6 ml and 95% 
agreement limit between -90.1 ml and 78.4 mls. All readings were the split into 3 
groups according to the VTe measured by the ventilator: VTe < 400 mL, VTe 400-650 
mL, VTe > 650 mL. Bland-Altman analysis of corrected VTe and VTe measured 
showed mean bias (± SD) as follows: VTe < 400 mL -25.8 mL ± 35.7 mL, VTe 400-
650 mL 6.0 mL ± 42.1 mL, VTe > 650 mL 21.6 mL ± 41.9 mL. Linear regression 
analysis showed VTe CO2SMO = 0.91*VT e Ventilator – 22.1. 
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3.7.3 Discussion 
The results of this study show that there was good agreement between deadspace as 
measured by the more conventional method of collecting mixed-expired gas and as 
measured by volumetric capnography using areas under the SBT-CO2 waveform. 
There was also good agreement between PECO2  measured by the volumetric 
capnography and corrected and uncorrected values measured in expired collected gas. 
There was poor agreement between expired tidal volume measured by the ventilator 
and the CO2SMO monitor. The agreement after correction for compressed gas 
improved between the 2 measured tidal volumes particularly in those patients 
ventilated with 400 – 650 mL breaths.  
 
Calculating dead space using a Douglas bag is impractical in busy intensive care 
units. Yet information regarding deadspace ventilation is important because it can be 
used for disease progression and prognostication. The findings of this study show that 
there was reasonable agreement between physiological deadspace calculated using 
CO2SMO plus and its software programme Analysis Plus! and the Douglas Bag 
method. The additional correction of for compressible gas only marginally reduced 
the mean bias between the 2 methods. The mean percentage bias across a wide range 
of physiological dead space abnormalities was 2.5% (± 7.6%). These margins are 
unlikely to represent a clinically significant value. 
 
The VCAP method of calculating physiological deadspace fraction with the Douglas 
bag method had previously been compared in lung model and in animal model. The 
results of these findings found significant correlation between the 2 methods (r2=0.84, 
p < 0.001) with a bias of 0.02. The findings of this study show a stronger correlation 
between the 2 methods, with a similar bias. The findings of this study were also 
similar to a previous study that showed similar correlation between physiological 
dead space calculated using volumetric capnography and metabolic cart (96). In turn 
the metabolic cart has been compared favourably to the Douglas Bag method of 
calculating deadspace (97).  
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The values of PECO2  derived by CO2SMO showed similar agreement with the 
Douglas Bag method. Calculating VD / VT phys using this value showed good 
agreement with the corrected Douglas Bag method (mean bias 6.7% ± 10.1%). The 
relevance of this finding is that the current generation of the volumetric capnography 
that are increasingly being incorporated into ventilator monitoring use these derived 
values to calculate deadspace. The NICO2 monitor that is used in some of the 
following studies also uses the derived PECO2 values to calculate deadspace. 
 
An unexpected finding of the study showed that the agreement between volumetric 
capnography derived PECO2  was better with the uncorrected PECO2 than corrected 
PECO2 . This may be explained by the use of the correction factor described by Forbat 
and colleagues. In their study the correction factor was validated in a very small group 
of patients across a relatively small group of patients using volume controlled 
ventilation (93). The patients in this group were ventilated with both mandatory and 
pressure controlled ventilation. Some of patients were ventilated with pressure 
support ventilation and it would be assumed that the dynamics of compressed gas in 
this group of patients might also behave differently. The agreement between corrected 
VTe and CO2SMO was much better in the range of 400mL – 650mL. Either side of 
these tidal volumes the mean bias increased. This suggests that correction factor used 
in this study is subject to unreliability when the tidal volumes are either small or very 
large.  
 
CO2 rebreathing has been identified as a source of error in deadspace calculation (98). 
Another advantage of using volumetric capnography is that inspired PCO2 is factored 
into the calculated value of PECO2 . Aside from dead space measurements volumetric 
capnography measures flow and calculates tidal volume at the airway opening (99). 
Values generated by the capnograph are much more likely to represent true expired 
volumes in comparison to expired volumes calculated by the pneumotachograph in 
the ventilator, which has inherent inaccuracies of compressed gas and often over-
estimates the true volumes. Volumetric capnography also allows for calculation of 
CO2 elimination ( !VCO2 ). Measuring !VCO2  is essential in the complete understanding 
the efficiency of CO2 elimination by the lungs. 
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There are several limitations to this study. Firstly, the data was collected from a 
convenience sample, i.e. only patients with respiratory failure were included into the 
study. This was in order to capture a group of patients anticipated to have a wide 
range ventilation-perfusion mismatch. Secondly, two different measurement systems 
were used to measure PCO2 in order to derive PECO2 . The Douglas Bag method used 
the BCI capnocheck whilst the PECO2  derived by the CO2SMO used the capnostat. 
Using two different methods to measure the same variable would subject the readings 
to inaccuracies and errors individual to the devices. Ideally both measurements would 
have been made using the capnostat. This was not possible as the CO2 analyser of the 
capnostat requires a steady waveform to measure PCO2 this was not feasible for the 
Douglas Bag.  
 
In summary, physiological deadspace fraction derived using volumetric capnography 
either using the areas under the SBT-CO2 waveform or from derived PECO2  shows 
good agreement with the Douglas Bag method. Future studies use these methods to 
measure deadspace. 
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Variable Data 
Age (years) 61 ± 15 
Weight (Kg) 76 ± 15 
Height (cm) 170 ± 9 
Sex, Male / Female 33 (69) / 15 (31) 
Admission Diagnosis  
LRTI / Exacerbation of COPD 15 (31) 
Intra-abdominal pathology 14 (29) 
Sepsis 9 (19) 
Cardiac Insufficiency 7 (15) 
Miscellaneous 3 (6) 
Underlying COPD / ILD 7 (16)  
Developed ARDS 5 (10) 
Table 3.2. Summary of baseline clinical characteristics of 48 patients. LRTI = Lower respiratory tract 
infection, COPD = Chronic obstructive pulmonary disease, ILD = Interstitial lung disease, ARDS = 
Acute respiratory distress syndrome. 
 
Variable Data 
APACHE II Score 19 (15 – 22) 
Tidal Volume (ml) 557 ± 128 
Peak inspiratory pressure (cmH2O) 24 (18.75-33) 
Mean airway pressure (cmH2O) 13 (9.75 – 16.25) 
Peak end-expiratory pressure (cmH2O) 8 (5-10) 
Dynamic compliance (ml.cmH2O-1) 41 ± 38 
!VCO2  (ml.min-1) 190 ± 59 
PaO2 / FiO2 Ratio 26.8 ± 13 
VD / VT 0.60 ± 0.09 
Table 3.3. Summary of baseline respiratory variables of 48 patients. !VCO2 = Rate of CO2 elimination 
per minute, VD / VT = Physiological deadspace. 
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 Volumetric Capnography Douglas Bag Uncorrected Douglas Bag Corrected 
 (kPa)  2.08 ± 0.69 2.00 ± 0.66 2.28 ± 0.70 
VTe (ml) 485.1 ± 130.1 542.1 ± 141.7 472.9 ± 145 
VD/VT  0.61 ± 0.13 0.64 ± 0.12 0.59 ± 0.12 
Table 3.4 Mean values of mixed expired CO2 (PECO2 ), expired tidal volume (VT e), and physiological 
deadspace (VD/VT) in all readings (n = 168). 
 
    
3.2 Bland-Altman plot of differences versus average of paired measured values for physiological 
deadspace. The dotted lines represent the 95% agreement limit. 3.2A. Plot of agreement between the 
VCAP and uncorrected Douglas Bag method. 3.2B Plot of agreement between the VCAP method and 
corrected Douglas Bag method. 
  
  
 
Figure 3.3 Scatter plot of VD / VT calculated by the 2 methods. 3.3A VCAP plotted against uncorrected 
Douglas bag method (r = 0.96, p < 0.01). 3.3B VCAP plotted against Douglas bag method corrected 
for compressed ventilator gas (r = 0.95, p < 0.01). 
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 Figure 3.4 Bland-Altman plot of differences versus average of paired measured values of . The dotted 
lines represent the 95% agreement limit. 3.4A Plot of agreement between the values derived from 
VCAP and uncorrected Douglas Bag method. 3.4B Plot of agreement between the values derived from 
VCAP and corrected Douglas Bag method. 
 
 
Figure 3.5 Correlation between expired tidal volume (VTe) as measured by the CO2SMO Plus! monitor 
and corrected VTe as measured by the ventilator.  
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Chapter 4: Validation of the Physiological 
Properties of Ventilatory Ratio 
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4.1 Study 2: Validation of the Physiological Model of Ventilatory Ratio Using 
a Benchside Lung Model 
 
The analyses in the previous chapter demonstrate the theoretical principles of VR. 
Before the workings of the ratio are assessed in patients, a simple lung model was 
designed in order calculate the ratio with measured variables. A physical bench model 
should enable stepwise changes to be made in either CO2 production ( ) or 
deadspace to determine if this conforms with mathematical expectations.  The aim of 
the study was to examine the behaviour of VR in a benchside lung model whilst 
controlled changes in !VCO2  and deadspace were made.  
 
4.1.1 Methods and Material 
 
A simple ventilated lung model was designed such that the fraction of deadspace and 
CO2 production ( !VCO2 ) could be controlled. The design of the benchside model is 
detailed in Section 3.1 and Figure 3.1. 
 
The port leading to the reservoir bag was connected to a Y-piece connector. One limb 
of Y-piece was attached to an Oxford ventilator via a Wright’s spirometer. This was 
the inspiratory limb. The second limb of the Y-piece was connected to a capnograph 
(NICO2, Respironics-Novametrix) and then to the exhaust of the ventilator. CO2 was 
added into the reservoir bag via tubing attached to a cylinder. The flow of CO2 was 
controlled by a rotameter. The flow passing through was measured using a mass flow 
meter (Mass-View®, Bronkhorst High-Tech). The tubing delivering the CO2 was 
inserted into the reservoir bag through a self-sealing valve ensuring a closed circuit. 
CO2 production was controlled using the rotameter. Additional elephant tubing 
between the Y-connector and ventilator on the inspiratory limb was used to change 
deadspace volume.  
 
The patient setting was for 70 Kg individual and the minute ventilation was set at 
7000 ml.min-1. This was achieved with a tidal volume of 500 mls and frequency of 14 
breaths per minute. The apparatus deadspace was set at 150 mls. 
! 
˙ V CO2
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In the first experiment !VCO2  was maintained at a steady rate of 200 ml.min-1 and the 
deadspace was sequentially altered. This was achieved by adding extra volume of 
elephant tubing to the circuit on the inspiratory limb. End-tidal CO2 was measured 
using the above mentioned capnograph and was taken as alveolar PCO2. Prior to 
recording of measurements 10 breaths were allowed for the system to equilibrate after 
a change in conditions. ETCO2  was measured for 10 consecutive breaths. For the 
second experiment similar recordings were made, however in these readings 
deadspace was left unchanged (as that of the circuit) and !VCO2  was sequentially 
increased.  
 
In order to calculate ventilatory ratio ETCO2  was used as a substitute for PaCO2 . VR 
was calculated using the mean of the 10 breaths of the measured ETCO2  and delivered 
minute ventilation. 
 
4.1.2 Results 
 
Tables 4.1 and 4.2 show the results of experiment 1 (steady !VCO2 ), and experiment 
2, (constant deadspace) respectively. There was little breath-to-breath variation in the 
recorded ETCO2 . As expected there was an associated increase in the measured ETCO2  
as either CO2 insufflation or deadspace increased. ETCO2  and CO2 production showed 
a linear relationship (Figure 4.1). The relationship of VR with deadspace was 
asymptotic (Figure 4.2). When deadspace volumes were large, further incremental 
increases in deadspace lead to a much larger increase in ETCO2 . The findings of these 
studies were in keeping the physiological analysis in the previous chapter.  
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CO2 Production 
(ml.min-1) 
ETCO2  (kPa) VR 
150 2.9 (± 0.3) 0.58 (± 0.05) 
200 4.1 (± 0.2) 0.82 (± 0.05) 
250 4.9 (± 0.2) 0.98 (± 0.04) 
300 6.2 (± 0.2) 1.24 (± 0.04) 
350 7.0 (0.1) 1.4 (± 0.03) 
400 8.35 (± 0.2) 1.65 (± 0.04) 
Table 4.1. Mean values of ETCO2  and Ventilatory Ratio (VR) with incremental increase in CO2 
production. Deadspace was kept constant at 150 ml. The values in the brackets represent standard 
deviation. 
 
 
Total Deadspace (ml)  (KPa) VR 
150 4.35 (± 0.19) 0.87 (± 0.04) 
200 5.3 (± 0.20) 1.06 (± 0.17) 
250 5.6 (± 0.17) 1.12 (± 0.04) 
300 7.6 (± 0.26) 1.52 (± 0.05) 
350 9.4 (± 0.15) 1.88 (± 0.03) 
400 13.8 (± 0.22) 2.76 (± 0.43) 
Table 4.2. Mean values of  and VR with incremental increase in deadspace. CO2 production was 
kept constant at 200 ml.min-1. The values in the brackets represent standard deviation. 
 
 
Figure 4.1. The relationship of VR and CO2 production. Physiological dead space fraction was kept 
constant at 0.3. 
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Figure 4.2. The relationship of physiological dead space and VR.  was kept constant at 200 
ml.min-1. 
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4.2  Study 3: Validation of VR using the Nottingham Physiology Simulator 
 
Following on from previous chapters we know that Equation 25 states that: 
 [24]  
and for an individual patient the predicted values would always remain constant. We 
can therefore restate VR for an individual patient: 
  [31] 
where k is the constant for predicted values for a given individual.  
The aims of this study were to: 
1. validate the physiological analysis of VR (Equation 1) 
2. assess the relative values of VR in 3 simulated patients with varying 
ventilation-perfusion mismatch 
 
4.2.1 Methods 
Three virtual patients were configured with varying levels of !V !Q  mismatch: normal, 
moderate, and severe. The details of the simulator configuration of each patient can be 
found below. In all three configurations the patient settings were for a 70 Kg, 170 cm 
individual, with a preset anatomical dead space of (VDanat) 147 ml, Hb 14.5 g/L, Temp 
37.2°C. FiO2 was set at 0.21 for the normal and 0.3 for moderately impaired patient. 
For the patient with severe lung impairment FiO2 was set at 0.5. Readings were taken 
with varying minute volumes at 7000 mls.min-1, 6400 mls.min-1, 5800 mls.min-1, and 
5200mls.min-1. At each minute volume the respiratory rates were altered between 10, 
12 and 15 breaths per minute. At each permutation of minute ventilation 3 separate 
readings were taken whilst altering !VCO2  at 150, 200, and 250 ml.min-1. This strategy 
ensured that VR was calculated whilst either physiological dead space fraction (VD 
/VT phys) or !VCO2  were altered in isolation. The range of values for physiological dead 
space and shunt fraction for the patients were configured as follows: normal patient 
VD /VT phys 0.24 – 0.44, shunt 1.2 – 2.1%; moderate mismatch VD /VT phys 0.52 – 0.60, 
shunt 12 – 22.1%; Severe mismatch VD /VT phys 0.60 – 0.71, shunt 46.1– 52.3%. 
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4.2.1.1 Patient Configuration 
In the NPS !V !Q  defects were configured by altering the bronchial resistance sliders 
(BRS) and vascular resistance sliders (VRS). Sliders 1–5 on each scale represents the 
anatomical progression from lung apex to base, with 1 being the apex. The larger the 
fraction the greater the dysfunction represented. The setting for the patients were as 
follows: 
 
Normal Patient:  
 
- BRS 1 9/2500 (1%), BRS 2 1/2500 (20%), BRS 3 1/2500 (50%), BRS 4 
1/2500 (80%), BRS 5 36/2500 (100%) 
- VRS 1 36/2500 (1%), VRS 2 1/2500 (20%), VRS 3 1/2500(50%), VRS 4 
1/2500 (80%), VRS 5 9/2500 (100%) 
  
Moderate abnormality: 
 
- BRS 1 400/2500 (1%), BRS 2 36/2500 (20%), BRS 3 4/2500 (50%), BRS 4 
4.8/2500 (80%), BRS 513/2500 (1%) 
- VRS 1 94.1/2500 (1%), VRS 28.4/2500 (2.1%), VRS 3 1/2500 (50%), VRS 
4 79.2/2500 (62%), VRS 51560/2500 (100%) 
 
Severe abnormality: 
 
- BRS 1 2500/2500 (1%), BRS 2 2440.4/2500 (62%), BRS 3 0/2500 (64%), 
BRS 4 1/2500 (80%), BRS 5 1/2500 (100%) 
- VRS 1 1/2500 (1%), VRS 2 1/2500 (20%), VRS 3 1/2500 (50%), VRS 4 
2.6/2500 (85%), VRS 5 349.7/2500 (100%) 
 
4.2.1.2 Statistics 
Data is presented as mean ± standard deviation and ANOVA was used to compare 
mean VR values of the various ventilatory settings across the 3 simulated patients.  
 
 
 
76 
4.2.2 Results 
The range of calculated values for Ventilatory Ratio from the three simulated patients 
was 0.63 - 2.64. As anticipated VR increases with the increasing deadspace and rate 
of CO2 production. The mean values and range of VR in the 3 patients were as 
follows: normal 0.89 (± 0.25), moderate 1.37 (± 0.31), severe 1.76 (± 0.46) (p < 
0.01)(figure 3). Similarly for each of the patients the values of VR were higher as 
!VCO2  increased. Figure 2a shows the relationship of ventilatory ratio and VD /VT phys 
and the interaction of !VCO2 with theses variables. As would be predicted by the 
physiological model the results show an asymptotic relationship between VD /VT phys 
and VR (Figure 4A). Figure 4B shows the relationship of VR with  and 
demonstrates a linear relationship. There was also a linear relationship between !VCO2  
and VR when VD / VT ohys was constant. 
 
 
Figure 4.3 VR values in the 3 patient configurations in the NPS with constant at 200 ml.min1.  
 
 
Figure 4.4A VR plotted against VD / VT phys. The isopleths represent configurations with 3 different 
rates of . 4.4B shows the relationship of VR with 1/E at different rates of , where E is 
efficiency or 1-VD/VT. 
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Figure 4.5. The effect of rising  on VR when dead space is kept constant for each of the 
configured patients. This graph is similar to the Figure 2.4.  
 
 
4.3 Discussion 
The aims of this chapter were to examine VR in a benchside lung model and a hi-
fidelity cardiorespiratory simulator. Additionally the aim was also to validate the 
physiological analysis presented in Chapter II. The results from the benchside model 
show that the relationship of the VD / VT and !VCO2  with VR is as described by the 
equations in the physiological analysis of VR. In this model VR behave as would be 
anticipated. The results from the Nottingham Physiology Simulator has demonstrated 
that both deadspace and !VCO2  influence VR. In patients in steady state where !VCO2  
is relatively unchanged, changes observed in VR would be representative of changes 
in physiological deadspace and vice versa. Patients configured to have higher VD /VT 
phys had higher values for VR. Increasing !VCO2 also led to higher values of VR. 
Results from the Nottingham Physiology Simulator validate the physiological model 
of VR described by equations 1 and 2. 
 
The lung model used in Study 2 is a basic and crude representation of the mechanics 
of the lung. Hence the absolute values of the calculated dead space and VR are 
difficult to interpret. The results do however show that the trends of the results 
obtained during the experiments are similar to those obtained during the mathematical 
analysis of the physiological model of VR described. Figures 1 and 2 illustrate this. 
The experiments in the lung model serves an additional purpose by clearly 
demonstrating that physiological model is easily studied using measurement systems 
that are intended for further studies in the thesis.  
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The NPS allows a greater degree of sophistication when compared to the benchside 
model and allows testing VR under varying physiological conditions. Equation 2 
states that VR is directly proportional to !VCO2  and inversely proportional to ‘E’. 
Figures 4.4a and 4.4B are representative of the graphs seen in Figures 2.3 and 2.4. 
The similarities between these graphs demonstrate the validity of the physiological 
analysis of VR.  
 
As seen in Figure 4.4A when dead space abnormalities are high small changes in VD / 
VT lead to larger changes in VR. This may be as a result of a combination of reducing 
ventilatory efficiency and increased shunt fraction contributing to venous admixture. 
Given that arterial PCO2 is used as a surrogate for alveolar PCO2 the contributions of 
intrapulmonary shunt is incorporated in VR. Therefore changes in shunt would also 
influence VR. This holds true for most methods of calculating physiological dead 
space (100). 
 
Another factor highlighted by figure 4.4A is that a given value of VR would represent 
a variety in VD / VT abnormalities depending on !VCO2 . As a pure marker for VD / VT, 
VR is a crude measure. The clinical value of VR is anticipated to be as a marker of 
the efficiency of the lungs to deal with the ventilatory demands of the body. A VR of 
1 is unlikely to be of concern regardless of !VCO2 . Conversely a VR of 2 is likely to 
represent inefficient CO2 elimination regardless of !VCO2 . It is anticipated that the 
clinical use of the absolute value for prognostication in respiratory failure will be as a 
tool to monitor efficiency of CO2 clearance. A possible clinical use of the value VR 
could be to estimate and then follow the efficiency CO2 clearance.   
 
Examination of Figure 5 shows that the gradient of linear relationship of VR is 
steeper when the  abnormalities are larger. i.e. for when dead space is large an 
increase in CO2 production will to a larger ventilatory road on the individual (larger 
VR). Whilst this may seem intuitive at first glance it is seldom factored in as a 
contributing factor in the rising observed in ventilatory failure. This 
physiological phenomenon may in part explain findings of a recent study where 
!V !Q
PaCO2
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paralysis and sedation in the early management of severe ARDS afforded survival 
advantage to patients (101). Deep sedation and paralysis would in theory result in 
lower CO2 production. In ARDS dead space fraction is known to be high (72). Aside 
from improved synchrony with the ventilator, neuromuscular blockade would in 
theory also reduce the ventilatory load on individuals thereby minimising the 
deleterious effect of protective lung ventilation on body pH.  
 
Another finding from the simulator modelling shows that 0.85 is mean VR value for 
the patient configured to represent ‘normal’ lungs. A figure close to 0.85 is probably 
nearer the “normal” value for VR rather than 1. Nomograms that were used as a guide 
to set the predicted values probably overestimate the required adequate minute 
ventilation (102, 103). Similarly, setting our ideal arterial PCO2 as 5 KPa has also 
resulted in a small overestimation of VR. An objective during the development of the 
ratio was that it should be simple to calculate at the bedside. Therefore a small degree 
of accuracy has been knowingly relinquished for the sake of ease of calculation.  
 
In summary the findings from the modelling work validate the theoretical analysis of 
the physiological properties of VR. It is anticipated that the physiologically intuitive 
properties of VR will stand true in patients. However the study of these variables 
would be more difficult as VD/VT and !VCO2 are control in individuals. The 
subsequent chapters study the influence of these 2 variables on VR. 
  
 
80 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5: CO2 Production in Mechanical 
Ventilation and its Influence on Ventilatory 
Ratio 
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From the physiological analysis of VR we know CO2 production has a direct 
relationship with ventilatory ratio. While this relationship has been demonstrated in a 
benchside and in-silico model (chapter 3), it has not been shown in clinical 
circumstances. The aims of this chapter are to assess the effect of !VCO2  in vivo.  
 
Of the two variables that influence VR, physiological deadspace is of greater interest 
to clinicians. The additional effect of !VCO2  on VR may be perceived as ‘noise’ or as 
a distortion of the ventilatory inefficiency signal of VR. The variability in  
would to an extent dictate the contribution of the ‘noise’ on VR. The second part of 
the chapter deals with the variability of !VCO2  in adult critically unwell mechanically 
ventilated patients.  
 
5.1  Study 4: The effect of Exogenous CO2 on Ventilatory Ratio 
Laparoscopic surgery requires creation of a pneumoperitoneum. CO2, due to its 
properties of rapid re-absorption, is the preferred gas for insufflation to create the 
pneumoperitoneum. Whilst direct infusion of exogenous CO2 would not normally be 
possible in a clinical study, patients undergoing laparoscopic surgery provide a simple 
in vivo method of examining the relative contributions of excess CO2 production on 
VR. Most patients selected for these procedures are ASA grade I and II where it 
would be anticipated that dead space volumes would remain relatively constant pre- 
and post-pneumoperitoneum. This would give us a unique opportunity to study the 
effect of !VCO2  on VR in relative isolation. 
 
5.1.1 Method 
Data was collected as part of a larger observational study designed to evaluate the 
changes in respiratory mechanics and gas exchange in patients undergoing routine 
upper GI laparoscopic surgery. The anaesthetic delivered was dependent on the 
Consultant anaesthetist. All patients were pre-oxygenated with 100% oxygen and 
received fentanyl and propofol at induction. Non-depolarising muscle relaxants were 
used universally. Intra-operatively anaesthesia was maintained using either 
sevoflurane or desflurane. A combination of oxygen and air was used to ventilate the 
lungs. 
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The protocol design was, of necessity, pragmatic to minimize disruption to the theatre 
list. Normal weight patients undergoing upper GI laparoscopic surgery were included 
along with those in the obese group having bariatric surgical procedures. The study 
protocol was approved by the National Research Ethics Services, REC Royal Free 
NHS trust, London. All patients with ASA classes I and II undergoing elective upper 
GI laparoscopic surgery were considered eligible for the study. Written informed 
consent was obtained and all patients were recruited between August 2010 and 
December 2010. 
 
All patients recruited underwent either laparoscopic: gastric bypass or banding, 
cholecystectomy, fundoplication, or removal of gastric bands / balloon. Patients were 
managed either using pressure controlled (PCV) or volume controlled ventilation 
(VCV) according to the preferences of the anaesthetist. All patients were ventilated 
using a Aestiva/5 anaesthetic machine ventilator (Datex-Ohmeda, Finland).  
 
Routine physiological monitoring was used in all patients. Additionally patients were 
consented for in-line volumetric capnography (CO2SMO Plus Novometrix Medical 
Systems USA) and radial artery catheters for blood gas sampling. Baseline 
measurements were taken 20 minutes after the patient had been connected to the 
ventilator just prior to CO2 insufflation (T1). The second reading was taken 20-25 
minutes post pneumoperitoneum (T2). Third reading was taken after 20 minutes with 
an increase in 5 cmH2O of PEEP (T3). A note of the patients position (Trendelenburg 
or reverse Trendelenburg) was made at the time of the reading. During the first 
reading almost all the patients were flat whilst the second and third reading most 
patients were in the head-up position. In line capnography was maintained throughout 
the study with no disruptions to the circuit.  
 
At each data point respiratory rate (RR), tidal volume (VT), minute ventilation (MV), 
EtCO2, oxygen saturation (SpO2), volume of exhaled CO2 ( !VCO2 ), peak inspiratory 
pressure (PIP) and mean inspiratory pressure (Pmean) were recorded. Arterial blood gas 
analysis was carried out at each data point and pH, PaO2, and PaCO2 were recorded. 
The volumetric capnography data was used to calculate values for deadspace 
measurements using Analysis Plus software (Novometrix Medical Systems, USA). 
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From Analysis Plus! anatomical deadspace, alveolar deadspace, physiological 
deadspace, and their respective fractions of tidal volume were calculated. Ventilatory 
efficiency was further assessed by calculating ventilatory ratio (Measured Minute 
volume*Measured PaCO2 / Predicted Minute volume*Predicted PaCO2). Oxygenation 
was assessed by calculating the alveolar-arterial gradient using the equation: 
FiO2*(PB-PH2O)-(PaCO2/RQ)-PaO2 (where PB is the barometric pressure, PH2O is 
the water vapour pressure, and RQ is the respiratory quotient). The heart rate (HR), 
blood pressure (BP), and abdominal pressures were also recorded at each time point. 
 
5.1.1.1 Statistical Analysis 
Average values for the variables at the various time points are expressed as mean ± 
standard deviation. Data were analysed using one-way ANOVA with repeated 
measures. Pearson’s correlation coefficient was used to examine the association 
between delta !VCO2  and delta VR. Linear regression model analysis was used to 
describe the relationship of !VCO2  and VR. 
 
5.1.2 Results 
In total 79 patients were recruited to study. 53 of these patients underwent bariatric 
corrective surgery. The remainder underwent non-bariatric related surgery. Baseline 
characteristics and summary of physiological variables are presented in Table 5.1.  
The mean values for !VCO2  were significantly higher at sequential time-points (pre-
pneumoperitoneum T0: 193.3 ± 41.0 ml.min-1; post-pneumoperitoneum T1: 205.6 ± 
40.6 ml.min-1; 2nd post-pneumoperitoneum T2: 227.4 ± 42.2 ml.min-1; p < 0.01). 
Similarly mean values for VR were higher at progressive time-points (T0: 1.13 ± 
0.28; T1: 1.24 ± 0.25; T2: 1.36 ± 0.27; p < 0.01). In contrast the mean values across 
the three groups were fairly similar for VD / VT phys (T0: 0.44 ± 0.07; T1: 0.45 ± 0.06; 
T2: 0.43 ± 0.07; p = 0.12).  
 
97 paired readings were identified where the change in VD / VT phys was between -0.02 
and 0.02. Of these 72 paired readings had a change of  > 5% in !VCO2  between the 1st 
and 2nd reading. The delta values for !VCO2  and VR were calculated for these 
readings. Figure 5.1 shows the percentage change VR plotted against the percentage 
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change of !VCO2 . The values show good correlation between the delta values of the 2 
variables (r = 0.79, p < 0.01). The range of change in !VCO2  pre and post exogenous 
CO2 addition (pneumoperitoneum) was – 22% to 66% (mean 13%). The range of 
delta VR pre and post exogenous CO2 addition was – 14% to 44% (mean 13%). 
Linear regression analysis described the relation of the delta values of the 2 variables 
as follows: Delta (%) VR  = 0.85 * Delta !VCO2  (95% CI slope: 0.77 – 0.93, p < 
0.01).  
 
 Obese (53) Normal-Weight (26) p Value 
Gender (Female:Male) 47 : 6 17 : 9 0.03a 
Age (years) 44 (31-50.5) 48 (34.75-58.8) 0.06b 
BMI 47.59 ± 7.025 26.81 ± 4.945 < 0.01b 
    
Mechanics 
Ventilation Mode 
(Volume:Pressure) 
28:25 21:5 0.03£ 
Minute Volume (l.min-1) 7.4 ± 1.6 6.6 ± 1.6 0.04 
!VCO2  (ml.min-1) 173.2 ± 43.2 141.8 ± 26.64 0.01 
Pmean (cm H2O) 10.55 ± 2.18 7.231 ± 1.61 < 0.01 
Static Compliance (ml/cm H2O) 77.32 ± 41.17 82.17 ± 14.86 0.56 
Gas Exchange 
FiO2 0.52 ± 0.02 0.54 ± 0.02 0.56 
EtCO2 (KPa) 4.36 ± 0.09 4.27 ± 0.13 0.61 
PaCO2 (KPa) 4.84 ± 0.96 4.73 ± 0.139 0.53 
PaO2 (KPa) 20.05 ± 1.21 31.23 ± 2.33 <0.01 
 Intra-abdominal pressure  
T2 14 (13-15) 14 (13.75-15) 0.55§ 
T3 14 (12-15) 14 (13-15) 0.37§ 
Table 5.1 Baseline demographics of the 2 groups post induction. BMI body mass index,VCO2 volume 
of expired CO2, FiO2 Fraction of inspired O2, EtCO2 End-tidal CO2, PaCO2 Partial pressure of arterial 
CO2, and PaO2 partial pressure of arterial O2 ( a. Fisher’s exact test. b. Unpaired t test. c. Mann-
Whitney test. (p values are for unpaired t test except where marked. § = Mann-Whitney test, £ = 
Fisher’s Exact test). 
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Figure 5.1. Delta !VCO2  plotted against delta VR. (The delta values were calculated by subtracting 
Pre-pneumoperitoneum values from post-pneumoperitoneum values). 
 
5.1.3 Discussion  
The findings of this observational study are similar to those seen in the model analysis 
in the previous chapter. A rise in !VCO2  was associated with a corresponding rise in 
VR if VD / VT phsy remained unchanged. The relationship between the delta values of 
two variables showed reasonable linearity. There was also strong positive correlation 
between the 2 variables. 
 
Linear regression equation of the delta values suggests that for a given percentage 
change in !VCO2  the corresponding percentage change in VR is slightly smaller. The 
exact reasons for these findings are difficult to deduce from this study. Although they 
may be explained by the following: 
 
1. The body would buffer a proportion of the exogenous CO2 absorbed during 
insufflation and would not all be directly eliminated. It would stand to reason 
that the magnitude of change in VR would be smaller than the corresponding 
change in VR. 
2. The second readings in the pair were taken after the introduction of 
pneumoperitoneum. This would invariably lead to changes in ventilatory 
efficiency. Whilst the readings with high delta values of deadspace were 
excluded from the analysis invariably there would be an effect of changing 
deadspace that would have influenced VR. 
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3. Whilst adequate time was factored in for equilibration prior to readings, there 
was constant addition of CO2 into the peritoneal cavity and a steady leak in the 
of CO2. This would inevitably lead a slight lag in !VCO2  measurements made 
by the capnograph.  
 
It is unrealistic to expect the correlation to be close to 1 as seen in the physiology 
simulator in chapter 4. Natural variations in readings in biological systems are 
inherent particularly in the context of repeated readings in multiple individuals using 
various measurement systems. Correlation coefficient of 0.79 between the delta 
values is probably clinically reasonable and in line with what would be anticipated 
within the limitations of the study design.  
 
In summary, findings in this study show that increased CO2 production leads to an 
increase in VR. The relationship between delta values of !VCO2 and VR exhibit 
linearity and validates the physiological analysis presented in the previous chapters. 
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5.2 Study 5: Variability of CO2 Production in Critically Ill Mechanically 
Ventilated Adult Patients 
 
5.2.1 Introduction 
We know that physiological analysis of VR shows that it is influenced by dead space 
and CO2 production ( !VCO2 ). 
    [32]   
where k is a constant specific to the patient and depending on their predicted values. 
Closer inspection of the above equation shows that VR is in effect similar to the 
concept of ‘ventilatory demands’ as described elsewhere (104-106). A rising value of 
VR would reflects a failure to meet the ventilatory demands of the body; be it as a 
result of ventilatory strategy or lung pathology or both. 
 
Primarily the high ventilatory demands seen in acute respiratory failure are mostly 
thought to be due to a rise in deadspace ventilation (84, 105, 106). In contrast Kiiski 
and colleagues have suggested that hypermetabolism rather than dead space 
ventilation is the leading cause of increased ventilatory demands seen in acute 
respiratory failure (104). In ARDS patients however they too found that deadspace 
ventilation was the more relevant contributor to increased ventilatory demands. In 
general high CO2 production in this group of patients is thought to be relatively 
uncommon (107).  
 
Whilst there have been studies examining the role of CO2 production in rising 
ventilatory demands, little is known of the variability of !VCO2  in this group of 
patients. To gain complete understanding of CO2 elimination it is essential to 
understand the dynamics of CO2 production. CO2 production is difficult to measure 
directly. As discussed in the methods section the NICO monitor combines a 
capnograph with a flow sensor. This allows for real time integration of CO2 
concentration with expired volume and thereby giving breath-by-breath volume of 
CO2 elimination ( !VCO2 ). !VCO2  measurements using this technique have shown 
reasonable correlation with metabolic cart which traditionally has been the standard 
VR =
!VCO2
1!VDVT
" k
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method of measuring !VCO2  (96). In steady state the amount of CO2 excreted by the 
lung equals the amount of CO2 produced by the body. Therefore in steady state !VCO2  
measurements may be used as a surrogate for CO2 production. 
 
The primary objective of this study was to examine the variability of !VCO2  in 
critically unwell patients in mandatory and spontaneous modes of ventilation. An 
understanding of the variability of !VCO2  would give an indication of the resulting 
variability in VR.  
 
It is anticipated that VR is likely to differ in patients breathing spontaneously 
compared to those in mandatory modes of ventilation. These differences in ventilatory 
efficiency would be as a result of either increased dead space fraction or increased 
CO2 production or both during spontaneous ventilatory support. A secondary 
objective of the study is to assess the relative participation of each of these variables 
in the observed changes in VR at the transition from mandatory to spontaneous modes 
of ventilation. 
 
5.2.2 Methods  
5.2.2.1 Patients 
This observational study involved retrospective analysis of prospectively collected 
data. The setting of the study was in a single-centre mixed medical-surgical adult ICU 
at Chelsea and Westminster Hospital, London UK. Mechanically ventilated patients 
anticipated to require prolonged intubation or with acute respiratory failure are 
routinely monitored with volumetric capnography during the first week of ventilation 
at the study centre. Permission was granted from the local institutional ethics board to 
analyse the data retrospectively. All patients were ventilated with Evita XL ventilator 
(Draeger, Leubeck, Germany). The modes of ventilation were either SIMV with 
assisted spontaneous breaths, BIPAP with assisted spontaneous breaths, or CPAP 
with assisted spontaneous breaths. Demographic data including age, sex, admission 
diagnosis, and past medical history were recorded for the purposes of the study. Only 
patients over the age of 18 were considered for the analysis.  
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For the purposes of analysis modes of ventilation were classified into three groups: 
1. Mandatory ventilation: if the patient was taking less than or equal to three 
spontaneous breaths per minute in addition to their mandatory rate.  
2. Spontaneous ventilation: when patients were in CPAP with assisted 
spontaneous breaths.  
3. Mixed mode ventilation: if patients took more than three added spontaneous 
breaths per minute whilst in SIMV or BIPAP mode.  
 
Data was only considered for analysis if patients were ventilated in a mode of 
ventilation for more than 10 consecutive hours. Readings for periods less than this 
were discarded as they were unlikely to yield meaningful information in terms of 
variability of CO2 production in a particular mode. Readings for individuals who 
returned to mandatory modes of ventilation from spontaneous mode were not 
considered for analysis.  
 
5.2.2.2 !VCO2  Measurements 
Patients were attached to a NICO monitor within 24 hours of their admission to the 
ICU. The capnograph of the NICO monitor is attached distal to the endotracheal tube 
and proximal to the Y-connector of the ventilator. Artifact of compressed ventilator 
gas is no longer a factor in the measurement of the expired volumes. This makes 
volumetric capnography a clinically practical tool to monitor CO2 kinetics.  
 
In the study !VCO2  was recorded hourly at a point when the patient was undisturbed 
and free from nursing and medical intervention for at least 5 minutes; as is the policy 
for recording all hourly vital signs on the ICU chart. Values for mixed expired CO2 (
) are also calculated by NICO. These were also recorded at same time as the 
!VCO2 . In addition hourly-recorded variables that were likely to influence !VCO2  
variability were also used for the analysis. These included sedation, muscle paralysis, 
temperature, heart rate, and feeding. For the purposes of the analysis the variables 
were recorded to give a binary outcome. For sedation and paralysis presence of a 
sedative agent or muscle relaxant as an infusion were considered as a positive. Total 
parenteral nutrition (TPN) or naso-gastric feeding at full feeding protocol was 
considered as a positive for feeding. For continuous data fever was considered if the 
PECO2
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temperature was greater than 38.0°c and tachycardia was considered as a heart rate 
greater than 110 beats per minute. 
 
5.2.2.3 Measuring Dead Space 
Dead space was calculated using the Enghoff’s modification of the Bohr equation:
  
   VDVT
=
PaCO2 !PECO2
PaCO2
    [7] 
Arterial  values were taken from the chart and the corresponding value of 
 for that hour was used to calculate physiological VD / VT. In the case of change 
of mode of ventilation readings within 3 hours of the transition were not considered 
for analysis. This was based on a study demonstrating that a minimum of 120 minutes 
was necessary to interpret !VCO2  measurements as a marker for metabolism following 
a change of ventilator settings (108). 
 
5.2.2.4 Statistical Analysis 
Data are presented as mean (± standard deviation) for continuous data and as median 
(inter quartile range) for ordinal data. Unpaired t-test was used to compare mean 
values between groups. Mann-Whitney U-test was used to compare groups where 
data were not normally distributed. 
 
The first !VCO2  reading after the connecting the patient to the NICO capnograph was 
considered as the baseline reading in that particular mode of ventilation. Variations in 
subsequent hourly readings were measured against this reading. The third reading 
after a change in mode of ventilation was considered as baseline for the new mode. 
Box-whisker plots of the percentage variation from baseline were constructed for 
individual patients in the each mode of ventilation. Box-whisker plot was also 
constructed for the median variability across the population in the 3 modes of 
ventilation. Bartlett’s test for equivalence of variance was used to assess the 
difference in inter-group variance. 
 
In order to assess the effect of fever, tachycardia, feeding, lack of sedation and lack of 
paralysis resulted in increased !VCO2 : two sub-groups were identified. High-change 
PaCO2
PECO2
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group consisted of all readings with percentage variation was greater than the third 
quartile. Normal-change group consisted of readings with percentage variation within 
the third quartile. Chi-square test was used to assess differences in the frequency of 
these variables in the two groups.  Stepwise multivariate logistic regression was used 
to examine the predictive effect of individual variables on large !VCO2  percentage 
increase in ventilation mode groups.  
 
To compare readings at the transition from mandatory to spontaneous ventilation 
Wilcoxon rank test was used to compare paired data for categorical data and paired t-
test was used to compare continuous data. 
 
5.2.3 Results 
Complete data to satisfy the pre-analysis requirements were available for 45 patients. 
The baseline characteristics and admission diagnoses of the patients are summarized 
in Table 5.2. In mandatory modes of ventilation data were available for 30 patients 
with a total of 1587 hourly readings. In spontaneous mode of ventilation 29 patients 
were eligible for analysis with a total of 1514 hourly readings. Data in mixed mode of 
ventilation was available in 9 with a total of 314 hourly readings.  
 
The range of !VCO2  in the all the readings was 90 to 410 ml min-1. Mean !VCO2  for all 
readings was 209 (± 57) ml.min-1. The range of !VCO2 in mandatory ventilation 
readings was 87 – 367 ml.min-1 with a mean value of 194 (± 50) ml.min-1. The range 
for mixed ventilation readings was 90 - 340 ml.min-1 with a mean value of 200 (± 51) 
ml.min-1. The range for spontaneous ventilation readings was 90 - 426 with a mean 
value of 227 (± 60) ml.min-1. Mean !VCO2was significantly higher for readings in 
spontaneous ventilation compared to mandatory (p < 0.01) and mixed ventilation (p < 
0.01). Mean !VCO2 was significantly higher in mandatory ventilation compared to 
mixed mode (p = 0.02). Table 5.3 summarizes the differences in the key variables 
between the mandatory and spontaneous ventilation groups. 
 
Figure 5.2 shows the box-plot for percentage variability in mandatory and 
spontaneous modes of ventilation. The median percentage variation for the three 
modes of ventilation across the population was as follows: Mandatory 3% (IQR -4% 
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to 13%), mixed 0 (IQR -7% to 9%), spontaneous 3% (IQR -7% to 15%). Bartlett’s 
test showed that variance from baseline was higher in the spontaneous group in 
comparison to mandatory (p < 0.01) and mixed (p < 0.01) modes of ventilation. There 
was no significant difference in variance between mandatory and mixed modes of 
ventilation (p = 0.29). Table 5.3 shows comparison of variance between mandatory 
and spontaneous modes of ventilation within individual patients in whom data was 
available for both modes. In 11 out of 20 patients the variance was significantly 
higher in spontaneous modes of ventilation (Table 5.5).  
 
In mandatory ventilation the number of readings with absence of sedation (p = 0.02) 
and feeding (p < 0.01) were significantly in the high-change group compared to the 
normal-change group. There were no significant differences in readings with 
tachycardia, paralysis, and fever between the two subgroups. In spontaneous 
ventilation readings with absence of sedation (p < 0.01) was the only variable that was 
in significantly greater numbers in the high-change group.  
 
After adjusting for all five variables in a stepwise logistic regression model, feeding 
was the only variable that significantly predicted large increases in !VCO2  in the 
mandatory ventilation group (OR 2.70, p < 0.01). In the spontaneous ventilation 
group absence of sedation remained strongly associated with the high-change group 
after adjusting for other variables in multivariate logistic modelling (OR 0.58, p < 
0.01). 
 
Data was available for 15 patients at the transition from mandatory to spontaneous 
modes of ventilation. In these patients analysis of paired data showed !VCO2  (p < 
0.01) and ventilatory ratio (p < 0.01) were significantly higher in spontaneous modes 
of ventilation. There was no significant difference in VD / VT in paired analysis 
between the 2 groups (p = 0.67). An increase in VR of more than 10% was seen in 13 
out of the 15 patients. Of these 8 were as a result of increased CO2 production 
(62.5%), 4 as a result of increased physiological dead space (30.8%), and 1 patient as 
result of increase in both variables (7.7%). 
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5.2.4 Discussion 
The results of the study show that variation in !VCO2  in this ICU population is small. 
In particular variation in mandatory modes of ventilation are lower than those seen in 
spontaneously ventilating patients. In patients breathing in mandatory modes of 
ventilation feeding and absence of sedation were predictors of high !VCO2  variability. 
During spontaneous breathing absence of sedation was the only variable that 
predicted higher !VCO2  changes. Paired data for patients between mandatory and 
spontaneous modes of ventilation showed that !VCO2  was significantly higher in 
patients breathing spontaneously. Ventilatory ratio was also significantly higher in 
spontaneously ventilating patients. 
 
5.2.4.1 Carbon Dioxide Production in Critically Unwell Patients 
One of the main objectives of ventilatory support in critically unwell patients should 
be to meet the ventilatory demands of the body. Failure to do so can result in 
hypercapnia and acidosis. This must however be tempered with the need to avoid 
barotrauma and volume-trauma both of which have been associated with poor 
outcomes (109). ‘Permissive hypercapnia’ is a widely used ventilatory strategy in 
critically unwell patients with survival advantage compared to more aggressive 
ventilatory strategies (89). Animal models suggest hypercapnic acidosis may be 
independently beneficial in lung injury (110, 111). This must be balanced with the 
known deleterious effects of severe hypercapnia seen in animal models (112) and in 
humans (113). A rising value of PaCO2 can be viewed as failure to meet increasing 
ventilatory demands of the body. During permissive hypercapnia this may in part be 
due to ventilatory strategies and in part due to underlying lung pathology. 
Understanding the variability of !VCO2  becomes essential in interpreting changes in 
ventilatory demands, and with it Ventilatory Ratio. In Study 4 we see a linear 
association between VR and !VCO2 . Yet despite the simplicity of their relationship the 
relative influence of !VCO2  on VR in clinical practice in the ICU is difficult to map 
because it remains poorly studied and poorly understood. To the knowledge of the 
author, this is the first study that examines variability of !VCO2  in the ICU population. 
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In the main !VCO2  has been studied with respect to energy expenditure and feeding 
(114, 115). Metabolic processes of the body produce CO2. In the intensive care 
patient several factors can influence the rate of CO2 production. These include 
hyperpyrexia, shivering, exercise, and feeding. Increased !VCO2  has been 
demonstrated during induced hyperthermia in animal models (116) and seen in 
malignant hyperthermia (117). Reducing temperature has been associated with lower 
CO2 production (118). Likewise induced hypothermia has also been associated with 
reduced CO2 production (119). Conversely shivering with or without hypothermia can 
lead to an increase in CO2 production (120, 121). 
 
The increased metabolic demand of exercise is also associated with increased CO2 
production. Weissman and colleagues have shown that routine interventions carried 
out in the ICU are known to transiently increase CO2 production in non-comatose 
ventilated patients (122). The study showed that at rest there was minimal increase in 
!VCO2  from its lowest values. The greatest increase was seen in activities such as 
chest physiotherapy where increases close to 40% from the lowest value were 
recorded. Even passive movements of the limbs are associated with a 10%-15% 
increase in !VCO2  (122, 123). However these changes are thought to be transient and 
return to baseline shortly after the cessation of activity. In non-comatose patients rest 
and inactivity were associated with lower !VCO2 (124).  
 
The findings of this study are in keeping with the above-mentioned studies. !VCO2  
was lower in patients in mandatory modes of ventilation where the patients are likely 
to have lower ventilatory demands as a result of ventilatory support and increased 
sedation and inactivity. Patients with acute severe respiratory failure requiring 
mechanical ventilation are more likely to remain in a steady state of CO2 production 
as a result of increased sedation (125) (126). Not only were the absolute values of 
!VCO2  lower in the mandatory ventilation group, from Figure 5.3 we can see the 
median variation was also smaller. Thus the effect of !VCO2  on changing values of 
VR in mandatory modes of ventilation is expected to be relatively small. Visual 
analysis of Figure 5.2 clearly demonstrates that across the population variation in 
!VCO2  was greater whilst patients were in spontaneous ventilation. Absence of 
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sedation was an independent predictor of increased !VCO2  variation during 
spontaneous ventilation. These findings are similar to with other studies that have 
examined the effect of sedation on !VCO2  (122, 127). The finding of significantly 
higher respiratory rate during spontaneous ventilation would further increase 
metabolic demands. All these factors would explain the higher !VCO2 and increased 
variability observed during spontaneous ventilation.  
 
Variations of !VCO2  in the region of 10% are unlikely to have a profound impact on 
VR. From the regression model in study 4 a change in 10% of !VCO2 is likely to result 
in a change of 8.5% in VR. This is unlikely to represent a clinically significant 
change. The maximum !VCO2  variation observed was during mandatory ventilation 
was of a magnitude of +66%. Variability of this magnitude was rarely encountered 
and may well have been a transient increase. Had such a change been sustained it 
would have resulted in an increase of VR of 56.1% as per the regression model.  
 
Multiple studies have demonstrated the association between elevated !VCO2  and high 
caloric enteral and parenteral feeding (128, 129). Altering the rate and type of calorie 
delivery has been proposed as a method to reduce the ventilatory load in patients that 
are difficult to wean from the ventilator (130, 131). The findings of this study showed 
that during mandatory ventilation feeding was a predictor of higher !VCO2 . This effect 
was not observed during spontaneous ventilation. Interesting to note is that during 
spontaneous ventilation the compensatory mechanisms for maintenance of CO2 
homeostasis are maintained i.e. individuals are able to respond by increasing their 
minute ventilation. This may be a factor why feeding was not a significant predictor 
of bigger changes in !VCO2  during spontaneous ventilation. The rise in metabolic 
demands as a result of feeding would manifest itself as a rise in minute ventilation in 
this group of patients. The theory is in part substantiated by significantly higher 
minute ventilation during spontaneous ventilation. During mandatory ventilation the 
prescribed minute ventilation if unaltered would results in an increase in !VCO2 . 
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Although elevated !VCO2  is an unquestionable adverse consequence of feeding in 
critical illness, its contributions to increased ventilatory demands is questionable 
particularly in patients with good ventilatory reserve. Raurich and colleagues showed 
that discontinuation of artificial nutrition only resulted in a 5% reduction !VCO2  in 
ICU patients (132). This is likely to represent an insignificant reduction in the overall 
ventilatory load in weaning patients.  
 
5.2.4.2 Transition from Mandatory to spontaneous modes of ventilation 
Paired analysis of patients transitioning from mandatory to spontaneous modes of 
ventilation showed that !VCO2  was significantly higher during spontaneous 
ventilation. The cumulative effect of higher values and greater variability of !VCO2  in 
spontaneously ventilating patients would lead to higher values of VR in this group of 
patients. !VCO2  will exert a greater effect on changing values of VR in comparison to 
mandatory modes of ventilation. Yet given that variance in !VCO2  is relatively small, 
even in spontaneous ventilation, changing trends in VR could continued to be used as 
an index of ventilatory performance. Its absolute value however would be anticipated 
to be higher in comparison to mandatory modes of ventilation. In patients in 
spontaneous modes of ventilation this would limit its use as a marker to monitor 
disease progression and its role as a prognostication tool is at present less clear. The 
absolute numerical values of VR obtained during sedated and resting spontaneous 
ventilation requires further examination. 
 
The increase in CO2 production at the transition from mandatory to spontaneous mode 
are in keeping with the findings of Kemper and colleagues (133) They also looked at 
rising values of !VCO2  at the point of transition as a predictor of successful weaning 
from mechanical ventilation. The study failed to show significant differences in 
!VCO2  between the successful and unsuccessful groups (133). This was a small study 
looking specifically at post-operative patients. It may be that in bigger populations 
kinetics of VR at the transition point from mandatory to spontaneous modes of 
ventilation may be used as an index to predict successful weaning.  
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5.2.4.3 Limitations 
There are several limitations to this study: 
1. This was an observational study therefore the results must be interpreted with 
a degree of caution and as a platform for future studies. 
2. For a patient in steady state CO2 elimination equates to CO2 production. The 
period to obtain steady state in this case was limited to 5 minutes. Whilst this 
may not be the ideal, in the practicalities of a busy ICU this period of time was 
thought sufficient. Studies have shown that 5-minute steady state 
measurements of correlate well with 30-minute steady measurements 
(134). 
3. The calculations made for physiological dead space used values for PaCO2 
that were taken at times that may not necessarily coincide with the exact times 
of the recordings of mixed-expired CO2. Although there was little hour-by-
hour variation in and in most cases blood gases would have been 
obtained five minutes either side of the recording.  
 
Summary 
CO2 production varies minimally in mandatory modes of ventilation. Large changes 
in ventilatory ratio in these modes of ventilation are likely to represent changes in 
physiological deadspace. Spontaneously ventilating patients show a significantly 
greater percentage variation in !VCO2 . VR in spontaneous mechanical ventilation is 
comparatively more likely to be influenced by , although this is still anticipated 
to be small. Transition from mandatory to spontaneous modes of ventilation led to 
significantly higher VR and .  
 
In the following chapter we examine more closely the influence of dead space 
ventilation on ventilatory ratio and the interaction of both  and dead space on 
changing values of VR. 
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Variable Data 
Sex: Male / Female 30 / 15 
Age (years) 62 (±15) 
Height (cm) 172 (±8) 
Weight (Kg) 76 (±12) 
APACHE II score 19 (15 – 24) 
Outcome: Survivors / Non-survivors 29 / 16 
Admission Diagnosis:  
Respiratory Insufficiency 13 
Intra-abdominal sepsis /perforation 10 
Cardiac Insufficiency 7 
Sepsis (Non abdominal / Respiratory) 7 
Neurological Pathology 3 
Others (DKA / Trauma) 2 
Table 5.2 Baseline characteristics and admission diagnoses (DKA = Diabetic ketoacidosis). 
 
 
Variables Mandatory Spontaneous p value 
Minute Ventilation (ml.min-1) 9.7 (± 2.9) 11.1 (± 3.1) < 0.01 
Tidal Volume (ml) 582 (± 147) 586 (± 182) 0.65 
Respiratory Rate  16 (12 – 20) 20 (15 – 27) < 0.01§ 
Heart Rate  91 (± 20) 95 (± 19) < 0.01  
Fever (Yes / No) 37.1 (± 1.1) 37.4 (± 0.9) 0.01 
Feeding (Yes / No) 1193 / 354 1093 / 338 0.66£ 
Sedation (Yes / No) 1371 / 178 882 / 518 < 0.01£ 
Paralysis (Yes / No) 228 / 1236 0 / 1432 < 0.01£ 
Table 5.3 Comparison of key variables in all readings between mandatory and spontaneous ventilation 
groups (p values are for unpaired t test except where marked. § = Mann-Whitney test, £ = Fisher’s 
Exact test). 
 
 Total Mandatory Mixed Spontaneous 
Minimum -67% - 33% -37% -67% 
1st Quartile -6% -3% -8% -7% 
Median 3% 5% 1% 3% 
3rd Quartile  12% 14% 9% 16% 
Maximum 225% 82% 75% 225% 
Table 5.4 Summary of the percentage variation from baseline (1st reading) in all readings in and in the 
three ventilation groups. 
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Patient  Mandatory Spontaneous 
 
 
Count  Variance Count  Variance  p-value 
2 15 164 54 1142 <0.01* 
3 28 405 11 925 0.10 
9 30 169 17 198 0.72 
10 26 273 43 328 0.61 
11 32 1343 76 1204 0.72 
12 10 827 81 1952 0.13 
13 11 28 22 463 <0.01* 
14 21 119 73 438 <0.01* 
16 39 196 96 1265 <0.01* 
17 11 30 40 524 <0.01* 
20 38 1811 31 3041 0.14 
22 15 661 51 1258 0.16 
25 38 226 49 2450 <0.01* 
27 14 986 20 5174 <0.01* 
29 78 213 31 814 <0.01* 
30 101 157 19 560 <0.01* 
33 87 562 17 776 0.39 
35 26 309 51 1327 <0.01* 
43 22 661 43 3238 <0.01* 
44 11 722 34 711 0.98 
	   	   	   	   	   	  
Table 5.5 Comparison of paired variance data within individual patients in mandatory and spontaneous 
modes of ventilation. Differences in variance were compared using Mann-Whitney U-test (* Denotes 
significant p-values). 
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Figure 5.2 Changes in  from baseline (1st reading) in the three modes of ventilation in individual 
patients. Figure 5.2a shows the percentage change from baseline in mandatory mode of ventilation. 
Figure 5.2b shows variation in mixed mode of ventilation. Figure 5.2c shows changes from baseline in 
spontaneous mode of ventilation. Central line of the box represents the median percentage whilst the 
Box parameters represent the IQR. Whiskers represent the minimum and maximum values. 
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Figure 5.3 Box-whisker plots of percentage change in across the population in the 3 modes of 
ventilation. Central line of the box represents the median percentage whilst the Box parameters 
represent the IQR. Whiskers represent the minimum and maximum values. 
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Chapter 6: The Influence of physiological dead 
space and CO2 production on Ventilatory Ratio 
in Mechanically Ventilated Patients 
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6.1 Study 6: The Influence of Physiological Dead Space and CO2 Production on 
Ventilatory Ratio- A Prospective Study 
 
We have previously seen that VR can be defined as: 
    [24]    
For a given individual, predicted values for E and  are constants. Therefore VR 
can be redefined as: 
     [33]     
where k is specific to the individual. From the above equation we can see that VR is 
directly proportional to !VCO2  and inversely proportional to E. An increase in VR 
would be as a result of an increase in physiological deadspace fraction (VD / VT) or 
 or both. Both these variables are seldom measured in mechanically ventilated 
patients. The value of VR lies as a surrogate of these variables. In previous chapters 
we have examined the relationship in computational models. The principal aims of 
this observational study were to evaluate the relationships of  and VD / VT in 
vivo in a sample of mechanically ventilated critically unwell patients.  
 
6.1.1 Methods 
The study was approved by the local ethics committee (The National Hospital for 
Neurology and Neurosurgery & Institute of Neurology Joint REC). The study was 
conducted at the intensive care unit (ICU) in Chelsea and Westminster Hospital, 
London. Assent was obtained from families prior to recruitment to the study. Data 
were prospectively collected in mechanically ventilated patients aged > 18 years and 
with a PaO2 / FiO2 ratio less than 40 kPa. All patients were emergency admissions to 
the ICU. Patient demographics and baseline characteristics of the study population are 
summarized in Table 3.2 and Table 3.3. 
 
To evaluate the relationship of VD/VT phys,  and VR, simultaneous 
measurements were made of PaCO2 , , VD/ VT phys and . Initial measurements 
were made following stabilization of the patient and within the first 24 hours 
predicted
predicted
actual
actual
COV
E
E
COV
VR
2
2
!
!
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following admission to the ICU. Measurements were then made once daily until either 
six consecutive recordings had been made, or the patient had been weaned from the 
ventilator or died, whichever was the shorter period.  For each set of measurements a 
note was made of the mode of ventilation; mandatory (SIMV or BIPAP) or 
spontaneous (CPAP). All modes of ventilation used non-bias flow triggering. 
 
6.1.1.1 Measuring Deadspace 
Physiological deadspace (VD/VT) was calculated using the CO2SMO®Plus capnograph 
(Novometrix Medical Systems, Wallingford, USA). The CO2SMO®Plus has a 
combined flow sensor and in-line capnograph that allows real-time simultaneous 
measurement of expiratory flow and expired CO2 concentration. The expired CO2 
concentration is plotted against the expired volume to produce a simple single-breath 
test (SBTCO2) waveform.  The software programme Analysis Plus! for Windows 
(Novometrix Medical Systems, Wallingford, USA) was used to estimate values for 
physiological deadspace (VD / VT), using areas under the SBT-CO2 waveform as 
described by Fletcher and colleagues (Figure 1.5A) (94).  
 
As a form of internal validation for the study VD/VT phys was estimated simultaneously 
using 2 methods. The second method used was the Douglas Bag method (VD/VT DB), 
where the mixed expired CO2 ( ) was measured in the exhaust gas of the 
ventilator. The results of this study are detailed in Section 3.8 (Study 1). 
 
 was measured using CO2SMO®Plus capnography. VR was calculated from 
measured PaCO2  and  as recorded by the flow sensors of the ventilator (Evita XL, 
Draeger). Ideal body weight was estimated using the formula set by the ARDSnet 
group(89). A period of 10 minutes was allowed for patients to reach steady state 
before the readings were made. 
 
6.1.1.2 Statistical Analysis 
All readings were grouped together to examine the relationship between VR and 
 and VD / VT. A modified Pearson’s correlation coefficient as described by 
Stratton and colleagues (135) was obtained to study the association between VR and 
VD / VT. This method was used to correct any bias in Pearson’s correlation coefficient 
PECO2
!VCO2
!VE
!VCO2
 
105 
as a result mathematical coupling because PaCO2  was used in computation of both 
VR and VD / VT. Multiple regression analysis was performed to evaluate the influence 
of VD / VT and  on VR.  
 
VD / VT phys was split into 3 categories according to clinical severity; normal: > 0.18 - 
< 0.51, moderate: > 0.51 - < 0.7 moderate, Severe: > 0.7 (72). Analysis of variance 
(ANOVA) was used to compare the mean values of VR in the VD / VT ordinal sub-
groups. Logistic regression analysis was applied to examine predictive probabilities of 
VR. Unpaired t-test was used to compare means between readings in the groups. 
 
From the previous chapter and other studies it was anticipated that  would be 
greater in spontaneously ventilating patients (133). Therefore for sub-group analysis 
readings were grouped depending on the mode of ventilation; mandatory or 
spontaneous. Fisher Z transformation test was used to compare correlation 
coefficients between subgroups. Paired t-test was used to compare variables between 
the 2 modes of ventilation within individuals.  
 
In individuals where data was available for serial measurements in the same mode of 
ventilation a note was made of those readings where delta VR was greater than 10%. 
Delta values of VD / VT and !VCO2  were also simultaneously noted. Changes in VR 
were apportioned to either VD / VT if the delta value was greater than 5% or !VCO2  if 
the delta value was greater than 10% or both. (delta VR > 10%). A 5% change in 
change in VD / VT was considered a clinically significant change. A 10% change in 
was considered a clinically significant change. 
 
Statistical software STATA/IC 11.1 (StataCorp, USA) was used for data analysis. 
Graphs were constructed using Prism 5 for Mac OS X (Graphpad Software Inc, San 
Diego California USA, www.graphpad.com). 
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6.1.2 Results 
48 patients (33 men and 15 women) were recruited to the study. In total 168 sets of 
daily readings were taken; 106 were taken whilst patients were in a mandatory mode 
of ventilation and 62 from patients in a weaning mode of ventilation. The median 
number of daily sets of readings per patient was 3 (range 2-6). The mean value of VR 
in all the readings was 1.97 (SD ± 0.82; range 0.79 – 5.4).  
 
There was significant positive correlation between VR and VD / VT (modified 
correlation coefficient = 0.71, p < 0.01) in all readings (Figure 6.1). In comparison to 
mandatory modes of ventilation, readings in spontaneous modes of ventilation 
showed weaker correlation between VR with VD / VT (modified mandatory mode: 
modified r = 0.76, p < 0.01; spontaneous mode: modified r = 0.67, p < 0.01)(Figure 
6.2A and 6.2B respectively). There was weak correlation between VR and  (rp 
= 0.14, p = 0.08). Table 6.1 summarises the differences in respiratory variables during 
mandatory and spontaneous ventilation.  
 
Multiple linear regression analysis was used to investigate the relative influence of VD 
/ VT  and  on VR. The analysis showed significant effect of VD / VT and  
on VR (VR = - 2.37 + VD / VT phys * 5.29 + * 0.005; p < 0.01). In the model VD 
/ VT had a greater effect on VR than  (standardized regression coefficients: VD / 
VT ! = 0.85,  ! = 0.37). 
 
Table 6.2 shows the correlation values for VR and VD / VT within patients over time 
in all patients with five consecutive daily readings. In most cases the correlation 
coefficient between the two variables was greater in individuals than in the total 
readings pooled together. 
 
Figure 6.3 shows VR values in different VD / VT ordinal sub-groups in readings taken 
in patients in mandatory modes of ventilation. One-way ANOVA showed that the 
mean values of VR in the groups were significantly different (p < 0.01).  Concordance 
values obtained from logistic regression analysis was used to measure the association 
of predictive probabilities of VR and observed ordinal response of VD / VT measure. 
In mandatory modes of ventilation the concordance between VR and the ordinal 
!VCO2
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groups of VD / VT  was 84.7% and in spontaneous mode of ventilation the 
concordance was 80.9%. 
 
Comparison of paired values between mandatory and spontaneous modes of 
ventilation in 21 individuals showed that VR was significantly higher during 
spontaneous ventilation compared to mandatory ventilation (2.03 vs 1.73, p < 0.01). 
 was also significantly higher during spontaneous ventilation (210 ml.min-1 vs 
186 ml.min-1, p = 0.02). There was no significant difference in VD / VT phys between 
the 2 modes of ventilation (spontaneous 0.56 vs mandatory 0.57, p = 0.48).  
 
In 57 paired readings a 10% increase in VR was observed whilst patients were in the 
same mode of ventilation. 37/57 (65%) of the changes were due to dead space alone. 
7/57 (12%) were due to changes in  alone. 8/57 (14%) were due to changes in 
both variables, and in 5/57 (9%) of the readings the variables moved in the opposite 
direction. 
 
6.1.3 Discussion 
The principal aim of this study was to examine the relationship of VR, VD /VT, and 
 in mechanically ventilated patients in the ICU setting. Observations in these 
patients show that as anticipated VR is influenced by both  and VD / VT phys. 
There was reasonable correlation between VR and dead space. Linear regression 
modelling shows that in this population VD / VT phys is more influential in predicting 
VR. In particular in patients in a mandatory modes of ventilation the correlation 
between VR and VD / VT phys appears stronger. Correlation of VR with VD / VT phys 
was also stronger in serial measurements within individual patients. VR was 
predictive of severity of dead space groups in 85% of the readings. 
 
Ventilatory Ratio is a marker of the body to cope with the ventilatory demands of an 
individual.  A rise in ventilatory demands would be as a result of either a rise in 
or a rise in VD / VT phys or both. The findings in this study show that in 79% of 
the patients changing values of VR was as a result of a change in dead space and in 
65% of these cases this was exclusively due to changes in dead space. Ravenscraft 
!VCO2
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and colleagues have similarly shown that in mechanically ventilated patients  is 
less of a contributor than VD/VT in rising ventilatory demands encountered during 
respiratory failure (84). In sedated and ventilated patients in steady state it is 
anticipated that  will remain relatively stable and this has been observed in 
Study 5 in chapter 5. In such patients the changes seen in VR are much more likely to 
be as a result of changes in VD / VT phys. The improved correlation and predictive 
power of VR in patients in mandatory modes of ventilation substantiates this.  
 
The results from this study show that  was greater when patients were 
spontaneously ventilating and VR was also greater in these patients. The described 
mathematical model of VR is similar to the physiological relationship of !VA , !VCO2 , 
and PaCO2  described by Nunn (85). As  increases the isopleth describing the 
relationship of !VA and PaCO2 shifts upwards. Once a patient reaches steady state, i.e. 
they are established on an isopleth subsequent changes in VR over time could 
continue to be utilized as effective tool to monitor efficiency regardless of the mode 
of ventilation. As a result of the increased variability in  in spontaneous 
ventilation however its absolute value may be more difficult to interpret in this 
setting. 
 
Improved correlation between VR and VD / VT phys over repeated measures in the 
same patient suggest that VR is more reliable as a marker of ventilatory efficiency 
within individuals (Table 6.2). Figure 6.4a to 6.4e illustrates changes in VR with 
corresponding changes in  and VD / VT phys in 5 selected patients. Visual 
analysis of these graphs show that within individuals VR behaves as would be 
anticipated given the respective changes in the 2 variables exerting influence on 
ventilatory demands.  
 
The findings of the study also show that VR has good predictive value of categorizing 
patients into subgroups according to severity of their dead space abnormality (Figure 
2). These findings add strength to the argument that VR could be used as a clinical 
tool to assess ventilatory efficiency.  
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It is worth restating that VR is not an absolute measure of deadspace. The premise of 
VR is that it should allow clinicians a relatively quick method of tracking the ability 
of the lungs to cope with the body’s ventilatory demands. Provided there has been no 
change in the ventilatory strategy, in a patient in steady state a change in VR is likely 
to indicate a change in ventilatory efficiency. If there was no evidence of altered dead 
space then the changes seen would most likely be as a result of changing . As 
seen from the study 5 large changes in !VCO2  are rare. The use of the predicted values 
for minute ventilation and PaCO2  allows comparison within patients over time and 
across populations. Whilst VR may be a relatively crude measure of ventilatory 
efficiency it has potential to allow clinicians to use the concept of dead space in day-
to-day practice with considerable ease.  
 
Figure 6.1 Ventilatory ratio plotted against VD / VT phys in all readings using the single-breath test. The 
results demonstrate the asymptotic relationship of the 2 variables. The results are from Study 6. 
 
  
 
Figure 6.2 Ventilatory ratio plotted against VD / VT phys in readings taken in mandatory (Figure 6.2A) 
and Spontaneous (Figure 6.2B) modes of ventilation. The results are from Study 6. 
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Figure 6.3. Shows VR, , and VD / VT phys plotted over the course of time in 5 patients. The Y-axis 
is scaled according to the individual patients to show changing values of VR within patients and the Y-
axis is not consistent between the graphs. Figure 6.3A Patient 3 with intra-abdominal sepsis and 
ventilator associated pneumonia. Figure 6.3B Patient 18 with sepsis and pulmonary oedema. Figure 
6.3C Patient 23 with necrotizing fasciitis that develops ARDS. Figure 6.3D Patient 29 with cardiac 
arrest and acute pulmonary oedema. Figure 6.3E Patient 55 develops ARDS following emergency 
small bowel resection. The results are from Study 6. 
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Figure 6.4 VD / VT phys categorized into subgroups in readings taken in a mandatory mode of ventilation 
(n = 106). Middle bar represents the mean values and the bars above are below represents 95% 
confidence interval (p < 0.01). The results are from Study 6. 
 
 
 Mandatory Mode Spontaneous Mode p-value 
VR 1.9 (± 0.83) 2.09 (± 0.80)  0.15 
VD / VT 0.62 (± 0.13) 0.59 (± 0.12) 0.10 
 (mls.min-1) 186 (± 57.3) 219 (± 68.2) < 0.01 
VE (l.min-1) 10.3 (± 3) 13.1 (± 4) < 0.01 
PaCO2 6.1 (± 1.3) 5.3 (± 1.5) < 0.01 
Table 6.1 Mean values of measured and calculated variables.  Values in the brackets show standard 
deviations. P-values were derived using unpaired T-test. 
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Patient number	   r 
3 0.96 
4 0.79 
5 0.97 
13 0.94 
14 0.94 
17 0.95 
19 -0.64* 
23 0.95 
24 0.71 
29 0.96 
37 0.90 
49 0.75 
55 0.99 
Table 6.2 Shows the correlation coefficients (corrected Pearson’s r) between VR and VD / VT phys in 
individual patients with readings for 5 days or more. (* represents a patient where VD / VT phy remained 
relatively stable and the variation in  was greater). All coefficient value were statistically 
significant.  
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6.2 Study 7: The Influence of Physiological Dead Space and CO2 Production on 
Ventilatory Ratio- A Retrospective Study 
 
A larger database was available to analyse the relationship of physiological 
deadspace, !VCO2  and VR. Patients in this study were the same as Study 5. Outlined 
briefly is a refresher of the methods used to collect data and the analysis protocol. The 
conditions in which data was acquired were uncontrolled. Neither the timings of the 
arterial blood gas sample nor the measurements of minute ventilation were regulated. 
These data could not be used for precise extrapolation or analysis. The purpose of the 
study was to examine trends in the relationship of VR, VD / VT, and !VCO2 . 
 
6.2.1 Methods 
The observational study involved retrospective analysis of prospectively collected 
data. The setting of the study was a single-centre mixed medical-surgical adult ICU at 
Chelsea and Westminster Hospital, UK. Mechanically ventilated patients anticipated 
to require prolonged intubation or with acute respiratory failure are routinely 
monitored with volumetric capnography during the first week of ventilation at the 
study centre. Permission was granted from the local institutional ethics board to 
analyse the data retrospectively. All patients were ventilated with Evita XL ventilator 
(Draeger, Leubeck, Germany).  
 
Patients were attached to the NICO capnograph within 24 hours of their admission to 
the ICU. !VCO2  was recorded hourly at a point when the patient was undisturbed and 
free from nursing and medical intervention for at least 5 minutes; as is the policy for 
recording all vital signs on the ICU chart. Values for mixed expired CO2 (PECO2 ) as 
calculated by the NICO monitor were also recorded hourly.  
 
Values recorded for the hour where arterial PCO2 was measured were used for 
analysis in the study. Values of PaCO2  and PECO2 recorded were used to calculate 
dead space using the Enghoff modification of the Bohr equation. The recorded hourly 
value for minute ventilation was used to calculate VR. 
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6.2.1.1 Statistical Analysis 
To recreate the graph in Figure 4.4A, three arbitrary but clinically distinct ordinal 
groups were created according to !VCO2 . The readings were grouped as follows 
!VCO2  125 ± 15 ml.min-1, 175 ± 15 ml.min-1, and 225 ± 15 ml.min-1. ANOVA was 
used to examine the differences in mean VR values between the 3 groups. 
 
The data were analysed for simple pattern recognition only. Graphs were constructed 
to examine the relationship of VR with the 2 other measured variables to elicit 
patterns.  
 
6.2.2 Results 
528 readings in 25 mechanically ventilated patients were available for analysis where 
data was available for !VCO2  and for calculation of deadspace and Ventilatory Ratio. 
Of these 230 readings were whilst patients were in a mandatory mode of ventilation, 
and 298 were whilst patients were in a spontaneous mode of ventilation. Figure 6.5a 
and 6.5b shows VR plotted against VD/VT in readings in mandatory and spontaneous 
modes of ventilation respectively. The two variables were significantly correlated in 
both modes of ventilation with stronger correlation in mandatory mode (Pearson r = 
0.78, p < 0.01) than spontaneous mode of ventilation (Pearson r = 0.54, p < 0.01). 
Figure 6.6 shows VR plotted against VD/VT with readings grouped according to 
. ANOVA showed the mean VR to be significantly different between the 3 
groups (p < 0.01).  
 
6.2.3 Discussion 
The results from the retrospective analysis of routine ICU data show that VR has an 
asymptotic relationship with dead space in mandatory modes of ventilation. The 
correlation between the variables is stronger when patients were in mandatory modes 
of ventilation in comparison to spontaneous modes of ventilation. As anticipated 
higher !VCO2  was associated with higher VR for a given value of VD/VT.  
 
There are several limitations to this study and therefore few conclusions can be 
reached. The large number of measurements do however allow for observation of 
!VCO2
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patterns of the relationship of VR with !VCO2 and VD/VT. One of the major 
shortcomings of the study was that the results were collected as part of routine 
monitoring and no active measures were taken to ensure that the patients were in 
steady state. This may account for the poor correlation between VR and deadspace 
during spontaneous ventilation. The timings of the ventilatory recordings were ad-hoc 
in relation to arterial blood gases.  
 
Figure 6 shows the relationship of VR with physiological deadspace in the three 
ordinal groups of !VCO2 . The figure illustrates the relationship is as anticipated. 
Higher !VCO2  resulted in higher VR for a given VD/VT. In the context of the 
limitations of this study the graph is a crude representation of the figures 4.4A 
observed in study 3.  
 
It is interesting to note that there was poorer correlation between VR and VD/VT in 
readings taken in spontaneous modes of ventilation. In particular the observed 
relationship was vastly different in this study compared to those observed in study 6. 
Aside from the timing of the collection of arterial blood gas sample, expired minute 
ventilation recorded on ICU charts is more likely to be idiosyncratic in patients 
breathing in spontaneous modes of ventilation. This could therefore easily lead to 
inaccuracies in calculating VR. This particularly highlights the need for a period to 
attain steady state before using the measured minute ventilation to calculate VR as 
was the case in study 6. Secondly, as demonstrated in the previous chapter there is 
increased variability in !VCO2  in spontaneously breathing patients therefore a longer 
period to achieve steady state may be more appropriate before recording arterial blood 
gas samples. 
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Figure 6.5 Ventilatory ratio plotted against VD / VT phys in readings taken in mandatory (Figure 6.5A) 
and Spontaneous (Figure 6.5B) modes of ventilation. The results are from Study 7. 
 
Figure 6.6 Ventilatory ratio plotted against VD / VT phys with readings categorized into groups according 
to . The  were grouped as follows 125 ± 15 mls, 175 ± 15 mls, 225 ± 15 mls. 
 
 
6.3 Chapter Summary 
In summary, the results from this chapter validate the physiological analysis of VR 
presented in chapter 2. Ventilatory Ratio is an intuitive and easy to calculate index. In 
mandatory modes of ventilation VR strongly correlates with VD / VT  and is able to 
predict the degree of abnormality. The values of VR in spontaneously ventilating did 
not correlate with physiological deadspace as well. Within individual patients changes 
in VR strongly correlates with changes in VD / VT phys. VR may be a simple and 
clinically useful tool for monitoring, prognostication, and researching ventilatory 
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efficiency in mechanically ventilated patients in steady state. Further analyses are 
required to assess its clinical utility in the ICU population. These are examined in the 
following chapter. 
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Chapter 7: Examination of Ventilatory Ratio as 
a Clinical Tool 
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7.1 Introduction 
In previous chapters we have discussed in detail the physiology behind the derivation 
of VR. We have also looked at the factors influencing VR both in models and in 
mechanically ventilated patients. The real imperative for an index such as VR is to 
provide information that is clinically useful and different to what is already available 
at the bedside. We know that VR gives us an idea about efficiency of ventilation. This 
could help categorise disease severity in patients with respiratory failure and ARDS. 
Current methods for categorizing patients using PaO2 / FiO2 already exist; however 
VR could provide additional and different information. The objective of this chapter 
is to examine the use of VR as a clinical tool in 4 different databases. 
 
To demonstrate clinical efficacy of VR we need to show: 
• An association with mortality 
• That it changes over time and this may reflect in changes in outcome 
• That it is different from existent indices  
• That it has similarities with other indices of ventilatory efficiency  
 
In chapter 3 the methods of collecting the databases has been described. The methods 
section of each of the databases listed below outlines the protocol for analysis of the 
database. 
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7.2  Royal Brompton Hospital Database  
7.2.1 Methods 
Permission was granted from the local ethics committee to analyse the data. Data 
were available for demographics, admission diagnosis and co-morbidities, respiratory 
variables, and arterial blood gas results. All patients included in the analysis were 
above the age of 18. In order to capture data for individuals of interest, only data for 
those patients mechanically ventilated for 5 days or more were included in the 
analysis. Low tidal volume ventilation was in practice during the period of database 
collection at the institution. Most patients were considered to be in mandatory modes 
of ventilation if they had less than five spontaneous breaths per minute whilst they 
were in SIMV or BIPAP modes. Conversely spontaneous ventilation was considered 
if patients were managed with pressure support ventilation only. 
 
The first blood gas sample of an admission was not used for analysis as this may have 
been a representation of the conditions surrounding intubation or the pre-intubation 
state. The second blood gas sample was used for the admission sample as this was 
more likely to representative of the lungs in steady state. The respiratory and 
ventilatory data at this time-point was considered as admission data (unless the 
subsequent ABG sample was > 4 hours later, in which case the first sample-point was 
considered as admission data). Subsequently, daily data recorded at the time of the 
ABG sample between 0500 – 1000 hours were used for analysis. Daily data was 
recorded until discharge from ICU or death. Laboratory blood results and APACHE II 
scores were not available for analysis.  
 
Primary end-point was considered as death prior to ICU discharge. Ventilator days 
were used as a secondary outcome measure. Patients were considered free of 
mechanical ventilation if they were no longer receiving pressure support ventilation.  
 
For comparison of VR with patients with lower clinical acuity, data were analysed for 
ventilated patients undergoing routine cardiac surgery admitted to the cardiac ICU. 
These patients were considered the control group. All patients in the control group 
were free from mechanical ventilation on either day 1 or day 2. 
 
 
121 
For subgroup analysis the study group were split into survivors and non-survivors. In 
addition the survivors group were further sub-divided into those with an admission 
VR of greater or equal to 1.4 and those with an admission VR < 1.4. The value of 1.4 
was chosen as the cut off as this was population mean. These groups were used assess 
the association of VR with ventilator days.  
 
To study the pattern of VR over time and its effect on outcome, VR for individual 
patients was plotted along time whilst they were in a mandatory mode of ventilation. 
Patients were excluded for analysis if there was a change in VR over time was less 
than 10%, the highest VR was less than 1.2, and there were less than three readings 
whilst the patient was in a mandatory mode of ventilation. 
 
The behaviour of VR during the transition from mandatory to spontaneous modes of 
ventilation was examined in 349 survivors. Delta VR was described as the first VR 
value during spontaneous ventilation subtracted from the VR value immediately 
before during mandatory ventilation (VRmandatory – VRspontaneous). The percentage 
change in VR at this point was calculated. To compare the effects of changing values 
of VR the population was then split in to two groups: those with delta VR greater than 
or equal to 30% and those where delta VR was less than 30% (n = 227) at the 
transition point. 
 
7.2.1.1 Statistical Analysis 
Normally distributed continuous data are expressed as mean and standard deviation. 
Non-parametric data are expressed as median and interquartile range. Unpaired t-test 
was used for intergroup comparison of means and Mann-Whitney test was used to 
compare medians for non-parametric data. Multiple comparisons of means of groups 
were made using one-way analysis of variance. Univariate logistic regression analysis 
was used to calculate odds ratios for multiple respiratory variables to individually 
predict mortality. To examine the relationship of hospital mortality and VR and 
adjusting for confounding variables multivariate logistic regression analysis was also 
performed. Stepwise multiple logistic regression analysis was performed to determine 
the prognostic value of ventilatory ratio after adjustment for non-pulmonary outcome 
modifiers. 
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Kaplan-Meier curves were constructed to examine the association of VR sub-groups 
and outcome (survival and ventilator days < 30 days). Log-Rank Test was used to 
compare curves of the groups and hazard ratios were calculated. 
 
7.2.2 Results 
Complete data was available for 14967 individual data time-points in 497 patients. Of 
these, 380 were admitted to the adult ICU following post-operative problems. 117 
patients were directly admitted from the wards or transferred from other centres. 
Table 7.1 summarises the primary admission diagnoses of the study group.  
 
Data was analysed for a further 86 patients that underwent routine cardiac surgery and 
were admitted to the cardiac ICU. This group served as a control group. There were 
no mortalities in this group. Mean values for VR on admission were significantly 
higher in the study group compared to the control group (Study group 1.44, 95% CI 
1.39 – 1.49 vs control group 1.02, 95% CI 0.98 – 1.06; p < 0.01). The differences in 
baseline characteristics in these groups are summarized in table 7.2.  
 
Data on outcomes was available on 479 patients in the study group. Outcome data on 
18 patients was unavailable because they were transferred to another hospital whilst 
still on ventilatory support. 358 (74.7%) patients in the study group survived until 
ICU discharge and 121 (25.3%) died whilst in ICU. Differences in demographic data 
and respiratory variables between survivors and non-survivors are presented in Tables 
7.3 and 7.4 respectively.  
 
Figure 7.1 shows a histogram of the admission values for VR in the study group. The 
range of value for VR at admission in this population was 0.6 – 5.4. Values for VR on 
admission were significantly higher in non-survivors compared to survivors 
(survivors 1.72 CI 1.58 – 1.85, non-survivors 1.33 CI 1.29 – 1.38; p < 0.01)(Figure 
7.2). Mean value of VR was significantly higher in patients with a diagnosis of ALI  / 
ARDS (n = 69) in comparison to the rest of the population (ARDS 2.02 CI 1.8 – 2.2, 
Non-ARDS 1.30 CI 1.26 – 1.34, p < 0.01). Mean values of VR were also higher in 
patients with a past medical history of COPD (n = 69) regardless of the admission 
diagnosis (COPD 1.71 CI 1.54 – 1.84, Non-COPD 1.34 CI 1.29 – 1.39; p < 0.01).  
 
123 
There were no significant differences in mean value of VR with patient gender (Male 
1.41 vs Female 1.45, p = 0.40).  
 
Alongside VR, PaCO2, FiO2, mean airway pressure (MawP), and peak inspiratory 
pressure (PIP) were significantly higher in the non-survivors group compared to the 
survivors group on day 1 (Table 7.4). Univariate logistic regression analysis with 
mortality as outcome showed VR to be an independent predictor of outcome on day 1 
(OR 2.74, CI 1.81 – 4.15), day 2 (OR 2.73, CI 1.66 – 4.48), and day 3(OR 1.88 CI 
1.08 – 3.14). Table 7.5 summarises the findings of univariate logistic analysis of other 
respiratory variables with mortality as outcome. Stepwise logistic regression analysis 
adjusting for PEEP, PIP, and OI showed that VR remained an independent predictor 
of outcome on day 1 and day 2 (Table 7.6). VR also remained an independent 
predictor of outcome after adjusting for COPD (OR 2.84 CI 1.84 – 4.4). 
 
In subgroup analysis of patients with respiratory failure (defined as a PaO2 / FiO2 
ratio of less than 40 kPa, n = 292) VR was significantly higher in non-survivors (n = 
77) compared to survivors (n = 215) (1.75 vs 1.45, p < 0.01). Univariate logistic 
regression analysis showed that VR remained an independent predictor of mortality 
on day 1 (OR 2.75, CI 1.7– 4.5), day 2 (OR 2.59, CI 1.5 – 4.6), and day 3 (OR 1.89, 
CI 1.0 – 3.6). 
 
To further analyze the ability of VR at admission to predict disease severity, 
ventilator days was used as a surrogate. Amongst survivors VR was greater or equal 
to 1.4 in 108 patients and less that 1.4 in 215. Kaplan-Meier curves were constructed 
to examine ventilator days in the 2 groups with the end-point being 30 days of 
mechanical ventilation (Figure 7.3). The median ventilation time was 16 days for the 
< 1.4 group and 19 days for the ≥1.4 group. The hazards ratio for mechanical 
ventilation for greater than 30 days for the ≥ 1.4 group was 1.36 (CI 1.02 – 1.75).  
 
In total 306 patients that were included for analysis of VR over time. Values of VR 
were plotted against time and the gradient of the slope of each of the curves were 
calculated. The patients were split in to groups according to those with a positive 
slope and the gradient between the first and last point ≥ 0.2 (n = 112) and those with a 
neutral or negative slope and / or gradient of < 0.2 between the first and last point (n = 
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194). In the ≥ 0.2 gradient group 53 (47.3%) patients died and 59 (52.7%) patients 
survived. In the < 0.2 gradient group 36 (18.6%) patients died and 158 (81.4%) (p < 
0.01).  
 
All readings from all patients were pooled together to assess the relationship of 
individual respiratory variables on VR (n = 14966). The findings are summarized in 
Table 7.8. There was weak negative correlation between VR and indices of 
oxygenation. Figure 7.4 shows the relationship between VR and PaO2 / FiO2 (r = - 
0.29). The correlation between these two variables was stronger on day 1 (r = - 38, p 
< 0.01).  
 
Across all readings mean value of VR was significantly higher in patients during 
spontaneous modes of ventilation compared to those breathing in mandatory modes of 
ventilation (Mandatory 1.522 ± 0.63 vs Spontaneous 1.68 ± 0.62, p < 0.01). Within 
individuals, data for comparison in both mandatory and spontaneous modes of 
ventilation were available in 373 patients. In 145 of these patients VR was 
significantly higher during spontaneous ventilation. 
 
At the transition point from mandatory to spontaneous ventilation there were 122 
patients where delta VR was ≥ 30% and 227 patients where delta VR was < 30%. The 
median ventilator days in those where delta VR ≥ 30% was significantly greater than 
those patients where VR < 30% (≥ 30% group median ventilator days: 8, IQR 4-17, < 
30% group: 4, IQR 2 – 8.5; p < 0.01, Figure 7.5).  
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Diagnosis n (%) 
Cardiovascular Insufficiency 156 (31.4) 
Cardiogenic shock 92 (18.5) 
Ventricular Failure 31 (6.2) 
Cardiac Tamponade 18 (3.6) 
Malignant Arrhythmia 9 (1.8) 
Acute Myocardial Infarction 3 (0.6) 
Pericardial Effusion 3 (0.6) 
  
Respiratory Insufficiency 155 (31.2) 
ALI / ARDS 43 (8.7) 
Lower Respiratory Tract Infection 41 (8.3) 
Acute Pulmonary Oedema 35 (7.0) 
Difficult respiratory wean 13 (2.6) 
Exacerbation of COPD  13 (2.6) 
Massive Haemothorax 5 (1.0) 
Bronchopleural Fistula 4 (0.8) 
Pneumonitis 1 (0.2) 
  
Cardiorespiratory Arrest 58 (11.7) 
Cardiac Arrest  55 (11.1) 
Respiratory Arrest 3 (0.6) 
  
Peri / Post-operative Major Haemorrhage 58 (11.7) 
  
Miscellaneous 70 (14.1) 
Multi-organ Dysfunction 20 (4.0) 
Neurological Complications 20 (4.0) 
Sepsis 14 (2.8) 
Acute Renal Failure 6 (1.2) 
Routine Cardiovascular Monitoring 6 (1.2) 
Gastrointestinal Complications 4 (0.8) 
Table 7.1 ICU admission diagnosis of the study group. 
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 Study Group 
(n = 497) 
Control Group 
(n = 83) 
p values 
Sex Male 316 (64%) 59 (71%) 0.19§ 
Age 63.4 ± 15.7 62.0 ± 15 0.44 
Weight 76.2 ± 14.4 74.1 ± 17 0.28 
Height 171 ± 8.5 169 ± 10 0.11 
PaO2 / FiO2 Ratio 34.4 ± 15.6 43.4 ± 16 < 0.01 
Ventilatory Ratio 1.4 ± 0.6 1.0 ± 0.2 < 0.01 
Table 7.2 Comparison of key variables between study and control group. P values are 
for unpaired T-test for continuous variables. § P-value for Chi-square test. 
 
 
 Survivors 
(n = 358) 
Non-Survivors 
(n = 121) 
P values 
Sex Male 231 (61.1%) 73 (50.3%) 0.69§ 
Age (years) 64.5 ± 14.9 60.9 ± 17.4 0.03 
Weight (Kg) 75.7 ± 17.4 69.0 ± 14.6 < 0.01 
Height (cm) 169.7 ± 9.7 168.1 ± 9.5  0.11 
Table 7.3 Comparison of demographic data between survivors and non-survivors. P 
values are for unpaired T-test for continuous variables; § Chi-square test. 
 
 Survivors 
(n = 358) 
Non-Survivors 
(n = 121) 
p Values 
Minute Ventilation (l.min-1) 7.8 ± 0.1 7.8 ± 0.2 0.88 
PaCO2 (kPa) 5.6 ± 0.1 7.0 ± 0.3 < 0.01 
Ventilatory Ratio 1.3 ± 0.07 1.7 ± 0.02 < 0.01 
PaO2 (kPa) 16.5 ± 0.4 17.7 ± 0.8 0.11 
FiO2 0.51 ± 0.01 0.58 ± 0.02 < 0.01 
PaO2/FiO2 Ratio 35.1 ± 0.82 33.0 ± 1.5 0.21 
PEEP (cmH2O) 5 (5 – 7) 5 (5 – 7.75) 0.80* 
Mean Airway Pressure 11 (10 – 15) 13 (10.25 – 18) < 0.01* 
Peak Inspiratory Pressure (cmH2O) 28 (24 – 32) 30 (25 – 36) < 0.01* 
Oxygenation Index (cmH2O.kPa-1) 50.1 ± 2.2 67.1 ± 6.3 < 0.01 
Table 7.4 Comparison of respiratory variables between survivors and non-survivors. P 
values are for unpaired T-test for continuous variables; * Mann-Whitney Test. 
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 Odds Ratio CI p value 
Ventilatory Ratio 2.74 1.81 – 4.15 < 0.01 
PaCO2 (kPa) 1.26 1.20 – 1.54 < 0.01 
Minute Ventilation (ml.min-1) 1.01 0.91 – 1.13 0.80 
Peak inspiratory pressure (cmH2O) 1.06 1.02 – 1.10 0.02 
Oxygenation Index (cmH2O.kPa-1) 1.02 1.01 – 1.05 < 0.01 
Mean Airway Pressure (cmH2O) 1.04 1.01 – 1.07 < 0.01 
PaO2 / FiO2 Ratio 0.99 0.98 – 1.01 0.31 
PEEP (cmH2O) 0.99 0.97 – 1.01 0.67 
Table 7.5 Odds ratio derived from univariate analysis of individual respiratory 
variables on day 1 with mortality as the outcome (n = 479). 
 
 Day 1 Day 2 
 Odds Ratio CI Odds Ratio CI 
Ventilatory Ratio 2.20 1.28 – 3.61 2.04 1.17 – 3.57 
PIP (cmH2O) 1.03 0.99 -1.08 1.04 1.00 – 1.08 
PEEP (cmH2O) 0.93 0.84 – 1.04 0.92 0.83 – 1.03 
Oxygenation Index 
(cmH2O.kPa-1) 
1.00 1.00 – 1.01 1.01 1.00 – 1.01 
Table 7.6 Stepwise multiple logistic regression analysis of respiratory variables with 
mortality as the outcome in all patients in the study group. Results in the table are 
from analysis using data from day 1 and day 2.  
 
 
 Day 1 Day 2 
 Odds Ratio CI Odds Ratio CI 
Ventilatory Ratio 1.89 1.1 – 3.3 1.88 0.99 – 3.6 
PIP (cmH2O) 1.06 1.0 -1.1 1.05 0.99 – 1.1 
PEEP (cmH2O) 0.94 0.84 – 1.1 0.94 0.83 – 1.06 
Oxygenation Index 
(cmH2O.kPa-1) 
1.01 1.0 – 1.02 1.01 0.99 – 1.01 
Table 7.7 Stepwise multiple logistic regression analysis of respiratory variables with 
mortality as the outcome in patients with respiratory failure as defined by PaO2 / FiO2 
ratio of less than 40 kPa (n = 292). Results in the table are from analysis using data 
from day 1 and day 2.  
 
 
 
128 
 Correlation Coefficient p Value 
PaO2 (kPa) - 0.19 < 0.01 
PaO2 / FiO2 Ratio (kPa) - 0.33 < 0.01 
Mean Airway Pressure (cmH2O) 0.33* < 0.01 
Peak Inspiratory Pressure (cmH2O) 0.29* < 0.01 
Peak End Expiratory Pressure (cmH2O) 0.14* < 0.01 
Dynamic Compliance (ml.cmH2O-1)   
Oxygenation Index (cmH2O.kPa-1) 0.03 < 0.01 
Table 7.8 Correlation coefficient for VR and other respiratory variables. * Represents 
Spearman’s correlation coefficient. All other values are Pearson’s correlation 
coefficient. There are a total of 14966 readings used for analysis. 
 
  
Figure 7.1 Frequency distribution of VR in the study group. 1A Frequency 
distribution in all readings. 1B Frequency distribution in readings taken at admission 
only. 
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Figure 7.2 Comparison of Ventilatory Ratio between survivors and non-survivors (p < 
0.01 unpaired t-test). 
 
 
Figure 7.3 Kaplan-Meier curve for ventilator days in survivors in the study group. The 
groups were divided into those with VR ≥1.4 and those with VR < 1.4 at admission. 
Log-rank test showed the curves are significantly different (p < 0.01). 
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Figure 7.4 Ventilatory Ratio plotted against PaO2 / FiO2 Ratio. The dotted line 
represent the point on the axis that is the variable defining criteria for acute lung 
injury. There are a total of 14966 readings used for analysis. 
 
 
Figure 7.5 Ventilatory days in ordinal groups of delta VR at the transition point from 
mandatory to spontaneous ventilation. (p < 0.01, Kruskal-Wallis test). Values at the 
top of the bar represented total numbers in each group. 
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7.3 Chelsea and Westminster Database 
7.3.1 Methods 
Permission was granted from the local ethics committee to analyse the database. This 
database was collected in real time.  Similar to the database described above arterial 
blood gas (ABG) samples were used to calculate VR and PaO2 / FiO2 ratio. The data 
for respiratory variables at the time of ABG were recorded and collected for analysis. 
As routine practice hourly data is recorded on ICU charts ensuing a short period from 
when the patient has been free from nursing and / or medical intervention. The second 
blood gas after admission was used as the admission time-point to allow the patient to 
reach steady state. This was considered more likely to represent the ventilation and 
clinical state of the lungs. The first blood gas measurement after intubation was 
discarded as it may be representative of conditions surrounding intubation. 
Subsequently daily measurements were recorded / calculated using the first ABG 
measurements between 0500 – 1000 hours.  The specifications for mandatory and 
spontaneous modes of ventilation were similar to those described in the previous 
database. Low tidal volume ventilation was routinely practiced at this intensive care 
unit during the period of data collection. Daily data was recorded until the patient was 
discharged from ICU.  
 
In order to compare VR values for ICU patients and patients undergoing elective 
surgery VR was calculated for 26 patients undergoing elective gastrointestinal 
surgery. Data for this study was available from part of another larger study looking at 
respiratory mechanics during laparoscopic surgery. The blood gas was taken 20 
minutes after induction of anaesthesia prior to introduction of pneumoperitoneum. All 
of these patients were extubated post-operatively and none required prolonged 
mechanical ventilation. For subgroup analysis patients were split into survivors and 
non-survivors. In addition the survivors group were further sub-divided into those 
with an admission VR of greater or equal to 1.4 and those with an admission VR < 
1.4. These groups were used to test the association of VR with ventilator days. 
 
Data during the transition from mandatory to spontaneous modes of ventilation was 
available in 71 survivors. Delta VR was described as the first VR value during 
spontaneous ventilation subtracted from the VR value immediately before during 
mandatory ventilation (VRmandatory – VRspontaneous). Due to the small number of patients 
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available for analysis the population was divided into those with delta VR greater than 
to zero and those where delta VR was less than or equal to zero.  
 
7.3.1.1 Statistical Analysis 
Normally distributed continuous data are expressed as mean and standard deviation. 
Non-parametric data are expressed as median and interquartile range. Unpaired t-test 
was used for intergroup comparison of means and Mann-Whitney test was used to 
compare medians for non-parametric data. Multiple comparisons of means of groups 
were made using one-way analysis of variance. Univariate logistic regression analysis 
was used to calculate odds ratios for multiple respiratory variables to individually 
predict mortality. To examine the relationship of hospital mortality and VR and 
adjusting for confounding variables multivariate logistic regression analysis was also 
performed. Stepwise multiple logistic regression analysis was performed to determine 
the prognostic value of ventilatory ratio after adjustment for non-pulmonary outcome 
modifiers. 
 
Kaplan-Meier curves were constructed to examine the association of VR sub-groups 
ventilator days (admission to 30 days). Log-Rank Test was used to compare curves of 
the groups and hazard ratios were calculated.  
 
7.3.2 Results 
Data were captured on 224 patients. 106 (47.5%) patients were females and 117 
patients were male. Table 7.9 compares salient baseline variables between this 
population and patients that underwent routine elective surgery (control group). 
Similar to the previous database VR was significantly higher in the ICU population 
compared to theatre patients (ICU mean VR 1.4, CI 1.33 – 1.47; theatre mean VR 
0.99, CI 0.91 – 1.08). Comparison of key variables between the 2 variables is 
presented in Table 2.1. Subsequent results presented are of the ICU population only. 
 
The admission diagnoses of the ICU patients are summarized in Table 7.10. Figure 
7.6 shows the frequency distribution of VR in the population. The mean value of VR 
on admission was 1.4 (range 0.70 – 3.49). 39 patients had underlying COPD. Values 
on admission were higher for these patients compared to the rest of the population 
(COPD VR 1.79 vs Non-COPD 1.32, p < 0.01). There were no significant differences 
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in values of VR when other premorbid conditions such as ischaemic heart disease and 
congestive cardiac failure were analysed. 
 
Survival outcomes were available for 214 patients. 9 patients were transferred out of 
the ICU and their outcome data was not available. Table 7.11 and 7.12 show 
comparative summaries of the demographic data and respiratory variables between 
survivors and non-survivors. 154 patients survived to ICU discharged and 60 patients 
died. VR was higher on admission in non-survivors (Survivors 1.32, CI 1.24 – 1.39; 
Non-survivors 1.55, CI 1.39 – 1.70). Univariate logistic analysis showed VR was an 
independent predictor of mortality (OR 2.3 CI 1.3 – 4.1, p < 0.01). On day 2 VR 
remained a significant independent predictor of outcome on univariate analysis (OR 
2.92, CI 1.41-6.01). Table 7.13 summarises the findings of univariate logistic analysis 
of respiratory variables. After adjusting for APACHE II score, PIP, and PEEP, VR 
remained an independent predictor of mortality (OR 2.34, CI 1.03 – 4.08, p = 0.04).  
 
To further analyze the ability of VR at admission to predict disease severity, 
ventilator days was used as a surrogate. Amongst survivors VR was greater or equal 
to 1.4 in 34 patients and less that 1.4 in 120. Kaplan-Meier curves were constructed to 
examine ventilator days in the 2 groups with the end-point being 30 days of 
mechanical ventilation (Figure 7.7). VR of greater that 1.4 was more likely to results 
in prolonged ventilation (p < 0.01, HR 2.2, CI 1.4 – 3.2).  
 
At the transition point from mandatory to spontaneous modes of ventilation delta VR 
greater than zero was more likely to lead to prolonged ventilation (p < 0.01, HR 2.24, 
CI 1.3 – 2.9). The Kaplan-Meier plot is presented in Figure 7.8. 
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 ICU 
(n = 223) 
Theatre 
(n = 26) 
p values 
Age 57.8 ± 16.9 48.1 ± 13.5 < 0.01 
Weight 74.3 ± 14.9 78.2 ± 16.4 0.24 
Height 170.7 ± 7.9 170.9 ± 11.35 0.90 
PaO2 / FiO2 Ratio 34.6 ± 18.0 57.6 ± 17.1 < 0.01 
Ventilatory Ratio 1.4 ± 0.53 0.99 ± 0.51 < 0.01 
Table 7.9 Comparison of key variables between patients admitted to ICU patients and 
patients undergoing routine surgery. p Values are for unpaired T-test.  
 
Diagnosis n (%) 
Gastrointestinal Complications 60 (26.9) 
Intra-abdominal Sepsis 20 (9.0) 
Bowel Perforation/Obstruction 21 (9.4) 
Pancreatic / Hepatic Failure 7 (3.1) 
Post-operative complications 6 (2.7) 
Gastrointestinal Bleeding 6 (2.7) 
  
Respiratory Insufficiency 47 (21.1) 
Lower Respiratory Tract Infection 21 (9.4) 
Exacerbation of COPD 10 (4.5) 
ALI / ARDS 10 (4.5) 
Acute Pulmonary Oedema 4 (1.8) 
Aspiration / Pneumonitis  3 (1.3) 
  
Cardiorespiratory Arrest 37 (16.6) 
Cardiac Arrest 35 (11.7) 
Respiratory Arrest 2 (0.8) 
  
Sepsis 16 (7.2) 
Urinary 5 (2.2) 
Skin 5 (2.2) 
Neutropenic 2 (0.8) 
Unknown 4 (1.8) 
  
Miscellaneous 52 (23.3) 
Neurological Complication 15 (6.7) 
Poisoning / Overdose 13 (5.8) 
Burns 12 (5.4) 
Gynaecological Problems 8 (3.6) 
Post-op Cardiovascular Monitoring 4 (1.8) 
Multi-Organ failure 4 (1.8) 
Metabolic / Trauma 6 (2.7) 
Table 7.10 Admission diagnoses of ICU patients. 
 
 
135 
 Survivors 
(n = 154) 
Non-Survivors 
(n = 60) 
P values 
Sex Male 82 (53.2%) 31 (51.7%) 0.84§ 
Age (years) 52.6 ± 19.3 62.2 ± 17.1 < 0.01 
Weight (Kg) 75.7 ± 18.5 72.1 ± 13.2 0.17 
Height (cm) 170.8 ± 7.9 170.7 ± 8.1  0.88 
APACHE II Score 15.5 (11 – 19) 20 (19 – 23) < 0.01* 
Table 7.11 Comparison of demographic data between survivors and non-survivors. P values are for 
unpaired T-test for continuous variables; § Chi-square test, * Mann-Whitney test. 
 
 Survivors 
(n = 154) 
Non-Survivors 
(n = 60) 
p Values 
Minute Ventilation (l.min-1) 7.7 ± 2.2 8.7 ± 3.3 < 0.01 
PaCO2 (kPa) 5.5 ± 1.3 5.8 ± 1.6 0.22 
Ventilatory Ratio 1.32 ± 0.5 1.55 ± 0.6 < 0.01 
PaO2 (kPa) 17.0 ± 6.4 18.5 ± 11.0 0.22 
FiO2 0.54 ± 0.21 0.65 ± 0.23 < 0.01 
PaO2/FiO2 Ratio 36.2 ± 18 31.4 ± 17.6 0.08 
PEEP (cmH2O) 5 (5 -10) 8 (5 – 10) < 0.01* 
Peak Inspiratory Pressure (cmH2O) 21 (16 – 26) 23 (18.25 – 30.75) < 0.01* 
Dynamic Compliance 46.0 ± 29.9 38.6 ± 23.8 0.09 
Table 7.12 Comparison of respiratory variables at admission between survivors and non-survivors. P 
values are for unpaired T-test for continuous variables; * Mann-Whitney Test. 
 
 
 Odds Ratio CI p value 
Ventilatory Ratio 2.31 1.30 – 4.11 < 0.01 
PaCO2 (kPa) 1.13 0.92 – 1.40 0.22 
Minute Ventilation (ml.min-1) 1.00 1.00 – 1.01 0.01 
Peak inspiratory pressure (cmH2O) 1.07 1.02 – 1.11 < 0.01 
PaO2 (kPa) 1.02 0.98 – 1.06 0.23 
PaO2 / FiO2 Ratio 0.98 0.97 – 1.01 0.08 
PEEP (cmH2O) 1.13 1.01 – 1.27 0.03 
Dynamic Compliance 0.99 0.97 – 1.00 0.1 
Table 7.13 Odds ratio derived from univariate analysis of individual respiratory variables on day 1 with 
mortality as the outcome (n = 223). 
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Figure 7.6 Frequency distribution of VR at admission in the ICU population. 
 
 
 
Figure 7.7 Kaplan-Meier plot of ventilator days in survivors (admission to 30 days). The population 
was divided into those with VR ≥1.4 (n = 34) and those with VR < 1.4 (n = 120) at admission. Log-
rank test showed the curves are significantly different (p < 0.01). 
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Figure 7.8 Kaplan-Meier plot of ventilator days at the transition point from mandatory to spontaneous 
modes of ventilation (admission to 30 days). The population was divided into those into those with 
delta VR > 0 and those with delta VR ≤ 0. 
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7.4 ALI/ARDS Australia New Zealand Intensive Care Society Database  
7.4.1 Methods 
This is a small database consisting of mechanically ventilated patients with ALI or 
ARDS. The study predates the low tidal volume paper as published by ARDS 
Network (89). Table 7.14 summarises the baseline respiratory variables. Although the 
database was collected prior to widespread use of low tidal volume ventilation, form 
Table 7.14 we can see the tidal volumes used were reasonable. Data was only 
available for analysis on the first day that patient developed ALI / ARDS. Primary 
outcome was ICU mortality. The population was subdivided into survivors and non 
survivors. Additionally, the population was divided into ALI and ARDS to compare 
VR values in these groups. 
 
7.4.1.1 Statistical Analysis  
Data are presented as mean ± standard deviation or median with interquartile range, 
where appropriate.  Intergroup comparison used unpaired t-test or Mann-Whitney test 
(depending on the distribution of the data). Multiple comparisons of groups were 
made using one-way analysis of variance. Chi-squared test for trends was used to 
analyze the association of mortality and ordinal groups of VR.. Univariate logistic 
regression analysis was used to calculate odds ratios for multiple respiratory variables 
to individually predict mortality. To examine the relationship of hospital mortality 
and VR and adjusting for confounding variables multivariate logistic regression 
analysis was also performed. Pearson’s correlation coefficient was derived to examine 
the relationship of VR and PaO2 / FiO2 ratio.  
 
7.4.2 Results 
121 of 168 of the patients from the original database were included in the data 
analysis. These were invasively ventilated patients only. The basic demographics of 
the patients are presented in Table 7.14. The range of VR in this population was 0.56 
to 3.27. The mean VR in this population was 1.47 (SD ± 0.58). Mean values for VR 
was significantly higher in non-survivors as compared to survivors (1.7 ± 0.64 vs 1.45 
± 0.56, p = 0.02) (Figure 7.9). Increasing value of VR was associated with an 
increased risk for mortality (chi-squared test for trends p < 0.01) (Figure 7.10). ROC 
curves were constructed for VR as a predictor for mortality. Area under the curve for 
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this model was 0.64 (CI 0.53 – 0.73, p = 0.02).  A cut-off for VR of 2.05 resulted in a 
specificity of 89% with a positive predictive value for mortality of 0.67. A cut-off 
value of 0.99 gave sensitivity of 89% for survival with a negative predictive value for 
mortality of 0.17.  
 
There was no difference in VR between those with direct and indirect causes of lung 
injury (1.55 vs 1.37, p=0.07). As illustrated in Figure 7.11 patients with ARDS had a 
significantly higher mean VR in comparison to patients with ALI (1.53± 0.53 vs 1.27 
± 0.46, p=0.01). Analysis of variance by groups based on the Murray lung injury 
showed that VR was significantly different in each of the groups (MLI score <2 VR 
1.21 ± 0.45, score >2 - <2.5 VR 1.37 ± 0.37, score > 2.5 VR 1.74 ± 0.62) (136). As 
seen in Figure 7.12 there was weak negative correlation between PaO2/FiO2 ratio and 
VR in the population (r - 0.4, 95% CI -0.54 to -0.23).  
 
Univariate logistic regression analysis showed VR to be an independent predictor of 
mortality (OR 3.55, CI 1.61 – 7.84, p < 0.01). Stepwise multivariate logistic analysis 
showed that VR remained an significant independent predictor of mortality after the 
addition of APACHE II score to the baseline model (OR 3.05, CI 1.35 – 6.91, p < 
0.01) and after addition of PEEP and PIP to the baseline model and APACHE score 
(VR OR 2.55, CI 1.06 – 6.14). The findings of the analysis are summarized in Table 
7.15. 
 
 Survivor (n = 85) Non-survivors (n = 36) p-value 
Age (years) 58.6 ± 20.4 66.4 ± 13.9 0.04* 
Height (cm) 1.72 ± 0.1 1.70 ± 0.08 0.65* 
Weight (Kg) 77.6 ± 14.3 74.2 ± 15.1 0.24* 
Tidal Volume (ml) 647 ± 112 634 ± 139 0.59* 
!VE  (ml.min-1) 7742 ± 1950 8772 ± 3104 0.22
§ 
Peak Pressure (cmH2O ) 27 (24 – 33) 29.5 (25.25 -35) 0.19§ 
Plateau Pressure (cmH2O)  22 (18 -25) 20 (19.5 – 27) 0.97§ 
APACHE 2 score  18.5 ± 9.1 24.7 ± 9 < 0.01* 
PaO2 / FiO2 Ratio 24.8 ± 8.2 17.5 ± 8.6 < 0.01* 
PaCO2 (kPa) 5.7 ± 1.5 6.5 ± 2 0.06§ 
Table 7.14 Demographic data and Respiratory Variables in Survivors and Non-survivors for the 
ANZICS database. 
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Day 1 Odds Ratio 95% CI 
Univariate Analysis   
Ventilatory Ratio  3.56 1.61 – 7.84 
Multivariate Analysis   
Base model + APACHE II score 3.05 1.35 – 6.91 
(Base model + APACHE II score) + PEEP 3.00 1.30 – 6.91 
(Base model + PEEP +APACHE II score) + PIP 2.55 1.06 – 6.15 
Table 7.15 The predictive value of Ventilatory Ratio with ICU mortality as primary outcome using 
logistic regression. Data is presented for univariate and multivariate analysis. 
 
 
Figure 7.9 Comparison VR in survivors and non-survivors. The bars represent median values and the 
5%-95% range. Mean values were compared using unpaired t-test. 
 
Figure 7.10 Proportion of mortality in grouped patients with rising values in VR. Numbers at the top 
the bar represent the total number of patients in each group. 
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Figure 7.11 Comparison of VR in ARDS and ALI patients. The bars represent median values and the 
5%-95% range. Mean values were compared using unpaired t-test. 
 
 
 
Figure 7.12 Comparison of the relationship of VR and PaO2/FiO2 ratio. As the PaO2/FiO2 ratio 
decreases there is a greater spread in the values of VR. The dotted line represents the transition point of 
ALI and ARDS. 
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7.5 ARDS Network Database 
7.5.1 Method 
The database was used to assess the use of VR in the ALI and ARDS patients. All 
patients ventilated for 3 days or more were included in the analysis. Limited 
information was released for each patient this included respiratory variables, aetiology 
of lung injury, and APACHE III score. The timings of each of the recordings in 
relation to the admission of the patient were unavailable. The main outcome for 
analysis was ICU mortality. Information for ventilator days was unavailable.  
 
In addition to calculating VR and PaO2 / FiO2 ratio, estimated VD / VT and VE 40 were 
also calculated at each time-point. VD/VTest was estimated using the following 
equations as described by Siddiki et al: 
 
   [34] 
 
where  is the arterial PCO2,  is the minute ventilation, and VT is the tidal 
volume. is the estimated CO2 production and is calculated using the modified 
Harris-Benedict equation(137): 
 
    [35] 
 
Where HBpred is the predicted resting energy expenditure (REE) and is gender 
specific. For females = 655.1 + (6.56 x WtKg ) + (1.85 x Htcm ) - (4.56 x age). For 
males = 66.45 + (13.75 x WtKg) + (5 x Htcm) - (6.76 x age). ‘hf’ is hypermetabolic 
factors defined as 1.13 per °C over 37°C, 1.2 for minor surgery, 1.35 for major 
trauma, and 1.6 for severe infection (138). However data was not available for these 
correction factors and were not applied to the calculations for VD/VT. Finally VE40 an 
index described by Jabour and colleagues which is conceptually similar to VR was 
calculated using the following equation: 
 
VD /VT =1!
(0.86" !VCO2est )
(PaCO2 " !VE )
#
$
%
%
&
'
(
(
PaCO2 !VE
!VCO2est
!VCO2est =
HBpred !hf !0.8
6.8644
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     [36] 
 
VE 40 has units of ml / kg / min and a value between 90-120 is considered in the 
normal range. 
 
7.5.1.1 Statistical Analysis 
Normally distributed continuous data are expressed as mean and standard deviation. 
Non-parametric data are expressed as median and interquartile range. Unpaired t-test 
was used for intergroup comparison of means and Mann-Whitney test was used to 
compare medians for non-parametric data. Univariate logistic regression analysis was 
used to calculate odds ratios for multiple respiratory variables to individually predict 
mortality at day 1 and day 3. To examine the relationship of hospital mortality and 
VR and adjusting for confounding variables multivariate logistic regression analysis 
was performed. Only variables that had a significant effect on mortality were included 
in the model.   
 
Stepwise multiple logistic regression analysis was performed to determine the 
prognostic value of the ventilatory ratio after adjustment for non-pulmonary outcome 
modifiers. Variables such as the APACHE III score, presence of shock, PaO2/FiO2 
ratio, and PEEP were added to the base model at day 1, day 2, and day 3 to assess the 
association of VR and mortality. Chi-squared test for trends was used to analyse the 
association of mortality and ordinal groups of VR. A modified Pearson’s correlation 
coefficient as described by Stratton and colleagues (135) was obtained to study the 
association between VR and estimated VD / VT. This method was used to correct any 
bias in Pearson’s correlation coefficient as a result mathematical coupling because 
 was used to calculate VR and VD / VT. A modified Pearson’s coefficient was 
derived to examine the relationship between VR and other variables.  
 
7.5.2 Results 
Complete physiological data and outcomes were available in 1636 mechanically 
ventilated patients. Overall 30.1% (n = 492) of the outcomes resulted in in-hospital 
mortality. A comparison of the respiratory parameters between survivors and non-
VE40 =
VE
bw !
PaCO2
40
PaCO2
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survivors is presented in Table 1. The mean value for VR was significantly higher in 
the mortality group (2.07 95% CI 2.00 – 2.15) when compared to the survivors (1.96 
95 % CI 1.92 – 2.00; p = 0.01).  
 
Univariate analysis it was showed that an increase in VR was associated with 
increased mortality at day 1 (OR 1.18 95% CI 1.04 – 1.35), day 2 (OR 1.33 95% CI 
1.16 – 1.53) and day 3 (OR 1.39 95% CI 1.22 - 1.60). At day 2 and day 3 VR 
independently predicted mortality after adjusting for APACHE III score and shock. 
Addition of PaO2/FiO2 ratio, VT, and PEEP separately to the base regression model 
showed that VR had significant effect on mortality on day 2 and day 3. This effect 
was not observed either at day 1 with the above variables or with oxygenation index 
on any of the days (Table 2). Six respiratory variables were identified on univariate 
analyses that were associated with increased mortality. After adjusting for these 
variables in a multivariate logistic regression model VR remained independently 
associated with increased in-hospital mortality (Table 3).  
 
Figure 1 shows the hospital mortality rate in quintile ordinal groups of VR at day 1 
and day 3. Groups with higher VR appear to be significantly associated with 
increased mortality (Chi-square test for trends; Day 1 p = 0.05; Day 3 p < 
0.01)(Figure 1). This effect was more pronounced on day 2 and day 3. An increase in 
VR between day 1 to day 3 was seen in greater proportion of patients that died 
(survivors 27.1 % vs non-survivors 35.6%, p < 0.01). The positive predictive value 
for in-hospital mortality for those patients in whom there was an increase in VR 
between day 1 and day 3 was 57.6% (n = 238). ROC curves for VR, VE40, and 
estimated VD / VT showed similar results for all three variables (AUC: VR 0.58, 
VE40 0.53, VD / VT 0.61). There was weak negative correlation between VR and 
PaO2 / FiO2 (r = - 0.32, p < 0.01). 
 
The clinical value of estimated VD/VT in this population has been presented elsewhere 
(139). There was strong correlation between VD/VT and VR on day 1 (modified r = 
0.80, p < 0.01) (Figure 7.14) and day 3 (modified r = 0.81, p < 0.01).  There was weak 
negative correlation between VR and PaO2 / FiO2 (r = - 0.32, p < 0.01).  
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Figure 7.15 shows VR plotted against PaO2 / FiO2 ratio. The vertical dotted line splits 
the population into ALI and ARDS. The ARDS population was then split into groups 
according to those with a VR of less than 2 (n = 470) and those with a VR greater or 
equal to 2 (n = 500). Chi-squared test showed mortality was significantly higher in the 
group with VR ≥	 2 (39.4% vs 28.7%; relative risk ratio 1.37, 95% CI 1.15- 1.64).	  
 
 Survivors (1144) Non-Survivors (492) P value 
PaCO2 (kPa) 5.57 ± 1.6 5.39 ± 1.6 < 0.05* 
Tidal Volume (ml) 454.6 ± 161.2 484.6 ± 177.4 < 0.05* 
PaO2 / FiO2 Ratio (kPa) 21.7 ± 9.7 19.9 ± 8.6 < 0.05* 
Ventilatory Ratio 1.96 ± 0.7 2.07 ± 0.9 < 0.05* 
Oxygenation Index  16.27 ± 9.5 18.58 ± 10.8 < 0.05* 
Ppeak (cmH2O) 33 (27.5 – 38.5) 35 (28.5 – 41.5) < 0.05§ 
Pplat (cmH2O) 26 (22 – 30) 28 (23 -33) < 0.05§ 
PEEP (cmH2O) 10 (7 – 13) 10 (7 – 13) 0.07§ 
Table 7.16 Comparison of respiratory variables between survivors and non-survivors at day 1. * 
Denotes unpaired t-test, § Denotes Mann-Whitney test. Ppeak = Peak pressure, Pplat = Plateau 
pressure, PEEP = Peak end expiratory pressure. 
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Day 1 Odds Ratio 95% CI n 
Per unit change 
Univariate 
Ventilatory Ratio  1.18 1.04 - 1.35 1636 
Multivariate 
Base model (shock +APACHE III score) 1.10 0.96 - 1.27 1596 
Base model + PaO2/FiO2 ratio 1.03 0.89 - 1.20 1590 
Base model + PEEP 1.15 1.00 - 1.33 1636 
    
Day 2    
Univariate    
Ventilatory Ratio 1.33 1.16 - 1.53 1417 
    
Multivariate    
Base model (shock +APACHE III score) 1.23 1.07 - 1.42 1384 
Base model + PaO2/FiO2 ratio 1.20 1.03 - 1.38 1411 
Base model + PEEP 1.20 1.03 - 1.40 1409 
    
Day 3    
Univariate 
Ventilatory Ratio 1.39 1.22 - 1.60 1309 
Multivariate 
Base model (shock +APACHE III score) 1.30 1.13 - 1.51 1269 
Base model + PaO2/FiO2 ratio 1.27 1.10 - 1.47 1308 
Base model + PEEP 1.21 1.04 - 1.41 1306 
Table 7.17 The predictive value of Ventilatory Ratio at day 1 and day 3 with hospital mortality as the 
dependent variable. OI = Oxygenation Index, PEEP = Peak end expiratory pressure, VT = Tidal 
volume. 
 
 Day 1 Day 3 
 Odds Ratio (95% CI) P Value Odds Ratio (95% CI)  P Value 
Oxygenation Index 1.02 (1.00 – 1.03) 0.01 1.04 (1.01 – 1.07) 0.01 
PaCO2 (KPa) 0.81 (0.72 – 0.90) < 0.01 0.75 (0.67 – 0.85) < 0.01 
Tidal Volume (ml) 1.00 (1.00 – 1.00) 0.05 1.00 (0.99 – 1.00) 0.95 
Ventilatory Ratio 1.43 (1.14 – 1.80) < 0.01 1.48 (1.17 – 1.88) < 0.01 
Ppeak (cmH2O) 0.99 (0.98 – 1.01) 0.71 0.98 (0.96 – 1.01) 0.19 
Pplat (cmH2O) 1.02 (0.99 – 1.04) 0.19 1.04 (1.01 – 1.07) < 0.01 
Table 7.18 Multivariate logistic regression model of respiratory variables with in-hospital mortality as 
the dependent variable. OI was used in preference to PaO2 / FiO2 ratio because univariate analysis 
showed OI had a greater association with mortality.   Ppeak = Peak pressure, Pplat = Plateau pressure, 
PEEP = Peak end expiratory pressure. 
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Figure 7.13 Trends in mortality in ordinal quintile groups of VR on day 2 and day 3. Day 2 Q1: < 1.46, 
Q2: ≥ 1.46 - < 1.76, Q3: ≥ 1.76 - < 2.06, Q4: ≥ 2.06 - < 2.56, Q5 ≥ 2.56 (Chi-Squared test for trends, p 
= 0.01). Day 3 Q1: < 1.46, Q2: ≥ 1.46 - < 1.77, Q3: ≥ 1.77 - < 2.06, Q4: ≥ 2.06 - < 2.57, Q5 ≥ 2.57 
(Chi-Squared test for trends, p < 0.01). 
 
 
Figure 7.14 Ventilatory Ratio plotted against estimated VD / VT on day 1 (Modified Pearson’s 
correlation r = 0.8). 
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Figure 7.15 Ventilatory Ratio plotted against PaO2 / FiO2 Ratio at Day 3. The vertical dotted line is at 
the cut-off point on the x-axis that defines ARDS. The horizontal line intercepts the y-axis at VR of 
2.06 (60th Percentile). Area A describes patients with ALI and VR ≤ 2.2; the mortality for this group 
was 24.3% (n = 275). Area B describes patients with ALI and VR > 2.2; the mortality for this group 
was 19.6% (n = 51). Area C describes patients with ARDS and VR ≤ 2.2; the mortality for this group 
was 29.7% (n = 582). Area D describes patients with ARDS and VR > 2.2; the mortality for this group 
was 29.7% (n = 400). 
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7.6 Discussion 
 
The objectives set out at the start of this chapter were to explore the clinical uses of 
VR. All four databases showed that higher values of VR were associated with 
increased risk of mortality. Non-survivors had significantly higher VR compared to 
survivors in all 4 databases. Values in ICU patients were also higher than in those 
patients undergoing elective surgery. A rising value in VR was shown to be 
associated with worse outcome. VR in all the databases examined showed weak 
negative correlation with PaO2/FiO2 ratio. This suggests that the information obtained 
from VR is unlikely to be extractable from PaO2/FiO2 ratio. VR also showed good 
correlation with estimated dead space a marker of ventilatory inefficiency derived 
from bedside variables. 
 
The results from the 2 locally derived databases will be discussed first followed by 
the ARDS databases. 
 
7.6.1 General ICU Population (RBH and CWH databases) 
 
Specifically in the general ICU databases VR was significantly higher in the study 
groups as compared to the control groups. Both databases showed VR was 
significantly higher at admission for non-survivors than survivors. A VR of greater 
than 1.4 was associated with increased risk of prolonged ventilation in both 
populations. VR was an independent predictor of mortality in both populations of 
patients. Both adjusted and unadjusted odds ratio were higher with rising values of 
VR in univariate and multivariate logistic models. In the RBH database a rising value 
of VR over time was statistically more likely to found in patients that died and was 
associated with prolonged ventilation. In analysis of all readings in the RBH database 
VR was significantly higher during mandatory modes of ventilation compared to 
spontaneous modes. There was weak correlation between VR and other respiratory 
variables. 
 
Figures 7.1 and 7.6 show the frequency distribution of VR at admission in the 2 
general ICU populations. The figures show that VR is normally distributed. Figure 
7.1A shows results of all readings in database and the data is normally distributed 
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although the peak of the distribution is centered more to the right with a higher 
population peak for VR compared to Figure 7.1B which is data from admission only. 
These findings can probably be explained by the fact that more readings in 
spontaneous modes of ventilation when all the readings are considered, this is likely 
to results in higher VR in the population. At admission more of the readings are likely 
to be whilst the patients are in mandatory modes of ventilation resulting in a more 
positive skew in the distribution of values. 
 
Comparison of data between the study groups and those patients undergoing elective 
surgery show that VR as anticipated is higher in ICU patients admitted as emergency. 
This suggests that emergency admissions to ICU in itself carries a cost of efficiency 
of ventilation. There may be several causes that result in this inefficiency. Often 
patients presenting to ICU are subject to multiple organ dysfunction leading to subtle 
changes in ventilation-perfusion mismatch, features of sepsis may also increase 
carbon dioxide production in patients, and mechanical ventilation in itself can also 
lead to increased dead space- both anatomical and physiological. Interesting to note 
are the findings that mean values of VR for patients in theatre and in cardiac ICU was 
almost 1. From physiological analysis and the modeling work it was anticipated that 
normal values would be lower than 1. The value of 1 is based on a normograms for 
ideal minute ventilation (82, 103). The assumed ideal PaCO2 of 5 may be also too 
high for a minute ventilation of 100 ml min-1. Therefore a value of 1 may not 
necessarily represent the genuine mean of a normogram for !VE !PaCO2 . The figures 
chosen as the ideal values whilst may be arbitrary, the associated increase in 
anatomical dead and positive pressure ventilation leads to a VR closer to 1 rather than 
a lower value. Although this must be tempered with the caveat that the ‘control’ group 
in this case was small in numbers. From the findings from the analyses however, a 
value of 1 is likely to represent lungs that are able to meet the ventilatory demands of 
the body. This value seems an adequate representation of what may be considered 
“normal” in the critical care setting. 
 
In both databases VR was found to be higher in patients that died. In addition logistic 
regression analysis showed VR was an independent predictor of mortality. This 
implies that as a physiological surrogate it has linkage with clinical disease severity. 
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There are several variables in the armamentarium of ICU physicians that are able to 
predict mortality. There are several features of VR that make it a potentially attractive 
tool for physicians in addition to markers already available. VR is simple to calculate 
at the bedside. To most physicians a composite function of two variables moving in 
opposite direction that tracks efficiency of CO2 clearance would be intuitively 
valuable. Table 7.8 and Figures 7.4, 7.12 and Figure 7.15 show that there was weak 
correlation between VR and other commonly measured respiratory variables, 
particularly PaO2 / FiO2 ratio. Hence it may be assumed that the information 
concerning the pathophysiological processes represented by changes in VR are 
currently not easily available to physicians using bedside measurements. 
 
The inadequacies of PaO2 / FiO2 ratio are well documented. Not only is its value at 
admission as a predictor of outcome uncertain, there are also uncertainties 
surrounding its ability to categorize severity of disease particularly in ALI / ARDS 
(140, 141). Studies also suggest that the level of PEEP and FiO2 may manipulate 
PaO2 / FiO2 ratio (142, 143). In contrast VR appears more robust as a marker of 
pathological state. There are fewer variables that can be externally manipulated to 
alter the value of VR. Specifically tidal volume and its ratio with frequency of 
delivered breaths can be altered to change VR. A decrease in tidal volume is likely to 
increase the VD/VT anat deadspace ratio and thereby lead to a rise in VR after a certain 
threshold point. The point at which this would lead to a rise in VR would depend on 
the underlying state of the lungs and the level of CO2 production.  
 
Analysis of the RBH database over time shows that in mandatory modes of 
ventilation an increase in VR from day 1 without a corresponding subsequent 
decrease, i.e. a positive gradient, was seen more frequently in patients that died. This 
suggests that there is an association between rising values of VR and mortality. There 
were similar findings in the ARDSnet database that will be discussed later in the 
chapter. Included in the analysis for rising VR were patient with a high VR on 
admission (> 2), it is highly probable that a lack of improvement in these patients 
would also be associated with increased mortality. The findings of this study suggest 
that trends in VR can be used as a tool monitor disease progression. 
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One of the potential problems of using VR is that it appears higher in those patients 
ventilating spontaneously, event though it is perceived that it is more efficient to 
breath spontaneously. There may be several factors that account for this. Patients 
breathing spontaneously are likely to be more lightly sedated. There is also the 
likelihood that in conventional forms of ventilation a spontaneously ventilating 
patient is more likely to represent an individual that is improving. Logic would dictate 
that efficiency of ventilation should improve. As examined in one of the previous 
chapters this may not be the case. Spontaneously ventilating patients may have an 
increase in their dead space ventilation particularly if their tidal breaths are small. 
Additionally in some patients there may be increased work of breathing resulting in 
increased CO2 production. In those patients unable to increase their minute ventilation 
adequately both these factors will lead to an increase in VR. The delta values of VR at 
the transition point from mandatory to spontaneous modes of ventilation could 
potential be used to assess the ability of the lungs to cope with the body’s ventilatory 
demands. Data from the RBH database show that there were increased ventilator days 
in those patients in whom there was an increase in VR of greater than 30% were 
ventilated longer from the point of transition. This suggests that there may be an 
association between big increases in VR when transitioning from mandatory to 
spontaneous modes of ventilation. Another potential cause for increased VR in 
spontaneous ventilation is the fact that VR is that the recorded tidal volume / minute 
ventilation is more likely to vary breath to breath. Unless the patient is in a steady 
restful state the recorded may be idiosyncratic. The findings from these studies 
suggest that unless patients are in a sedated or steady state the absolute values of VR 
during spontaneous ventilation should not be relied on. Further studies are required to 
assess the validity of VR in spontaneous ventilation under more controlled conditions 
where the data is collected prospectively.  
 
7.6.2 ANZICS Database 
Examination of VR in this ALI / ARDS population demonstrates that VR was 
significantly higher in non-survivors as compared to survivors. Higher values of VR 
are associated with increased mortality. Logistic regression analysis showed VR was 
an independent predictor of mortality after adjusting for other variables. VR was also 
significantly higher in patients with ARDS as compared to patients with ALI. There 
was weak negative correlation between VR and PaO2/FiO2 ratio.  
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The results appear to indicate that the ratio has prognostic significance with higher 
values associated with poorer outcome. The ratio did not differentiate between 
intrinsic and extrinsic aetiology of the lung injury. VR is higher in non-survivors than 
in survivors. VR was also significantly higher in groups with higher Murray lung 
injury scores. These results suggest a relationship between severity of lung injury and 
VR. Figure 7.10 shows that higher ordinal groups of VR were associated with an 
increased risk in mortality. These findings are in keeping with the findings of other 
studies that have looked at ventilatory efficiency as a prognostic marker (30, 72).  
 
In the context of this study being on previously collected data, ROC curve analysis of 
the data allows inferences to be made regarding the clinical parameters of VR. A 
value of less than one is associated with much better outcomes and conversely a value 
of greater than 2 had a greater association with death. The results of this study suggest 
a direct relationship between VR and outcome.  
 
Patients with ARDS had higher VR than those with ALI. VR appears to increase as 
oxygenation decreases or as lung injury worsens. Though when the relationship 
between PaO2/FiO2 ratio and VR was examined the correlation was poor (Figure 
7.12). This is as expected. The value of VR as a clinical tool can be interpreted from 
this evaluation. A tight correlation between oxygenation and ventilatory efficiency 
would suggest the physiology of oxygenation and of CO2 clearance are the same and 
that is clearly not the case. Therefore when looking at this database VR not only 
performs as might be expected it also provides clinicians with additional information 
about the state of the lung that cannot be extracted from indices of oxygenation. 
 
ARDS clinically is defined by the PaO2/FiO2 ratio as the only measured respiratory 
variable (144). The adequacy of the current definition of ARDS has hence been 
questioned (145). Figure 7.12 shows the there is a bigger spread in VR in the ARDS 
group of patients in comparison to ALI group. Coupled with an increased association 
of death with higher values, perhaps VR could assist in better categorization of 
patients with ALI/ARDS. 
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7.6.3 ARDS Network Database 
This large retrospective secondary observational study of mechanically ventilated 
patients with ALI / ARDS shows that higher ventilatory ratio is independently 
associated with mortality. Both higher values of VR and a rising value of VR were 
associated with increased mortality. VR was also shown to have strong positive 
correlation with estimated dead space fraction. VR correlated poorly with PaO2 / FiO2 
ratio. When ALI / ARDS patients are categorised according to ordinal groups of VR 
there appears to be an association with better prognostic categorization of these 
patients.  
 
The database has several shortcomings. Following personal communication with Prof 
B Taylor Thompson (ARDS Network, Mass General Hospital) these problems were 
highlighted. Enrollment into the database mandated a single daily arterial blood gas 
sample. This sample however was not necessarily taken at the same time as the 
respiratory and ventilatory data recorded. Whilst many of the data were collected at 
the same time, it is conceivable that the ABG sample may have been collected 12 
hours after the respiratory variables. The study has been useful to demonstrate that 
even in a database where the quality of data is variable there continues to be a signal 
for VR and outcome. 
 
The results of the study clearly indicate an independent association of VR and 
outcome. Incremental increases per unit change in the regression model results in an 
18% increase in mortality on day 1. The findings were more convincing day 2 and 
day 3 where similar increases resulted in an increase in mortality by 33% and 39% 
respectively. The findings of day 3 were similar to those found by Nuckton and 
colleagues using VD / VT as a predictor of mortality (72). Figure 7.17 shows that 
ordinal groups of VR similarly resulted in an increase in mortality on day 2 and day 3 
in groups with higher VR demonstrating an association between mortality and VR.  
 
The suggested association of VR and ventilatory efficiency may allow early initiation 
of alternative methods of lung support such as high frequency oscillation or 
extracorporeal support. It may also offer a simple tool to monitor the sustained 
efficacy of recruitment manoeuvers. Although conjectural, VR may be a means of 
determining whether various interventions have an impact on ventilatory efficiency 
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and hence lung function. From the analysis it can also be observed that a rising value 
of VR is associated with an increase in mortality. An increase in VR between day 1 
and day 3 had a positive predictive value for mortality approaching 58%. Hence 
monitoring VR may be a useful method of monitoring disease progression in ARDS. 
 
Figure 7.14 shows the relationship of VR and PaO2 / FiO2 ratio. Similar to previous 
studies the correlation between these two variables was poor. The dotted lines on the 
graph divide the ventilated population into 4 groups. Of particular interest the ARDS 
group is divided into 2 groups with significantly different outcomes. Hence it is 
suggested that VR may potentially be a useful variable in sub-categorizing ARDS 
patients. The 2 groups would in all probability describe very different populations in 
terms of pathological processes. It has been previously suggested that dead space 
fraction may be used to re-define this population (146). Within the limitations of this 
retrospective study VR provides a more simplistic method of categorizing ARDS 
patients according to severity of ventilatory impairment without relying on 
sophisticated monitoring. 
 
Since VR was first described, other methods to measure dead space using variables 
recorded at the bedside have been proposed clearly demonstrating an increased 
awareness for a need to monitor ventilatory efficiency. These methods describe 
equations to estimate VD / VT phys using linear regression modeled from recorded dead 
space data (54) or the alveolar gas equation (estimating using the Harris-
Benedict equation) (139). Whilst these methods are useful, the additional 
complexities associated with the described methodologies for extrapolation of a 
quantified value for deadspace would render them less accessible as a quick reference 
tool. Although in comparison VR may be crude as a tracker of deadspace fraction, it 
is easy to calculate and appears to be useful as a clinical tool for assessing disease 
severity and predicting mortality. Perhaps a more intuitive way to view VR would be 
as a marker of an individuals ventilatory demands.  
 
In comparisons to other methods to estimate ventilatory efficiency using bedside 
variables, such as ‘VE40’ and estimated VD / VT, VR performs similarly when 
analyzing ROC curves with mortality as the outcome. The advantages VR affords is 
!VCO2
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that it has easy to calculate in comparison to estimated VD / VT and in comparison to 
VE40 VR has been derived from sound physiological principals. VR is unit-less and 
both physiologically and clinically intuitive (147). In many respects recategorising 
ARDS using VR is akin to categorizing respiratory failure as type I and type II. 
 
There are other several limitations to this study. The study was a retrospective 
analysis of prospectively collected data that was collected for various different. Any 
findings from the analyses of these studies can only be considered as loose 
associations. These factors could explain the weaker association between mortality 
and VR in this study. The result of logistic regression on day 1 is further testament to 
these observations. It is possible that the recordings on day 1 were from the very first 
reading at a point when the patient was not in steady state and the minute volume or 
PaCO2 may not be indicative of the state of the patient’s lung but rather of the 
conditions surrounding intubation or the patients pre-intubation state. This would lead 
to higher values of VR in comparison to those calculated in steady state. In addition 
there was evidence of results in the database that can only be attributed as artifact. 
Values of VR > 5 were frequently encountered in the database. These values were 
seldom encountered in any of the other database. Not only that several of these 
patients went on to survive. In the other databases almost of patients with a VR > 5 
died. Moreover some of the patients in the ARDSnet database with VR > 5 were 
liberated form the ventilator within 24 hours. 
 
7.7 Summary 
Despite these major limitations of retrospective study design there appears to be 
compelling clinical evidence that VR may be a monitoring method that provides 
additional and clinically intuitive information that has previously not been available 
with such ease at the bedside. High values of VR and increasing values of VR 
associated with poorer outcomes. This has been demonstrated in four separate and 
discreet populations. 
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Chapter 8: Discussion 
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8.1 Summary of Chapters 
In Chapter 1 we examined deadspace measurements and its uses in mechanical 
ventilation. We also explored some of the reasons why deadspace is seldom measured 
in ICU despite being a key physiological component of the efficacy of ventilation and 
having known associations with outcome for example in ARDS. Neither the Douglas 
Bag method nor volumetric capnography are widely used in ICUs although there is 
growing interest in the latter as well as interest in techniques such as impedance 
tomography to visualize efficacy of ventilation distribution.  
 
The standard approach to looking at lung disease in ICU tends to focus on the 
PaO2/FiO2,ratio, which has been and is widely used in clinical practice. It is the basis 
of categorizing disease severity in ARDS. The PaO2/FiO2 ratio is a simple composite 
of two variables that are often moving in opposite directions. Ventilation and its 
impairment are frequently observed but rarely measured formally. One of the main 
reasons for this is that there are no easy indices available to monitor ventilatory 
failure at the bedside. Clearly a rise in arterial PCO2 is a measure of ventilatory failure 
but as Nunn described so is a rise in minute ventilation. The complexity in 
mechanically ventilated patients is that minute ventilation often moves in the opposite 
direction to arterial PCO2. A lack of an index that amalgamates the two variables has 
perhaps meant that this crucial portion of the breathing process is largely ignored. 
Keeping these principles in mind we thought that a composite of these two variables 
could be a marker of ventilatory efficiency and would be a clinically useful marker. 
Two hypotheses were generated; these were tested in the subsequent chapters. 
 
The hypotheses were: 
Null 1: An index that is a composite of arterial PCO2 and minute ventilation 
will not be responsive to changes in ventilatory efficiency.  
 
Null 2: Higher values and increasing values of such an index will not be 
associated with worsening disease severity in mechanically ventilated patients. 
 
Using principles of the alveolar gas equation we have derived a simple bedside index 
that monitors efficiency of CO2 clearance. In Chapter 2 Ventilatory Ratio was 
defined.  
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Proof of the derivation VR dictates that VR would be influenced by deadspace and 
CO2 production. In Chapter 4 the physiological analysis of VR was validated in a 
benchside lung model and in a hi-fidelity in silico model. It was shown that VR 
increases as deadspace and CO2 production increase. In Chapter 5 we examined the 
influence of rising on VR. VR was measured in patients undergoing 
laparoscopic surgery, pre and post pneumoperitoneum. This model allowed us to 
study the effects of rising CO2 from an exogenous source. The variability of measured 
 was also shown in a group of ICU patients. In general, the variability of  
during the course do admission was small. The median variability across the 
population in hourly readings from baseline (described as 1st reading) was 3% (IQR -6 
to 12%).  variability was greater during spontaneous ventilation. In Chapter 6 
we saw that VR showed strong positive correlation with deadspace ventilation and the 
correlation was stronger during mandatory ventilation. VR showed reasonable ability 
to predict groups of deadspace according to levels of severity. In a high percentage of 
cases a changing value of VR was as a result of change in deadspace.  
 
In Chapter 7 the clinical uses of VR were examined in 4 databases, in a total of 2468 
patients. Two databases were of general ICU patients and 2 were of ARDS patients. 
VR was consistently higher in non-survivors compared to survivors. Higher VR was 
also consistently associated with mortality. In the databases where it was possible to 
assess VR over time an increase in VR was associated with increased mortality or 
increased ventilator days. 
 
8.2 Ventilatory Ratio as a Physiological Entity 
As a physiological entity VR is intuitive.  Viewed simply as a product of the values 
from which it is derived, VR is a composite of two variables that are inversely related. 
At first glance this consolidates the two most crucial measured ventilatory variables. 
Another possible interpretation of VR is that it is a marker of how the ventilatory 
setting with the underlying lung pathology is coping with ventilatory demands of the 
body.  
 
!VCO2
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Alternatively VR we know is influenced by deadspace and CO2 production. It is 
anticipated that deadspace fraction is much more likely to change in critically unwell 
patients particularly in patients that are in steady state. Equally in steady state a rising 
value of VR is also likely to represent changes in deadspace. It must be reiterated that 
VR is not an index of deadspace. In the proof of its physiological derivation VR 
solves for VD/VT but this is a conceptual construct that encompasses all forms of 
 abnormality termed physiological dead space and is not true dead space per se.   
VR may be viewed as a crude surrogate for deadspace. Clinicians encountering high 
VR in sedated patients must view this as an inability of the lungs to adequately clear 
CO2. This in most instances would be as a result of increased deadspace either as a 
manifestation of the ventilatory strategies or lung pathology. Alternatively it may be a 
result of abnormally high carbon dioxide production, which is actually a rare 
occurrence in critically unwell patients and should be easily clinically discernible (e.g. 
agitation, tachycardia, and hyperthermia). 
 
Caution must be exercised when interpreting deadspace. Current methods of 
measuring deadspace are not gold standards. In particular in severely diseased lungs 
deadspace measurements are difficult to interpret. This is partly to do with the current 
interpretation of deadspace, i.e. using the Enghoff modification of Bohr equation and 
partly as a result of the measurement systems. A high deadspace fraction informs us 
that there is a  problem, but the absolute value is relatively meaningless as it is 
difficult to interpret the exact contribution of high deadspace and shunt. 
Longitudinally over time a changing value in deadspace can be reliably interpreted as 
an improvement or deterioration in ventilatory efficiency. VR offers clinicians similar 
information. A high value of VR signifies an issue with ventilatory efficiency. 
Likewise longitudinally over time changes in VR are likely to represent changing 
ventilatory efficiency given that variation in was generally low in the studied 
population. The added advantage being that VR is much simpler to calculate.  
 
8.3  Ventilatory Ratio as a Clinical Tool 
Analysis of the databases clearly demonstrates the value of VR both in the general 
ICU population and in patients with ARDS. Higher VR is associated with increased 
mortality and ventilator days. Rising values of VR were also associated with 
!V !Q
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increased mortality and prolonged ventilation. Once again this would be expected. It 
stands to reason that patients with failure of oxygenation and ventilation (Type II 
respiratory failure) respiratory would lead to a worse outcome than failure of 
oxygenation only (Type I respiratory failure). Compared to other respiratory variables 
VR was most strongly associated with mortality in all the databases. In all the 
databases apart from the ARDS Network database VR remained an independent 
predictor of mortality after adjusting for APACHE II score. As a physiological 
scoring system nature of the APACHE II score is comprehensive and covers most 
aspects. Given that VR remains an independent predictor of outcome after adjusting 
for APACHE II score suggests that it identifies an area of pathophysiological 
dysfunction that is not currently engaged by the APACHE scoring system. The 
addition VR appears to add prognostic value to the APACHE II. Given its poor 
correlation with the commonly used respiratory variables, the clinical information 
clinicians can derive from VR is readily extrapolated from available  information. 
This combination of simplicity, association with mortality, and distinct clinical 
information makes VR an attractive clinical tool.  
 
8.4  Ventilatory Ratio as a Tool to Classify ARDS 
Currently, PaO2/FiO2 ratio is the only measure variable that is used to classify ARDS. 
This is despite the fact that PaO2/FiO2 ratio is widely believed to be a poor predictor 
of outcome (140, 148) and easily influenced by other variables(141-143). Recently, 
the Berlin classification of ARDS has been proposed (149). The authors of the paper 
should be commended on reclassifying the syndrome which was previously vague. 
Acute lung injury (ALI) as a condition was ambiguous and its definition arbitrary. 
Acute lung injury by its name suggests a pathophysiological process, however, as a 
clinical phenomenon it was nothing more than a milder form of ARDS.  
 
Whilst the abandoning of ALI as a spectrum of the syndrome was welcome, the new 
classification goes some way short of separating the population according to 
underlying pathological processes. The current classification separates ARDS into 
mild, moderate, and severe according to their PaO2/FiO2 ratio with the introduction of 
PEEP as a very crude discriminator. The investigators of the study found that this was 
the only variable that could divide the studied into clinically meaningful data. There 
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was increased mortality associated with the increased severity of the PaO2/FiO2 
abnormality. 
 
In the database examined in the study, the majority of which was the ARDS Network, 
the authors examined the utility of the corrected minute ventilation ( ).  
is defined as the measured minute ventilation multiplied by the measured arterial 
PCO2 divided by 40 mmHg. This was used a surrogate for deadspace. The authors 
used a  of 10L as their cut-off to test for association with mortality. They failed 
to find a significant association with mortality. There are several reasons to explain 
these findings. Factors inherent to the calculation of  lend it to be a less 
powerful tool than VR.  does not adjust for predicted minute ventilation. 
Calculations of  are independent of the patient’s weight.  The analysis of 
association of with mortality was adjusted for weight in the Berlin 
classification study and despite this they found no significant association. VR 
accounts for the patient’s weight for its calculations. Accounting for individual weight 
when assessing ventilatory inefficiency is much more likely to have meaningful yield 
than retrospective adjustments. The findings of the thesis suggest that had VR been 
used to split the ARDS population (as seen in Figure 7.15), the results may have been 
clinically significant in terms of outcome.  
 
The majority of the patients in the database used to analyse the association of the 
variables with mortality were from the ARDS Network database. As previously 
discussed the collection of data for minute ventilation and the arterial blood gases 
were not synchronous.  values calculated are therefore unlikely to be clinically 
relevant. 
 
Finally, it is unsurprising that the variable for recruitment of patients into a database is 
the one that splits the population into clinically meaningful groups. Invariably, given 
its nature of the Berlin classification is only marginally better than the previous 
classification. Some of the inadequacies of the previous classification remain. These 
include the problems of using PaO2/FiO2 as the sole measured variable. The division 
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of ARDS into groups according to oxygenation may be clinically relevant but adds 
little new information about pathophysiology. It gives us little or no insight into the 
underlying abnormalities, be it at a physical or cellular level. ARDS is not a disease 
but a syndrome. If a syndrome containing several different aetiological entities is 
classified according to two distinct variables it is much more likely that we can 
phenotype ARDS according to cause in large epidemiological studies. Current 
classification does not change the heterogeneous nature of the ARDS population, 
thereby making it difficult to implement treatment strategies studied in these 
populations to individuals. The ability for VR to define ARDS according to patients 
with respiratory failure and ventilatory failure needs further exploration.  In an age 
where novel strategies to support CO2 elimination are clinically viable, these 
questions take on additional importance.  
 
8.5  Limitations of Ventilatory Ratio 
As documented in previous chapters there are several limitations to VR. Ventilatory 
ratio is a crude measure of deadspace. If solely viewed as a measure of deadspace it 
offers many opportunities for misinterpretation. If however it is viewed as a tool to 
assess the ability of the lungs to cope with the ventilatory demands of the body, VR 
becomes easier to interpret. Like most measurements of physiological system VR is 
influenced by several factors. Clinicians interpreting VR must be aware of these. VR 
is specific for an individual and over-time it can used to assess changes in either 
deadspace or CO2 production, although as seen from previous results the latter is 
uncommon in the critical care setting. 
 
The effect of CO2 production can lead to misinterpretation of the value of VR as a 
surrogate of deadspace. A person with the same deadspace fraction can have a range 
of VR depending on the rate of CO2 production. This is specifically true for patients 
that are not breathing in steady state. The additional variability of CO2 production 
during spontaneous ventilation whilst the patients are being weaned means that results 
during spontaneous ventilation is difficult to assess. 
 
Shunt fraction will also affect VR. Using PaCO2 as a surrogate for shunt means that 
the contribution of venous admixture to overall arterial PCO2 will lead to an increase 
in VR as a result of shunt.  
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Accurate calculation of VR is dependent on accurate measurement of minute 
ventilation. This becomes an issue in patients that have large breath-to-breath 
variation in their tidal volumes or in those patients in whom the respiratory rate is 
subject to big variations. Patients in weaning modes of ventilation and those with 
frequent added spontaneous breaths in mandatory modes of ventilation are more 
likely to be subjected to these conditions. The interpretation in this group of patients 
would be uncertain.  
 
8.6  Limitations of the Thesis 
There are several limitations to the thesis. The limitations to each of the individual 
studies have been discussed in the relevant chapters. This section discusses overall 
shortcomings in the thesis: 
 
• The exact role of CO2 production and its influence on VR in sedated patients 
that were spontaneously ventilating was not closely examined. Spontaneously 
ventilating ICU patients recruited to validation study (Study 6) were patients 
spontaneously ventilating with a view to liberation from the ventilator. It is 
anticipated that these patients would have higher  because they are 
generally without sedative agents. Increasingly patients are spontaneously 
ventilating even in the context of severe respiratory failure. This population 
sub-group were not specifically studied. 
 
• Factors dictating  at ICU admission were not studied either. This would 
be a complex investigation and was beyond the scope of the studies. Several 
factors would dictate the level of CO2 production. The patients weight would 
be anticipated to be a factor. Conventionally, 3 ml Kg-1 min-1 is considered to 
be the average  in adults. In addition, the patients underlying pathology 
may also dictate the amount of CO2 production. Severe sepsis illustrates the 
complexity measuring !VCO2  in the ICU population. We know that in acute 
severe sepsis when the patient is in hyperdynamic cardiovascular state the 
resting energy expenditure is high. Alternatively at other times acute sepsis 
may results in lower energy expenditure. This may be as a result of 
!VCO2
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mitochondrial dysfunction. As patients recover from sepsis their energy 
expenditure and !VCO2 increases. As discussed in previous chapters the level 
of sedation would also influence !VCO2 . Whilst it is difficult to predict the 
absolute level of !VCO2 of an individual, the fact that VR uses predicted body 
weight as part of its calculation does mean that across the population there is a 
degree of standardization.  
 
• Three of four databases analysed and collected were retrospective and 
therefore direct causal relationship of rising values of VR and outcome cannot 
be established. There are biases that exist that as a result of the study and 
analysis designs. Using 4 different databases, 2 of which were not constructed 
by the author, addresses some of the issues with selection bias. The thesis 
lacks a large prospective study of patients with respiratory failure. This would 
be important in establishing the validity of the ratio as a clinical tool. Using 
the ANZICS database as a framework (SD 0.58), to detect a difference of 0.3 
in VR between survivors and non-survivors in ARDS patients with a power of 
0.8 and two-sided 0.05 significance level, 120 patients would need to be 
recruited to the study. 
 
• The study looking at the validation of the ratio in the ICU population suffers 
from some design weaknesses. In hindsight the recordings should have been 
made with greater attention being paid to the ventilatory modes and levels of 
sedation. The transition from mandatory to spontaneous ventilation and the 
changing ventilatory efficiency during this transition point needs further 
examination. There may be some useful clinical information to be extracted 
from this data in regards to the readiness or success of weaning. 
 
8.7 Future Investigations  
The thesis has allowed the exploration of VR as a physiological entity and its use in 
clinical practice. Whilst the studies may have answered some questions, several others 
have been generated and remain unanswered. The future line of investigations would 
look to answer these questions and address some of the shortcomings of the thesis. 
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• VR needs to be validated in an ICU population where the data has been 
collected prospectively. The advantage of collecting prospective data is that it 
eliminates some of the biases inherent to retrospective data analysis. 
Preferably the investigation would be a multicenter study. 
 
• The differences in ventilatory efficiency in different modes of ventilation need 
closer examination. In particular in those patients that are in steady state. 
Spontaneous modes of ventilation offer many advantages. The ability to 
instigate protective lung strategies being one. The alterations in ventilatory 
efficiency between these tools in unknown. The transition from mandatory to 
spontaneous also requires closer examination.  
 
• The relative contributions of dead space and carbon dioxide production 
towards the increased ventilatory demands in ARDS are controversial. A study 
looking at the relative contributions of each of these variables in ARDS would 
be interesting.  
 
• In theory we could use VR to assess changes in ventilatory efficiency 
following interventions. It would be interesting to observe changes in VR 
following recruitment maneouvers, draining of effusions, and prone 
positioning. VR could also be potentially used for assessing progress and 
changes in the endogenous ventilatory efficiency of lungs whilst patients are 
on extra-corporeal respiratory support. A falling VR in the context of constant 
extra-corporeal CO2 removal would signify improving lungs and vice versa. 
We have looked at the behaviour of VR in patients on extracorporeal CO2 
removal. The findings of these studies are not presented here. The results 
show that in patients that are improving VR usually decreases over-time whilst 
other variables are remains constant. Conversely, VR tends to remain constant 
in patients that fail to respond to therapy.  
 
• Computerized Tomography (CT) scans are increasingly being used to gauge 
the severity of ARDS. It would be interesting to evaluate CT scores of patients 
and look at correlation of scores with abnormalities in VR. A comparison with 
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other respiratory variables and the relative strength correlation would be 
interesting. The ability to tie physiological abnormalities with specific CT 
abnormalities could potentially allow finger-printing and matching ARDS 
abnormalities according to CT and observed physiological abnormalities. 
 
8.8 Achievements of the Thesis 
• A new index to monitor ventilatory efficiency using bedside parameters has 
been described. 
• The physiological analysis of the ratio has been validated in a benchside, hi-
fidelity simulation model, and ventilated patients with respiratory failure. 
• Deadspace measurements using volumetric capnography has been shown to 
agree well with the Douglas Bag method of measuring deadspace. 
• VR has been shown to be associated with clinically useful outcomes (mortality 
and / or ventilator days) in 4 databases. Changing values of VR over time was 
shown to be associated with outcome. 
 
8.9 Conclusions 
Ventilatory Ratio is an index that offers a simple solution to monitoring ventilatory 
efficiency at the bedside. Increased VR is associated with adverse outcome, be it 
mortality or ventilator days. VR offers information that is currently not easily 
available from bedside measurements or indices. Incorporating VR into general ICU 
practice could offer clinicians with clinically meaningful information and would 
allow us the opportunity to study ventilatory failure in large populations. A greater 
emphasis on monitoring CO2 clearance will lead to a better understanding of 
respiratory failure and its interaction with mechanical ventilation. VR may be at the 
forefront in the resurgence in our understanding of ventilatory failure. 
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